







TIME PACING IN CHONDROGENESIS MEDIATED 


















TIME PACING IN CHONDROGENESIS MEDIATED 




Graduate School of  
Natural Science & Technology 




     Major Subject: Life Sciences 




School registration No.: 1123032312 
Name:         NGUYEN QUYNH LE 
Chief advisor:        PROF. YUKIO YONEDA 
  
Acknowledgements 
Now that I’m reaching the end of my PhD, I start to be 
sentimental about the time I spent in the laboratory of Professor 
Yukio Yoneda. It was a great time – a good mixture between 
excellent but also tough moments. During my PhD, I had the 
opportunity to meet many different people. Some of them were 
teaching me while others nicely gave me help. All these memories 
would never have become real if my respectful academic 
supervisor, Prof. Yoneda, had not given me the chance to do my 
Ph.D in his lab. Hence I thank him for this special opportunity 
and for his kind support and generosity. He was always ready to 
help me whatever the problem was by his fruitful inspiration. I’m 
grateful for every precious thing I learned in his lab! 
I would like to express my gratitude to Mr. Hinoi as my 
academic advisor for his enthusiastic support and Mr. Takarada 
for his adorable direct instructions. Also, thankfulness from deep 
in my heart is dedicated to Ms. Araki and Ms. Azechi for their 
support and sincere. 
However, I would never have been able to finish this PhD 
without the friendship and the help of the other lab members from 
the very first day in the lab until now. I’d appreciate Mr. 
Fukumori for his helpful tutoring as well as experimental 
mentoring during the first two years, Ms. Nakamura, Mr. 
Fujikawa and Mr. Nakazato for their useful advice as well as 
collaboration. In addition, I’d like to thank Ms. Tsuruta, Ms. Hida 
and Ms. Kou for keeping on motivating me whenever it was 
necessary and everything they did for me. Again, my special 
  
thanks to all the laboratory members: Mr. Fujita, Mr. Iezaki, Mr. 
Hashizume, Ms. Tsuchikane, Ms. Takamori, … for their 
understanding and cooperation for almost the past three years. I 
will forever cherish all the cheerful moments we spent together 
along with all the ‘chit-chats’ since when we’ve learnt to know 
each other. 
Moreover, I’d like to express my deepest gratitude to my 
Homeland Vietnamese Government, Ministry of Education and 
Training, who sponsored me during three years to complete my 
course. I would like to dedicate my gratefulness to Kanazawa 
University for their supportive aids in organizing all those 
additional things that are needed to accomplish my PhD. I also 
sincerely acknowledge Hanoi University of Pharmacy and my 
dear colleagues in the Department of Microbiology and Biology 
for the stepstone and on-going facilitation to me in achieving my 
PhD. 
Most of all I thank my beloved parents, sisters and brother 
together with their children, who gave me much encouragement 
to reach the end of this thesis. 
Kanazawa, January, 2014 
 
 
Nguyen Quynh Le 
  
TABLE OF CONTENTS 
                                                                                                  Page 
ACKNOWLEDGEMENTS                                                                   
CHAPTER I              
GENERAL INTRODUCTION 
1.1.Circadian rhythms ............................................................................. 1 
1.1.1.Circadian oscillators ...................................................................... 1 
1.1.2.The mammalian circadian oscillator .............................................. 2 
1.1.2.1. The central oscillator – The SCN ........................................... 2 
1.1.2.2. SCN anatomical properties ................................................... 3 
1.1.3. Peripheral oscillators – a hierarchical organization ..................... 5 
1.1.4. Biological clock under molecular scope ...................................... 6 
1.1.4.1. The core loop – heart of the circadian oscillator ................. 7 
1.1.4.2. Circadian gene regulation – the interlocked loops .............. 8 
1.2. Cartilage and bone growth ............................................................. 12 
1.2.1. The Bone .................................................................................. 12 
1.2.2. The cartilage ............................................................................. 14 
1.2.3. Chondrogenesis regulation ....................................................... 15 
1.2.3.1. Chondrocytes – developmental units of cartilage ............... 15 
1.2.3.2. Chondrogenesis .................................................................. 17 
1.2.4. Chondrogenesis – in vitro studies ............................................. 19 
1.3. Clockwork integration into bone and cartilage development ....... 20 
1.4. Aims of the dissertation ................................................................. 23 
1.5. Abbreviations ................................................................................. 23 
  
1.6. Materials ........................................................................................ 27 
1.7. Data statistical analysis .................................................................. 28 
CHAPTER 2 
PTH INDUCES THE INCREASE IN PER1 EXPRESSION  
2.1. Introduction ...................................................................................... 29 
2.1.1. Parathyroid hormone pharmacological properties ....................... 29 
2.1.2. PTH effects on bone ..................................................................... 30 
2.1.3. Sox family and chondrogenesis .................................................... 31 
2.1.4. Runx family .................................................................................. 34 
2.2. Methods ............................................................................................ 35 
2.2.1. ATDC5 cell culture ....................................................................... 35 
2.2.2. PTH supplement .......................................................................... 35 
2.2.3. Quantitative Real-time PCR (qPCR) .............................................. 35 
2.3. Results ............................................................................................... 36 
2.4. Conclusions........................................................................................ 37 
CHAPTER 3 
THE UPREGULATION OF PER1 AFFECTS CHONDROCYTIC 
DIFFERENTIATION 
3.1. Clock gene Per1 overexpression ........................................................ 39 
3.2. Promoter activation of SOX9 target genes during chondrogenesis .. 39 
3.3. Gene delivery in mammalian cells .................................................... 40 
3.4. Methods ............................................................................................ 41 
3.4.1. Establishment of stable Per1 transfectants ................................ 41 
3.4.2. Reporter assay ........................................................................... 42 
3.4.3. Northern blot ............................................................................. 43 
  
3.4.4. qPCR and ATDC5 culture ............................................................ 43 
3.5. Results ............................................................................................... 43 
3.5.1. Per1 was transfected stably into ATDC5 cells ............................. 43 
3.5.2. Early chondrogenic genes in response to Per1 overexpression .. 44 
3.5.3. Col II transcription reduced in Per1 stable transfectants ............ 45 
3.6. Conclusions........................................................................................ 46 
CHAPTER 4 
CHONDROGENIC DIFFERENTIATION IN COORDINATION 
WITH PER1 REPRESSION 
4.1. Gene silencing by short-interference RNA ........................................ 48 
4.1.1. siRNA processing ........................................................................ 48 
4.1.2. Systematic nature of silencing ................................................... 50 
4.1.3. Gene Knock down by SiRNA delivery in vitro .............................. 51 
4.2. Methods ............................................................................................ 52 
4.2.1. Transfection ATDC5 cells with Per1-siRNA ................................. 52 
4.2.2. ATDC5 cell culture ...................................................................... 52 
4.2.3. qPCR .......................................................................................... 52 
4.2.4. Western blot .............................................................................. 52 
4.2.4.1.Cell lysate preparation ........................................................ 52 
4.2.4.2. Polyacrylamide gel electrophoresis (SDS-PAGE) ................. 52 
4.2.4.3. Protein blotting .................................................................. 53 
4.2.4.4. .Blocking – Incubation with antibodies – Detection ............ 53 
4.2.5. Reporter assay ........................................................................... 54 
4.3. Results ............................................................................................... 54 
4.3.1. Per1 was down regulated in siRNA transfected cells .................. 54 
4.3.2. Sox6 and Col II transcriptional activity was upgraded ................. 55 
  
4.4. Conclusions........................................................................................ 56 
CHAPTER 5 
CLOCK GENE EXPRESSION AFFECTS CHONDROGENESIS                                       
5.1. Analysis of protein – DNA interaction in E-box binding motif .......... 57 
5.2. Methods ............................................................................................ 58 
5.2.1. Sox6 promoter design ................................................................ 58 
5.2.2. Reporter assay ........................................................................... 58 
5.2.3. PCR ............................................................................................ 59 
5.2.4. ATDC5 culture ............................................................................ 59 
5.2.5. Chromatin Immunoprecipitation (ChIP) assay ............................ 59 
5.3. Results ............................................................................................... 59 
5.3.1. Effects of different clock combine to Sox6 promoter activity ..... 59 
5.3.2. Effect of Per1 upregulation on Sox6 promoter activity ............... 60 
5.3.3. Clock gene Per1 expression and Sox6 transactivation ................ 61 
5.4. Conclusions........................................................................................ 62 
CHAPTER 6 
DISCUSSION 
6.1. Summary ....................................................................................................................63 
6.2. Critical remarks ........................................................................................................64 
 





1.1. Circadian rhythms 
The term circadian comes from Latin roots: circa (about) and dies (day). 
A circadian rhythm is an endogenous rhythm whose every cycle length is 
approximately 24 hours (h) and has existed in many kinds of living things, 
from unicellular prokaryotic to multicellular eukaryotic animals (Herzog, 
2007). The fundamental feature of endogenous circadian oscillations is that 
their oscillations will be perpetuated even when isolated from any 
environmental time cues or Zeitgeber, ZT (i.e. time giver). However, the 
oscillations may drift with respect to any 24-hour-based time and are referred 
to as "free-running". The free-running period of an organism that sleeps (e.g. 
rodents) is under genetic control and will persist for generations in the absence 
of environmental time cues (Aschoff, 1981). In mice (Mus musculus), the 
circadian oscillator that drives wheel-running activity exhibits a standard 
deviation of about 0.6%, or nine minutes less per 24-hour cycle (Pittendrigh 
and Daan, 1976). In terms of length, biological rhythms could be categorized 
in circadian (a cyclic period length is equal to 24 h) e.g. rhythmicity of aveolar 
bone periosteal and cemental cells showed 24-h DNA synthetic cycles (Tonna 
et al., 1987), ultradian (~ longer than a day)  (Stavreva et al., 2009), and 
infradian (~ shorter than a day) (Refinetti and Menaker, 1992). Nevertheless, 
the period of a circadian oscillator is not a constant and can be modulated by 
both external and internal influences, like changes in light pulse in 
environment (Sumová et al., 2004), hormonal milieu (Ratajczak et al., 2009), 
and even the age of an organism (Dubrovsky et al., 2010; Nakamura et al., 
2011). Jetlag syndrome, a consequence caused by the effect of environmental 
changes, is a light response (Cermakian and Boivin, 2003). 
1.1.1 Circadian oscillators 
Circadian oscillators (pacemakers) generate a rhythm which repeats with 
a frequency of about 24 hours. In order to correctly respond to external 
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environment, such machinery systems must be synchronized to the exact 24-
h cycle of the physical world to catch up with local time. A process of 
synchronization is referred to as entrainment (Daan, 2000; Golombek and 
Rosenstein, 2010). Empirically, the phase (φ) of the oscillator must be 
adjusted so that the endogenous period of the oscillator (tau, τ) equals the 24-
hour period (T) of the physical world (Pittendrigh and Daan, 1976; Pittendrigh, 
1972). The circadian cycle of light and dark (LD), acting through light-
induced phase advances and delays of the endogenous rhythm, is the dominant 
cue to organisms to synchronize their circadian oscillators to the environment, 
probably because dawn and dusk are the most reliable and noise-free 
indicators of time available to organisms in most habitats. Organisms are also 
able to use many other cues for entrainment, including social factors 
(Golombek and Rosenstein, 2010), temperature cycles (Zimmerman et al., 
1968; Herzog and Schwartz, 2002), and food availability (Feillet et al., 2007; 
Mendoza et al., 2005; Graff et al., 2005), which shows the flexibility of 
entrainment systems. Circadian rhythms, therefore, should possess several 
fundamental features: (i) they are endogenously generated oscillations that 
cycle with a frequency of about 24 h, (ii) they exhibit homeostasis of period, 
(iii) the period is conserved in length under various temperature values or 
temperature compensation, and (iv) they are synchronized by periodic 
environmental signals, or entrainable to external cues (Zimmerman et al., 
1968; Daan and Pittendrigh, 1976; Rosbash, 1995).  
1.1.2 The mammalian circadian oscillator 
Mammals have evolved a set of anatomically discrete cell populations that 
function as a physiological system to provide temporal organization on a 
circadian time scale commonly include three components: (i) a master 
oscillator is responsible for the generation of the circadian rhythm, (ii) input 
pathways by which the external cues and other components of the nervous 
system transmit information to the master clock, and (iii) output pathways that 
ultimately receive temporal information from central clock to act on a wide 
variety of physiological and behavioral outcomes. 
1.1.2.1. The central oscillator – The SCN 
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The dawn of ideas on suprachiasmatic nucleus (SCN) as a central 
pacemaker arose from an ablation “somewhere in the hypothalamus” caused 
a disruptive rhythmicity. This area was then attributed to a bilaterally paired 
nucleus in the mammalian hypothalamus, due to the fact that an ablation of 
the SCN made circadian rhythms vanished. It was the first to implicate the 
SCN as a circadian oscillator (Pittendrigh, 1972). The rhythm in electrical 
activity continued inside the "island" containing the SCN but not in other 
regions of the nervous system (Inouye and Kawamura, 1979). SCN is an 
autonomous oscillator (Yamaguchi et al., 2003) and once destroyed or 
functionally removed from an organism, many of the behavioral rhythms 
should disappear as unavoidable consequences. Brain transplantation 
(Tousson and Meissl, 2004) could ideally rescue such phenotype (Antle and 
Silver, 2005). In animals received SCN transplantation from another species, 
the rhythm could be generated by the transplanted SCN tissue but not to some 
trophic interaction with the host tissue (Lehman et al., 1987; Mayer-Bernstein 
et al., 1999). And the utilization a mutant hamster SCN showed a circadian 
rhythm with a period much shorter than normal – the so-called tau mutant 
(Shearman et al., 1999; Reppert and Weaver, 2001). SCN tissue 
from tau mutant animals was transplanted into SCN-lesioned wild-type 
animals and vice versa so that locomotor activity rhythms having the shorter 
period of the donor tissue were restored or the rhythms exhibited the normal 
period of the donor animals in the latter case (Yamazaki et al., 1998; 
Pendergast et al., 2010). On the evidence of these compelling results, the SCN 
is the circadian oscillator in rodents and it could oscillate autonomously. 
1.1.2.2. SCN anatomical properties 
Within the hypothalamic region, there lies a complex population of 
different tiny nuclei. Of those, the central oscillator exists in pair of two nuclei 
located right in the anterior part of the hypothalamus and dorsal to the optic 
chiasms to the third ventricle, thus termed suprachiasmatic nucleus (SCN). 
Observations from complete elimination of the bilateral nuclei implied that 
SCN is the master operator of circadian rhythms in locomotor activity, feeding, 
drinking, adrenal corticoids, core body temperature and sleep-wake behavior 
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(Moore and Eichler, 1972; Feillet et al., 2007; Oster et al., 2006; Refinetti and 
Menaker, 1997; Refinetti and Menaker, 1992; Warren et al., 2006). In brief, a 
suprachiasmatic nucleus is a dense accumulation of small neurons lying dorsal 
to the optic chiasm and lateral to the third ventricle (Figure 1.1). In mice and 
rats, two pear-shaped nuclei cover around 10,000 ~ 16,000 heterogeneous 
neurons (Welsh et al., 1995, Abrahamson and Moore, 2006) and each is 300 
μm in width plus 350 μm in height and 600 μm in length (Abrahamson and 
Moore, 2006). Each nucleus can be subdivided into two part: the ventrolateral 
or core (vlSCN) and the dorsomedial or shell (dmSCN). A calculation of 
subdivision volumes by immunoreactive detection indicates that the shell 
volume is 0.0022±0.0004 mm3 and the core 0.0014±0.0002 mm3, reviewed in 
(Moore et al., 2002). The two SCN regions distinguish themselves among the 
others by neuropeptides they secrete (Piggins et al., 1995), their pacemaker 
ability as well as their response to external cues (Quintero et al., 2003). The 
dorsal neuron’s firing in shell region reach the top earlier than those in the 
ventral part during day time. Whilst, the shell area mainly secret arginine 
vasopressin (AVP), the core parts generate vasoactive intestinal peptide (VIP) 
and gastrin-releasing peptide (GRP) (Abrahamson and Moore, 2001; Welsh, 
2007). Single SCN cells showed circadian oscillations in spontaneous neural 
activity which drift out of phase with one another as if each cell contains an 
independent oscillator (Quintero et al., 2003; Ruan et al., 2008). This structure 
implies synaptic interactions which might be important for the inputs to and 
outputs from the SCN oscillator rather than responsible for the generation of 
the circadian rhythm itself. Without SCN, it possibly just blocks the signal to 
be transmitted. Those substances appear to have a transduction function from 
SCN to periphery (Gillette and Reppert, 1987; Shinohara et al., 1995). 
To date, it has been announced of three different input pathways existing: 
retinohypothalamic tract (RHT) (Goel et al., 1999; Moore and Klein, 1974), 
geniculohypothalamic tract (GHT) (Moore, 1989; Moore and Speh, 1994), 
and serotonin (5-HT) (Rea and Glass, 1994; Morin and Blanchard, 1991). 
Signals travel within the SCN via intrinsic transmitters including the amino 
acid γ-amino butyric acid (GABA) and peptides. GABA is the major 
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transmitter used by SCN neurons (Moore and Speh, 1993; Abrahamson and 
Moore, 2001; Jursky et al., 1994; Meister, 2007). 
 
Figure 1.1. The two suprachiasmatic nuclei are situated in the anterior part of the 
hypothalamus immediately dorsal to the optic bilateral chiasms to the third ventricle and 
functional regions inside SCN. Each SCN is subdivided into shell (dorsomedial part) and 
core (ventrolateral part) regions containing hetero-groups of neurons categorized in 
accordance with substances they secrete. ENK: Enkephalin; VIP: Vasoactive intestinal 
polypeptide; AVP: Arginine vasopressin peptide; GRP: Gastrine-releasing peptide; CalRe: 
Calretinin. Afferent pathways includes: RHT: retinohypothalamic tract; GHT: 
geniculohypothalamic tract; 5-HT: serotonine. Output (efferent) signals transmitted into 
SCN from its superior side, and output pathways vary upon on which parts those signal 
impact. The output from shell region involves in: MPO: medial preoptic; DMH: 
dorsomedial hypothalamus; and VLPO: ventrolateral preoptic nucleus, those form core 
region towards sPVz: subparaventricular zone. (The optic nerve and the optic tracts (left) 
adapted from Gray’s Anatomy). 
1.1.3 Peripheral oscillators – a hierarchical organization 
Studies on retinas from hamsters homozygous for the circadian mutation 
tau, which showed a genetically programmed circadian oscillator that 
regulates its synthesis of melatonin (Tosini and Menaker, 1996), provided a 
particularly clear demonstration that circadian oscillators exist outside of the 
SCN region in mammals (Pickard and Kahn, 1984; Albrecht, 2012). 
The motif of single cells can perpetuate its circadian rhythmicity 
autonomously not only in the SCN cells (Herzog and Schwartz, 2002) but in 
almost peripheral cell populations and cultured cells as well (Balsalobre, 
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2002; Balsalobre et al., 2000). In mammals, time signal, often in the form of 
light pulse, is first sent to the SCN and believed to be orchestrated with 
peripheral clocks to exert its synchronization at cellular level in a particular 
tissue. A study on peripheral organ isolated from SCN-lesioned animal (Yoo 
et al., 2004) demonstrated that cells within a given tissue can synchronize in 
circadian rhythmicity. By changing medium in cell culture, every single cells 
could reset and become desynchronized oscillators (Yamazaki et al., 1998). 
On the other hand, peripheral tissues could become uncoupled to the SCN 
rhythmicity by resetting time under the influence of external cues. Feeding 
time is considered to be a dominant Zeitgeber in mouse liver (Le et al., 2001) 
as well as in other peripheral tissues, circadian clock-controlled gene 
expression become shifted compared to that within the SCN (Damiola et al., 
2000; Schibler et al., 2003). As in another demonstration, grafting mouse 
fibroblasts for studying the entrainment of peripheral oscillators has been 
found that the grafted mouse embryonic fibroblasts (MEFs) encapsulated in a 
collagen disk under the skin of mice a few days after implantation and 
displayed circadian mammalian period-homolog 2 (Per2) gene expression 
that was in phase with in the recorded host organs’ Per2 expression (Pando et 
al., 2002). It is possibly that metabolism and circadian oscillations are 
interwoven with each other in a tight knot by complicated feedback 
mechanisms (Hirota and Fukada, 2004). In addition, temperature also acts as 
external cue for resetting peripheral clocks without altering the central pace 
maker – the SCN (Brown and Schibler, 1999). 
A simile: “The SCN act like the conductor of an orchestra that gives the 
pace he reads from the score (e.g. the sun). The music, however, is played by 
the instruments, the peripheral oscillators controlling the physiological and 
the behavioral state of the organism” (Oster, 2006) somehow nicely 
summarizes the complexity of how the central oscillator function may 
impinge on the peripheral circadian pacemakers. 
1.1.4 Biological clock under molecular scope 
An early observation of Syrian hamsters tau mutation with the period of 
circadian locomotor activity shortened (Ralph and Menaker, 1988) was then 
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clarified that a cytosine to thymine nucleotide transversion (Lowrey et al., 
2000) occurred in casein kinase 1-epsilon gene, (Ck1ε) protein at amino acid 
178, causing its deficiency in ability to phosphorylate Per proteins 
(Etchegaray et al. 2009; Gallego and Virshup 2007; Meng et al. 2008). Hence, 
there should be an urged demand for elucidating clockwork’s functions at both 
local (organ/tissue) and systemic (body) levels. 
1.1.4.1. The core loop – heart of the circadian oscillator 
The core components of mammalian clockwork has been revealed as 
follows: circadian locomotor output cycles kaput or Clock (Martha Hotz 
Vitaterna et al., 1994), brain and muscle-ARNT like protein 1 or Bmal1 
(MOP3) (Kondratov et al., 2003), neuronal-PAS domain protein 2 or NPAS2 
(Reick et al.,2001), period homologs Per1, Per2, Per3 (Shearman et al., 2000; 
Viola et al., 2007; Zheng et al., 1999, 2001), Cryptochrome homologs Cry1 
and Cry2 (Griffin Jr. et al., 1999). They could be functionally separated into 
two parts in regulation: negative and positive loops. 
The positive loop is particularly composed of two proteins, Clock and 
BMAL1, carrying Per-Arnt-Sim (PAS) domain, thus belong to PAS (MOP, 
members of PAS) family (Hogenesch et al., 1998). Anchoring inside both of 
these proteins is a specific basic-Helix-Loop-Helix (bHLH) domain where 
DNA can bind during their action (Shearman et al., 1999; Zhou et al., 1997). 
Clock protein is found to be a histone acetyltransferase (HAT) which is 
required for the circadian expression of many clock-controlled genes (CCGs) 
as it facilitates chromatin activation state (Doi et al., 2006). Mutant mice 
deficient in Clock gene lost their behavior of rhythmic wheel-running as a 
consequence of being kept in constant darkness (DD) for two weeks 
(Vitaterna et al., 1994). Npas2 as Clock-substitution as its action could 
compensate for the absence of Clock in Clk-/- mutant mice by thorough 
investigations in SCN and periphery (Abraham et al., 2006; Haque et al., 
2010; Debruyne et al., 2007). 
In contrary, the negative loop assembles of repressors to Clock 
(Npas)/Bmal1 literally known as Per1, Per2, Per3, and  Cry1, Cry2 as well 
as other members, including : Rev-erbα/β or Nr1d1/ Nr1d2 ( Bugge et al., 
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2012; Preitner et al., 2002), Dec1 and Dec2 (Bhlhb1 and Bhlhb2 or Sharp1 
and Sharp2)  (Sato et al., 2004 ; Kawamoto et al., 2004), and t imeless  
(Tim)  (Gotter et al., 2000; Zylka, Shearman, Levine, et al., 1998). These gene 
expressions are facilitated by heterodimer Bmal1/Clock binding to the E-box 
sequence in their promoters. Resulting proteins, in turn, act on Clock and/or 
Bmal1 as transcriptional repressors (Cho et al., 2012; Maywood et al., 2013; 
Reppert and Weaver, 2002), phosphorylation inhibitors of the heterodimer 
proteins (Dardente et al., 2007), or remodeling chromatin (Grimaldi et al., 
2009), thus preventing their own transcriptions (Nakashima et al., 2008; Ueda 
et al., 2005). Recently, a nuclear receptor cofactor and master metabolic 
regulator, peroxisome proliferator-activated Pparγ coactivator encoding gene 
(Pgc-1α) (Liu et al., 2007; Kawakami et al., 2005) is thought to be a bridge 
linking the circadian clock activity to metabolism for its circadian rhythmicity. 
In recent years, antiphase circadian expression of Per (mRNA level peaks 
at the beginning of evening of subjective day) versus Bmal1 mRNAs (peaks 
at starting dawn) in eye, heart, kidney and lung sampled from rat at different 
times of the day has been observed (Oishi et al., 1998). In the mouse the 
oscillatory expression of the Per mRNA in liver, skeletal muscle and testis 
(Zylka et al., 1998) and of the Per1 mRNA/Per1 protein in pars tuberalis 
(anterior lobe of pituitary gland) was also obtained (von Gall et al., 2002). 
Oscillation of Per1 and Per2 clock genes and Rev-Erbα, Dbp-clock-controlled 
genes has also been demonstrated in cultured rat fibroblasts after serum-shock 
(Balsalobre et al., 1998). In capuchin monkey, Cebus paella, as a diurnal 
mammal experimental model, the expression of the clock genes Clock, Bmal1 
and Per2 was also observed in the adrenal gland both in vivo and in vitro  
(Richter et al., 2004). 
1.1.4.2. Circadian gene regulation – the interlocked loops 
To date, four cis-regulatory elements that are known to participate in the 
circadian regulation: E-box, Dbp/E4bp4 binding elements (D-box), Rev-
erb /Ror  binding elements (Rore) and cyclic AMP responsive elements 
(CRE) (King et al., 1997; Ginty et al., 1993; Cho et al., 2012; Ripperger and 




Figure 1.2. The clockwork regulation. 
The Clock(Npas2)/Bmal11 heterodimer is at the heart of the cycle. As the master clock 
gene in positive regulatory loop, the heterodimer recognizes E-box in CCG promoter, 
binds, then activates gene transcription. Other gene regulatory elements (D-box, CRE) 
exist in CCGs’ promoters. In the feedback loop, CCG product in turn block their own gene 
transactivation mainly by preventing the heterodimer from binding to their E-box 
sequence (Cry1/2; DBP), and even to other CCGs’ E-boxes Per1/2; Dec1/2) while some of 
them repress Bmal1 transcription (Rev-erbα/β , Rorα). 
Clock machinery functions as the combination of alternative activation/ 
repression within each 24-h cycle. Core loop consisting of Bmal1/ Clock or 
Bmal1/ Npas2 heterodimer plays a central role in generating and maintaining 
circadian rhythms at both local (within a particular tissue/ organ) and systemic 
(body/ organism) levels. Typically, once binding to cognate E-box(es) resided 
in targeted promoter(s), the heterodimer acts as a transcriptional activator 
(thus, termed to positive), resulting in accumulation of products, e.g. Per1,  
Per2, Per3, Cry1, Cry2,  Rev-erb α/β, Rorα, Dec 1/2 proteins. These circadian 
products, in turn, act as inhibitors to suppress Clock (Npas2)/ Bmal1 at 
multiple levels, thus, shut down their own transcriptions (Sato et al., 2006). 
These products can also interfere one another’s transcriptions by block Clock 
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(Npas2)/ Bmal1 accessing effectively to targeted promoters (e.g. Per1, Per2, 
Per3 and Dec1, Dec2 proteins could repress each other’s promoter activity. 
Fig.1.2). This autoregulatory feedback network participate in multiple levels 
of gene regulation and could be hardly untwined. As an element for enhancing 
gene expression, Dbp- and E4-promoter-binding protein 4 (E4bp4) act as 
activators or repressors, respectively, of the transcription of D-box containing 
genes. Dbp transcription itself is E-box regulated, whereas transcription of 
E4bp4 is regulated through a Rore in its promoter (Korenčič et al., 2012). 
Expression level of a particular gene should take the ratio between 
synthesis and degradation of its mRNA into account. mRNA oscillations are 
controlled by rhythmic transcription, and normally, the amount of mRNA 
reflects the amount and activity of its resulting protein. These assumptions 
seem to be true for many genes; however, various existing mechanisms can 
interfere with mRNA and relative protein at both levels and potential activity 
(Garbarino-Pico and Green, 2007). In detail, the amount of a particular mRNA 
can decrease although its transcription increases if the speed of its degradation 
increases even more, and protein abundance is not exceptional. The final level 
and activity of a given protein is tightly regulated at several steps from the 
gene to the active protein. Although the transcriptional/ translational loop 
(TTL) model is universal as the basis of the circadian clockwork, many studies 
have suggested that it does not sufficiently explain the accuracy of the clock 
machinery (Reddy et al., 2005; Hastings et al., 2003). Therefore, additional 
levels of regulation must exist, e.g. posttranscriptional regulation: cyclic 
adenosine-3’-5’-monophosphate (cAMP) response elements (CRE) and 
structural modifications of chromatin. CRE motifs (TGACGTCA) have 
been found in Per1 (Hida et al., 2000) and Per2 promoters (Travnickova-
Bendova et al., 2002). Upon light stimulation CREB is phosphorylated (p-
CREB), then activated by Erk1/2 pathway. p-CREB binds to CRE recruiting 
the two co-activators CBP and p300 (Johannessen et al., 2004; De Cesare et 
al., 1999). It is noteworthy that CRE-mediated transcription seems to be 
independent of Clock/Bmal1 regulation (Travnickova-Bendova et al., 2002). 
Another mechanism of circadian gene activation is chromatin remodeling 
which results in chromatin loosening or tightening (Kadam and Emerson, 
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2002). The histone acetyltransferases (HAT) CBP and p300 interact 
rhythmically with Clock and Bmal1 proteins (Etchegaray et al., 2003; 
Takahata et al., 2000). By contrast, histone deacetylase (HDAC) causes gene 
repression, e.g. CRY1-mediated repression of Per1 and Per2 (Naruse et al., 
2004), and Bmal1 transcription perished as a result of REV-ERBα modulating 
HDAC3 migration towards Bmal1 promoter to reduce acetylation in H3 and 
H4 (Yin and Lazar, 2005). Not only acetylation but also histone methylation 
changes rhythmically in a demonstration of Per1 promoter (Etchegaray et al., 
2006) and of the clock-controlled gene Dbp (Ripperger and Schibler, 2006), 
transcription of the orphan nuclear receptors Rev-erbα/β and Rorα (Preitner 
et al., 2002; Sato et al., 2004).  Reports on miRNAs possibly integrated into 
circadian entrainment in the mouse SCN (Cheng et al., 2007; Pegoraro and 
Tauber, 2008) were also obtained. 
Posttranslational modifications are believed to stabilize clock loops by 
phosphorylation and ubiquitination to assure accuracy of clock oscillators 
(Garbarino-Pico and Green, 2007; Gallego and Virshup, 2007). Casein kinase 
1ε and 1δ (CK1ε/δ) phosphorylate the clock proteins Per1, Per2, Cry1 and 
Cry2 (Partch et al., 2006; Etchegaray et al., 2009) whilst, F-box E3 ubiquitin 
ligase (FBXL3) ubiquitinates Cry1 and Cry2 (Busino et al., 2007; Hastings et 
al., 2007) and thus, controlling Per1/2 and Cry1/2 accumulation by marking 
them for proteasome degradation. With the same motif, Fbxl21 and Fbxl3, 
respectively, are essential for coordinating the 24-h variation of protein 
abundance of Cry1 and Cry2 (Hirano et al., 2013). Besides, a recent work (Shi 
et al., 2013) reported that Fbxl3 could serve as ‘a bridge’ linking the negative 
and positive circadian feedback loops by either direct or mediate E-box/D-
box-containing-gene expression. Another kinase, Gsk3β, targets to Bmal1, 
thus, the resulting p-Bmal1 modulates both protein stabilization and 
amplitude maintenance of circadian oscillations (Sahar et al., 2010). 
Adenosine monophosphate (AMP)-activated protein phosphate kinase 
(AMPK) interacts with Cry1/2 (Iitaka et al., 2005; Nomura et al., 2006) and 
contributes to facilitating gene activation, protein stability and anabolic 
process, hence, altering the pace of rhythms (Bae and Edery, 2006). 
Phosphorylation of PER proteins by Ck1ε/δ regulates their own dimerization, 
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stability, and nuclear translocation (Etchegaray et al., 2009; Takano et al., 
2004; Virshup et al., 2007). In human, disruptive phosphorylation of circadian 
clock hPer2 resulting in familial advance sleep phase syndrome (FASPS) 
(Toh, 2001; Xu et al., 2005). Therefore, Ck1ε/δ could modulate rhythmicity 
for negative limb through Per proteins. 
Interestingly, circadian clock genes could play multifaceted roles during 
their cycles (Albrecht et al., 2007).  Per2 and Npas2 have been reported to get 
involved in tumor suppressor recruitment (Fu et al., 2002; Hoffman et al., 
2008). Besides, Per2 is involved in the signal transduction cascade for cold-
induced thermogenesis in brown adipocyte as a causative factor of less fit for 
survival under natural conditions in mice (Chappuis et al., 2013). Per1 gene 
could also act on malignant transformation in terms of inhibiting prostate 
cancerous growth in vivo and suppressing progression of several human 
cancer cell lines in vitro (Cao et al., 2009; Gery et al., 2006). 
In summary, despite all varieties, circadian clock genes have evolved as a 
unique system in organisms during natural selections, and functioned to 
anticipate periodical environment during an animal’s lifetime with high 
flexibilities. Via predict fluctuations of surroundings, organisms could survive, 
evolve and eventually thrive, making clockwork to be a huge curiosity. 
1.2. Cartilage and bone growth 
1.2.1. The Bone 
The basic multicellular unit of bone comprises the osteocytes, osteoclasts 
and osteoblasts. Its activity of the unit is regulated by mechanical forces, bone 
cell turnover, hormones (e.g. parathyroid hormone-PTH, growth hormone-
GH), and paracrine factors (Fawcett, 1994b; Karsenty, 2003). Osteocyte 
activation responds to detection of mechanical stress as well as to biochemical 
stimuli. This activation results in the lining cells of the endosteal surface are 
retracted, and digested by matrix metalloproteinases of the endosteal 
collagenous membrane. Next, osteoclasts are recruited, and fusion of 
activated osteoclasts resulting in formation of multinucleated osteoclasts. 
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Activated osteoclasts mediate resorption of the underlying bone. 
Subsequently, osteoblasts migrate to the resorption cavity and lay down new 
osteoid, which eventually becomes calcified (Roodman, 1999); this process is 
completed in approximately 3-6 months in human (Parfitt, 1976a). The rate 
of bone turnover varies according to the type of bone, being highest in sites 
where trabecular bone predominates such as vertebrae, or epiphyses of long 
bones, and lowest at sites high in cortical bone such as the hip. 
 
Figure 1.3. Cartilage to bone formation. 
A. Formation of bone collar in hyaline cartilage model; 
B. Cavitation of the hyaline cartilage within the cartilage model; 
C. Invasion of internal cavities by the periosteal bud and spongy bone formation; 
D. The resulting bone is a thick walled cylinder that encloses a central bone 
marrow cavity. 
Bone formation begins when mesenchymal cells form condensations or 
clusters of cells (Goldring et al., 2006). These cells either differentiate directly 
into bone forming osteoblasts (intramembranous ossification of flat bones, e.g. 
skull, scapula) or into chondrocytes that lay down a cartilage mold and is 
subsequently replaced by ossified bone (endochondral ossification of long 
bones, e.g. tibia, humerus, femur) (Caplan, 1991). The epiphyses and 
metaphyses of long bones originate from separate ossification centers that are 
separated by a set of embryonic cartilage remnants (Fig.1.3). 
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Certain significant functions are attributed to bone as it maintains and 
supports the body shape, movement and mechanical protection. Of more 
important, long bone trabecular (e.g. femur, thigh bone) is the source of 
hematopoietic stem cells, thus, contributes significantly in body immunity. On 
the other hand, skeletal bone is the source for minerals including calcium and 
phosphorus, which serve as neurotransmitter along with cellular metabolism 
(Tare et al., 2008; Kubota et al., 2009; Li, 2006). 
1.2.2. The cartilage 
Cartilage is a connective tissue of predominantly mesodermal origin that 
provides mechanical support and structural form to many areas of the 
musculoskeletal system (Fawcett, 1994a; Staines et al., 2013). Cartilage 
differs from most other tissues due to the fact it does not contain vascular, 
nervous or lymphatic structures (Salter, 1998). It is composed of a single cell 
type referred to as the chondrocyte and a complex extracellular matrix 
consisting mostly of collagen and proteoglycans (Knudson and Knudson, 
2001; Roughley, 2006). Cartilage is classified in three types – elastic, fibrous 
and hyaline – based on its structure and composition (Bi et al., 2001). Articular 
cartilage is a smooth while hyaline cartilage contains an extracellular matrix 
(ECM) in which cells are sparsely positioned. It is an avascular tissue and 
more than 60% of its content is water. Articular cartilage could be 
distinguished into four zones, ranging from the superficial zone at the articular 
surface, via the transitive zone, to the deep zone which connects to the 
subchondral bone through the calcified cartilage zone (Lotz et al. 2013; 
Martel-pelletier et al., 2008). The extracellular matrix also has a distinct 
organization around the cell, which is described as pericellular closest to the 
cell, territorial and interterritorial (Burdan et al. 2009). The extracellular 
matrix of cartilage is composed mainly of water (60-87%), collagens (10-
30%), and proteoglycans (3-10%) (Knudson and Knudson, 2001). The 
collagens are the major proteins of cartilage and make up about 60% of its dry 
weight. The fibril-forming collagen type II is the most abundant, providing 
tensile strength to the tissue and maintains its volume (Barbieri et al., 2003). 
Together with cartilage oligomeric matrix protein (COMP) to form a collagen 
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network bound to the surface of the filaments (Kamisan et al., 2013). 
Typically, aggrecan is an ECM marker defining the stage of chondrogenesis 
(Kiani et al., 2002). 
During embryonic development, mesenchymal stem cells (MSCs) form 
two types of cartilage: permanent and transient cartilage (Kronenberg, 2003). 
Permanent cartilage arises mostly from distal ends of developing bones and 
embraces stable chondrocytes which secrete hyaline cartilage matrix at 
articular terminals. Whilst, in postnatal development, transient cartilage 
contributes to bone formation via endochondral ossification (Figure 1.3). In 
the center of the diaphysis, beneath the periosteal cuff, the cartilage is being 
replaced by bone in a so-called primary ossification center, allowing the 
penetration of blood vessels which recruit the osteoblast and bone marrow 
precursors with them (Fig.1.3.C, D). In the fetus, the primary ossification 
center forms first in the diaphysis (Fig.1.3.A and B). Later on a secondary 
ossification center forms in the growth plate. In brief, hyaline cartilage is 
replaced by bone in the epiphysis and diaphysis, except in the postnatal 
epiphyseal plate region.  
1.2.3. Chondrogenesis regulation 
1.2.3.1. Chondrocytes – developmental units of cartilage 
 
Figure 1.4. The bone is formed onto a temporary cartilage mode. The cartilage model 
grows from reserved region (resting zone) adjacent to proliferating zone where cells are 
in progression to become mature chondrocytes (pre- and hypertrophic zone). Finally 




Chondrogenic cell lineage which normally accounts for 5% in total volume 
of cartilage are generally round or polygonal in shape and vary greatly in size 
based on the type of cartilage, developmental zone as well as states of 
differentiation. Their cell size ranges from 10-20 μm in diameter with one 
round nucleus per cell. These cells are solely capable of producing and 
maintaining the extracellular matrix via their possessive widely expanded 
Golgi apparatus which well reflects this primary role (Schofield 1975; Harper 
and Klagsburn 1999). Also, these cells are very responsive to various 
chemical mediators including hormones, growth factors and cytokines, as well 
as mechanical and possibly electrical stimuli (Donkelaar and Wilson, 2012; 
Yang et al., 2011; Kobayashi et al., 2005; Burdan et al., 2009). 
Cartilage plays a pivotal role in endochondral ossification, a multistep 
process whereby most bones develop in vertebrate organisms. This process 
starts in the embryo with the formation of cartilage primordia that already 
prefigure definitive bones. These primordia then develop growth plates that 
enlarge skeletal elements and are progressively replaced by bone from fetal 
stages until adulthood. Upon condensation of mesenchymal cells, 
chondrogenic cell lineage differentiate sequentially into prechondrocytes. The 
onset of chondrogenic maturation starts with the activation of type II collagen 
(Col II), aggrecan (Agc1), and subsequent other cartilage-specific ECM genes 
to produce a large amount of ECM materials making pre-chondrocytes to 
actively proliferate. Although epiphyseal chondroblasts are maintained at an 
early differentiation stage throughout gestation, diaphyseal and metaphyseal 
chondroprogenitors mature to form growth plates and induce the formation of 
primary ossification centers. Within a normal growth plate, chondrocytes are 
organized into layers (Fig.1.4) at each epiphyseal end. Chondroprogenitor 
cells exist separately and in small clusters to form the reserve or resting zone. 
Cells of this zone lie in isogenous cellular groups, two or more cells in a space 
called lacuna/cell nest. Progressing towards the metaphysis chondroblasts 
become flattened and undergo clonal expansion forming discrete columns that 
generate the proliferative zone, thus named as columnar cells. Upon 
undergoing pre-hypertrophy, they cease mitotic expansion and sequentially 
activate Pth1-r synthesis (receptor for parathyroid hormone and parathyroid 
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hormone–related peptide), Ihh (Indian hedgehog), and Col X (type X 
collagen). When becoming hypertrophy, they stop expressing Col II, Agc1, 
and other early markers, progressively downregulate Pth1-R and Ihh, 
concomitantly upregulation of Col X and Runx2 expression and induction of 
cartilage matrix mineralization. Hypertrophic chondrocytes stop to express 
Col X, activate Opn (osteopontin) and Mmp13 (matrix metalloproteinase-13), 
and ultimately undergo apoptosis to leave a cartilaginous framework that 
forms a scaffold for invading osteoblasts to lay down newly mineralized bone 
within the primary spongiosum (Gary Gibson, 1998). Osteoclasts, osteoblasts, 
and blood vessels then invade and replace the cartilage with bone. 
1.2.3.2. Chondrogenesis 
Chondrogenesis initiates with a hallmark in mesenchymal condensation 
facilitated by multi-signaling composing of different transcription factors 
activated via the Wnt (Macsai et al., 2008), BMP, Sonic Hegdehog (Shh), 
Indian Hegdehog (Ihh) (Adams et al., 2007; Kubota et al., 2009; Tavella et al., 
2004; Kim et al., 2013) as well as hormones (Locker et al., 2004). 
Chondrogenesis is tightly regulated under various hormonal signals. 
Insulin could promote the differentiation of pre-chondrocytic ATDC5 cell 
model in vitro (Atsumi et al., 1990) as well as in vivo (Phornphutkul et al., 
2006). Studies on thyroid hormone (T3/T4) suggested a paracrine signaling 
during endochondral ossification (Miura et al., 2002). T3-regulated 
chondrogenesis in vitro facilitating investigation of the molecular events 
which mediate direct T3 induction of hypertrophic chondrocyte differentiation 
in the absence of other signaling pathways (Robson et al., 2000). Other several 
hormones were also investigated: adrenaline (Takarada et al., 2009), a 
causative factor in delaying maturation of chondrocytes; adiponectin, a key 
factor in cartilage homeostasis (Lago et al., 2008; Lee et al., 2007; Goldring, 
2006); prolactin which promotes apoptosis in hypertrophic chondrocytes 
using 3D-micromass culture of ATDC5 cells, thus increasing bone growth 
(Seriwatanachai et al., 2012), and parathyroid hormone, a very long known 
factor in bone mineral metabolism (Parfitt, 1976a). 
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Not only under hormonal impacts have chondrocytes also perceived 
influences from different cytokines through paracrine signaling pathways 
(Osawa et al., 2006). In a model of metatarsal organotypic culture, it was 
proved that a member of transforming growth factor beta (TGFβ) family, 
TGFβ2 from perichondrium, mediated Shh effects on hypertrophic 
chondrocyte differentiation (Alvarez et al., 2002). The overexpression of 
parathyroid hormone-related peptide (PTHrP) in chondrocytes leads to a delay 
in chondrocyte maturation and bone formation such that mice are born with a 
completely cartilaginous skeleton (Weir et al., 1996). Another Hegdehog 
signal, Ihh, is one of the key regulators of transformation from cartilage to 
bone via endochondral ossification (Minina et al., 2001) for its controlling: (i) 
the initiation of hypertrophic differentiation as Ihh signals act on the distal 
periarticular chondrocytes to upregulate the expression of parathyroid 
hormone-related peptide (PTHrP), which in turn signals back to the 
proliferating chondrocytes and inhibits the differentiation of proliferating 
cells into the early hypertrophic Ihh-expressing cell type (St-Jacques et al., 
1999); and (ii) the regulation of chondrocyte proliferation and (iii) induction 
of the ossification of the perichondrium in PTHrP-independent manner 
(Akiyama et al., 1999; Kronenberg, 2003). Thus, this regulatory feedback 
loop at least controls the transition from proliferation to hypertrophy stages of 
chondrocytes within growth plate (Kobayashi et al., 2005). In other words, 
interactions between Ihh and PTHrP determine the lengths of proliferating 
columns of chondrocytes in the growth plate and hence the pace of bone 
growth. Other important molecules involved in chondrogenesis include bone 
morphogenetic proteins (BMPs) (Alvarez et al., 2002; Keller et al., 2011), 
fibroblast growth factors (FGF-1 and FGF-2), and insulin-like growth factors 
(IGF-1) (Jakob et al., 2001; Renard et al., 2012). 
Several types transcription factors (TFs) control skeleton patterning and 
cell differentiation at these early stages including three Sry-related HMG box-
containing proteins (Sox-Trio) consisting of Sox5/ L-Sox5, Sox6, and Sox9, 
and runt-related protein (Runx) family. The Sox-Trio components are 
coexpressed in all cartilage primordia of the mouse embryo and may 
cooperate to directly activate Col II. Sox9 is required for prechondrogenic cell 
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condensation, prechondrocyte and chondroblast differentiation, and activation 
of Sox5, Sox6, and cartilage matrix genes.  (Later discussed in Chapter 2). 
Cell cycle genes can also make changes on growth speed of growth plate 
chondrocytes (Beier et al., 1999). An increase in expression of cyclin-
dependent kinase (Cdk) impacts cell progression, thus, influences the rate of 
proliferating in proliferative zone, e.g. cyclin-dependent kinase inhibitor 1C 
(Cdkn1c, Fig.1.4). Cdk inhibition is necessary for cell-cycle exit upon onset 
of hypertrophic and differentiation of chondrocytes (LuValle and Beier, 2000). 
Terminally differentiated chondrocytes entering apoptosis is considered to be 
an essential event for the replacement of cartilage with bone in a favor of 
facilitation for tissue structure-cellular activity coordination (Gibson et al., 
1997; Gibson, 1998). 
In summary, the rate of chondrocyte differentiation has to be carefully 
regulated so that, ultimately, the proper shape and length of the bone will be 
both achieved and maintained. 
1.2.4. Chondrogenesis – in vitro studies 
Recently, many studies have focused on chondrogenic expansion in vitro 
(Melero-Martin and Al-Rubeai, 2007) or utilization of ATDC5 cells for 
investigating signal effects on chondrocyte maturation (344 studies, latest 
Pubmed search in November 2013). ATDC5 cell line, isolated from a 
differentiating culture of AT805 teratocarcinoma cells, had shown a lot 
identical properties to chondroblasts in vivo, from cell morphology and under 
insulin induction, was able to produce cartilage nodule-like aggregates to 
ultimately chondrogenic differentiation at a very high percentage compared 
to other chondrogenic cell lines in use, C3H10T1/2 and RJC3.1 (Atsumi et al., 
1990). Because insulin promotes chondrogenesis and ossification in vivo 
(Phornphutkul et al., 2006) and in vitro in human mesenchymal stem cells 
committed chondrocytic fate (Chen et al., 2009). It is widely used in 
combination with transferrin plus selenium known as ITS mixture 
supplemented in culture system for stimulating chondrogenic differentiation 
(Shukunami et al., 1998; Chua et al., 2005). However, its effect could be 
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blocked when treated cells with dexamethasone in a chondroblastic cell 
culture model (Fujita et al., 2004). In brief, after condensation, cells could 
produce and secret extracellular matrix protein like type II collagen and 
aggrecan. Thus, ATDC5 cells possess typical characteristics of chondroblasts 
in terms of their chondrogenic potential, morphology, growth behavior, and 
ECM collagen synthesis that have been proved to be the same as reality 
(Shukunami et al., 1996; 1997; 1998). ATDC5 differentiation process is also 
under many different influences of hormones, growth factors/cyotkines and 
transcription/inhibition factors (Newton et al., 2012; Yao and Wang, 2013). 
TC6 cells derived from articular cartilage of transgenic mice with 
temperature-sensitive simian virus 40 large T-antigen gene, were also utilized 
in demonstrating that Sox9 enhanced Agc1 transcription (Sekiya et al., 2000). 
1.3. Clockwork integration into bone and cartilage development 
Long bone growth and bone metabolism have long been to exhibit 
noticeably periodic activities in a circadian fashion by the biological clock. 
Well-established models found out molecular ultradian clocks in bone during 
the segmentation stage (Tonna et al., 1987). These clocks is crucial for 
somitogenesis in a periodic fashion with a cycle of a few hours, while the core 
loops of circadian clock genes are harbored in bone and cartilage and 
modulate them (Iimura et al., 2012). Ultradian clocks in human bone could be 
observed over three signaling pathways: Notch, Wnt, and FGF (Aulehla and 
Herrmann, 2004; Goldbeter and Pourquié, 2008) as genes expresses 
oscillatory mode in the anterior presomitic mesoderm (PSM) of mouse 
embryos (every 120 min). 
Both central and peripheral circadian pacemakers are regulated by TTLs 
of clock genes (DeBruyne et al., 2007; Schibler et al., 2003; Shearman et al., 
1999). Transgenic mice with clock gene disruption were generated and under 
several investigations. Per-/- and Cry-/- mice (Vitaterna et al., 1999; Zheng et 
al., 2001) expressed a phenotype of high bone mass (HBM) starting from 6 
week old individuals in vertebral and longitudinal bones and became worse 
over time regulated by sympathetic pathways in osteoblasts. Ihh oscillated in 
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mouse cartilaginous ribs at 24-h cycles (Takarada et al., 2012), and evidence 
from endochondral ossification in longitudinal bone also appeared to be under 
regulation of core circadian clock Bmal1. In an attempt to search for putative 
clock controlled genes in a specific cartilaginous cell population, a recent 
study revealed that ECM Agc1 and Col2a1 were circadian oscillated. 
Interestingly, no control elements were found in Sox9 gene, which is an 
upstream regulator of Col2a1 (Honda et al., 2013). Analyzing circadian gene 
expression in bones using DNA microarray (Zvonic et al., 2007) revealed that 
rat bones also displayed enhanced calcification at night (Russell et al., 1984), 
and induced circadian variation in bone resorption (Bjarnason et al.,  2002). 
Therefore, the rhythms in endochondral bone formation might be 
synchronized with those in membrane bone formation. 
Due to the fact that bone formation from cartilage requires complex 
signaling pathways, any alteration in these factors might influence bone 
development at various level, from unseen to mild or even severe to lethal 
abnormalities. Hormonal signal changes during a particular day in insulin and 
leptin levels were observed as they appeared to be lower during the light phase 
but started to increase a few hours before the onset of the dark phase 
concurrently with feeding time (Bertani et al., 2010). Besides, IGF-1 levels 
showed an increase during the light phase in parallel with the increase in GH 
levels, but shifted 2 hours forward, perhaps due to the role of GH in 
influencing IGF-1 synthesis and secretion plus IGF-1-derived pancreatic β-
cells has their own intrinsic pacemaker (Sadacca et al., 2011; Vieira et al., 
2012). Another study revealed PTH in human subjects oscillated in circadian 
manner (Jubiz et al., 1972). Not surprisingly, circadian rhythmicity of 
circulating hormones in preclinical animals should be taken into consideration 
when designing experiments and assessing data in pharmacological studies. 
Cartilage of various types showed matrix formation to be synchronized via 
the circadian expression of numerous relevant genes at the transcriptional 
level. In a recent genome-wide analysis of circadian expression in growth 
plate cartilage, 4% of total expressed genes in the growth plates were flagged 
with probes, thus, showed statistically significant circadian rhythms, 
including mRNA levels of Col II and Agc1 (Honda et al., 2013). Amazingly, 
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the transcriptional oscillations of these gene showed the same as their 
translational phase. Of all oscillating genes under that investigation involved 
in matrix synthesis, some expressed in the same circadian phase with peak in 
the early morning (CT22-2), while others showed an opposite oscillated phase, 
peaking in the evening (CT10-14). Likewise, chondrocytes in culture showed 
circadian rhythms of Agc1 protein synthesis, too (Nickla et al., 1999). 
Genes involved in matrix degradation showed circadian expression as well. 
For instance, Pai-1, a clock-controlled gene, expressed under the circadian 
mode at both protein and mRNA levels (Ohkura et al., 2006; Urano et al., 
1990). Notably, a balance between Pai-1 and plasminogen activator is also 
crucial in cartilage matrix degradation (Oleksyszyn and Augustine, 1996). In 
growth plates, the Pai1 mRNA levels increased >10-fold in the evening. In 
terms of aetiology, highly active Pai-1 is indication of impaired fibrinolysis 
(Masuda et al., 1994). Furthermore, patients with variant angina showed 
circadian variation in plasma Pai-1 activity in with a peak in the early morning 
coincident with the frequency of the attacks (Oleksyszyn and Augustine, 1996. 
Therefore, it is likely that the degradation of cartilage matrix is also under 
circadian regulation. 
The observations of changes in gene transactivation also appear to reflex 
relative fluctuations in protein synthesis. In rat cartilage, the incorporation of 
radiolabelled precursors into Col II and Agc1 was enhanced in the morning 
under LD conditions (Simmons, 1964; 1966; 1974; Russell et al., 1983; 1984) 
and that the peak time of these protein syntheses is consistent with the peak 
time of the expression of the respective genes. It became more persuasive that 
the amplitude of type II collagen and aggrecan synthesis at the mRNA level 
was similar to what observed at the protein level. Taken together, these 
findings suggest that the cell-autonomous clock plays a pivotal role in the 
circadian variations of cartilage matrix synthesis. 
Transcriptional factor Runx2 was found to express in circadian oscillation 
mode within rodent SCN (Reale et al., 2013). Circadian oscillation results in 
mesenchymal hematopoietic stem cells isolated from murine and human were 
also obtained (Wu et al., 2008). Adipogenesis could be altered by Bmal1 
through Wnt pathway (Guo et al., 2012; Kennaway et al., 2013; Lee et al., 
2013; Shimba et al., 2005).  
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Recently, a circadian clock gene product, Sirt1 (a nicotinamide adenine 
dinucleotide NAD+-dependent sirtuin ortholog in mammals, class III histone 
deacetylases), is believed to mediate the inhibition of peroxisome 
proliferative-activated receptor (Ppar)-γ expression. For Pparγ is a major 
inhibitor of osteoblastogenesis, consequence outcome was significant skeletal 
changes in Sirt1-null mice compared with that in wild type (WT) littermates. 
Hence, Sirt1 is a potential candidate as an anabolic approach to the treatment 
of osteoporosis in a circadian manner via suppressing sclerostin (Sost), a 
critical inhibitor of bone formation, by modifying histone III acetylation at the 
Sost promoter (Cohen-Kfir et al., 2011). In addition, Sirt1 also at the crossroad 
linking circadian clock (Belden and Dunlap, 2008; Nakahata et al., 2008) 
influence on and angiogenesis and cancer (Jung-Hynes et al., 2010).  
In preclinical trials, patients with malfunctions in bone when administrated 
medicine at a particular time of day may alter drug effects on their bone 
metabolism, not surprisingly, due to the presence of the autonomous “tick-
tack” in bone as well as in its ally organs. 
1.4. Aims of the dissertation  
(i) To establish an in vitro chondrogenesis model using ATDC5 cell line 
for observing possible changes utilizing gain/loss-in-function of a 
particular clock gene, Per1, and 
(ii) Thereby, to unravel the mysteriously underlying mechanism of clock 
gene Per1 alteration towards chondrogenesis. 
1.5. Abbreviations 
2-ME 2-mercaptoethanol 
5-HT  5-hydroxytryptamine/serotonin 
AC Adenylyl cyclase 
ACH Acetylcholine 
Agc1 Aggrecan 
Ago2 Argonaute protein 2 
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ALP Alkaline phosphatase 
AMPK AMP-activated protein kinase 
AVP Arginine vasopressin 
bHLH Basic helix-loop-helix 
Bmal1 Brain and muscle aryl hydrocarbon nuclear translocator-like protein 
BMP Bone morphogenetic protein 
BPB Bromophenol blue 
CalRe Calretinin 
cAMP Cyclic adenosine mono phosphate 
Cbfb Co-activator core binding factor b 
CCG(s) Clock-controlled gene(s) 
CDK Cycle-dependent kinase 
cDNA Complementary DNA 
ChIP Chromatin Immunoprecipitation 
Ck1ε Casein kinase 1 epsilon 
Clock Circadian locomotor output cycles kaput 
Col II (Col2a1) Type II collagen (alpha chain 1) 
Col X (Col10a1) Type X Collagen (alpha chain 1) 
Col11a1 Type XI collagen alpha chain 1 gene 
COMP Cartilage oligomeric matrix protein 
CRE Cyclic adenosine-3’-5’-monophosphate (cAMP) response elements 
CREB cAMP responsive element binding protein 
cRNA Complementary RNA 
Cry Cryptochrome 
CT Circadian Time 
Dbp D-site of albumin promoter (albumin D-box) binding protein 
DBTSS Database of transcription start sites 




DMEM/F12 Dulbecco’s Modified Eagle Medium / Nutrient Mixture Ham’s F-12=1:1 
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DMH Dorsomedial hypothalamic nucleus 
DNA Deoxyribonucleic Acid 
dsRNA Doubled-strand RNA 
E4bp4 E4-promoter-binding protein 4 
ECF Extracellular fluid  
ECL Enhanced chemiluminescence 
ECM Extracellular matrix 
ENK Enkephalin 
Erk1/2 Extracellular signal-regulated kinase 1 / 2 
FBS Fetal Bovine Serum 
Fbxl21 F-box E21 ubiquitin ligase 
Fbxl3 F-box E3 ubiquitin ligase 
FGF Fibroblast Growth Factor 
GABA γ-amino butyric acid 
Gapdh Glyceraldehyde 3-phosphate dehydrogenase 
GH Growth hormone 
GHT Geniculohypothalamic tract 
GLU Glutamate 
GPBS Phosphate-Buffered Saline containing glucose 
GRP Gastrine-releasing peptide 
Gsk3β Glycogen synthase kinase 3 beta 
HAT Histone acetytransferase 
HDAC Histone Deacetylase  
HEK293 Human Embryonic Kidney 293 Cells 
IGF-1 Insulin-like growth factor 1 
Ihh Indian Hedgehog 
ITS Insulin - transferrin - selenite 
LD 12 h light/12 h dark 
Mapk Mitogen-activated protein kinase 
MEFs Mouse embryonic fibroblasts 
Mmp13 Matrix metalloproteinase 13 
MPO Medial preoptic nucleus 
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MSCs Mesenchymal stem cells 
NAD+ Nicotinamide adenine dinucleotide  
NPAS2 Neuronal Per-Arnt-Sim domain protein 2 
NPY Neuropeptide-Y 
PAS 
Period circadian -Aryl hydrocarbon receptor nuclear translocator- Single-
minded domain 
PBS Phosphate-Buffered Saline 
Pebp2b Polyoma enhancer binding protein 2b 
Per Period protein 
PKA Protein kinase A 
PKC Protein kinase C 
Pparγ Peroxisome proliferative-activated receptor γ  
Prx1 Paired related homeobox 1 
PSM Pre-somitic mesoderm 
PTH Parathyroid hormone 
PTHrP Parathyroid hormone-related peptide 
PVDF Polyvinylidene difluoride 
RANK Receptor activator of nuclear factor kB 
RANKL Receptor activator of nuclear factor kB ligand 
RdRP RNA dependent RNA polymerase  
Rev-erbα/β Retinoic acid-related orphan receptor response element 
RHT Retinohypothalamic tract 
siRISC Small interference RNA Induced Silencing Complex  
RITS RNA-Induced Transcriptional Silencing Complex  
RNA Ribonucleic acid 
RNase RNA nuclease 
Rore Retinoic acid-related orphan receptor response element 
Rorα Retinoid-related orphan receptor alpha 
Runx Runt related transcription factor 
SCN Suprachiasmatic nucleus/nuclei 
SDS Sodium dodecylsulfate 
SDS-PAGE SDS-polyacrylamide gel electrophoresis 
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Shh Sonic Hedgehog 
SID-1 Systemic RNA Interference – Deficient 1 
siRNA Small interference RNA 
Sirt1 Silence mating type information regulation 2 (sirtuin) homolog 1 
Smad7 Mother against decapentaplegic homolog 7 
Sox Sex determining region Y (SRY)-related HMG box-containing gene 
SPVz Subpaparaventricular zone 
TBST Tris-Buffered Saline Tween 
TGFβ Transforming growth factor beta 
Tim Timeless protein 
TTL Transcriptional/Translational Loop 
VIP Vasoactive Intestinal Polypeptide 
VLPO Ventrolateral preoptic 
Wnt Wingless-ints 
WT Wild type 
ZT Zeitgeber Time 
1.6. Cell culture and Reagents 
ATDC5 was purchased from RIKEN BioResource Center (Tsukuba, 
Japan). The feltal bovin serum (FBS), supplement of cell culture, was 
purchased from Equitech-Bio (Ingram, TX, UK). The ChIP Assay Kit was 
purchased from Upstate Biotechnology. Protein G sepharoseTM 4 Fast Flow 
and the Peroxidase-labeled anti-Goat IgG antibody was purchased 
(Buckinghamshire, England) from Amersham Life Science. Taq polymerase 
as well as restriction enzymes (REs) were purchased from Takara Shuzo Co 
(Otsu). Trypsin was purchased from DIFCO (Detroit, MI, USA). Bio-Rad 
Protein assay regent was purchased from Bio-rad Laboratories (Hercules, CA, 
USA). Lipofectamin2000, M-MLV Reverse transcriptase, Ultra-Pure agarose, 
Plus regent, and Lipofectamine regent was purchased from Invitrogen (San 
Diego, CA, USA). Dual-Luciferase Reporter Assay System pRL-TK, and 
pRL-SV40 was purchased from Promega (Madison, WI, USA). Dulbecco's 
Modified Eagle Medium (DMEM), Opti-MEM1 Reduced-serum Medium, 
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Dulbecco's Modified Eagle Medium / Nutrient Mixture Ham's F-12 = 1:1, 
Phosphate-bufferd saline (PBS), ethidium bromide solution was purchased 
from Gibco BRL (Gaithersburg, MD, USA). DNase, transfferin, insulin, 
Sodium Selenite were purchased from Sigma Aldrich (St.Louis, MO, USA). 
Antibody of BMAL1 (Anti-Bmal1) was purchased SANTA CRUZ 
Biotechnology. ISOGEN was purchased from Wako Pure Chemical Industries 
(Osaka, Japan). NBT / BCIP Stock solution DIG RNA Labeling Kit, and anti-
DIG antibody was purchased (Mannheim, Germany) from Roche Diagnostics. 
Mouse Clock and hamster brain and muscle aryl hydrocarbon receptor 
nuclear translocator-like (Bmal1) expression plasmids were generously 
donated by Dr. Reppert (University of Massachusetts Medical School, 
Massachusetts, USA). 4 tandem copies of SOX9 binding site linked to the 
minimal Col II gene promoter in the luciferase reporter plasmid is from Dr. 
Benoit de Crombrugghe (Anderson Cancer Center, TX, USA). All chemicals 
and compounds in use were at a special analysis grade available commercially. 
1.7. Data statistical analysis 
Each result was expressed as mean ± SE. and statistical significance was 
determined by two-tailed and unpaired Student’s t-test/ one-way analysis of 












PTH INDUCES THE INCREASE IN PER1 EXPRESSION 
2.1. Introduction 
2.1.1. Parathyroid hormone pharmacological properties 
PTH is synthesized and secreted by the chief cells in four tiny parathyroid 
glands, which are located adjacent to the larger thyroid gland (Parfitt, 1976a; 
Fawcett, 1994c; Okabe and Graham, 2004). PTH is initially synthesized as a 
115-amino acid polypeptide namely pre-pro-PTH, which is cleaved within 
parathyroid cells at the N-terminal portion first to pro-PTH (90 amino acids) 
and then to fully functional PTH (84 amino acids) (Fawcett, 1994c).  PTH 
maintains calcium homeostasis minute-to-minute by controlling extracellular 
fluid (ECF) calcium concentration within the narrow range of 1.0-1.3 mM. It 
is quite important because extracellular calcium ions have an effect on the 
stability of voltage-gated ion channels (Jubiz et al., 1972) which is crucial for 
a vast of essential cellular processes. The stimulus for PTH secretion 
is hypocalcaemia (low calcium in the blood). The effect of PTH in the body 
is to raise the ECF calcium concentration via three specific actions (Fig.2.1, 
left): (i) PTH stimulates the release of calcium from bone by stimulating bone 
resorption; (ii) PTH decreases the amount of calcium excreted in the urine, by 
stimulating calcium reabsorption in the kidney, and (iii) PTH indirectly 
promotes calcium absorption by the digestive tract, because it activates the 
enzyme in kidney cells that produces the steroid hormone 1,25-(OH)2D3 (the 
active form of vitamin D). 
PTH exerts its action via primarily via binding to PTH1 receptor (PTH1-
R) on both osteoblasts and chondrocytes in all animals investigated, including 
rodents and human (Chorev, 2002; Hoare and Usdin, 2001). Its homologs, 
parathyroid hormone-related peptides (PTHrPs) are also expressed in a wide 
variety of adult and embryonic cell types, including osteoblasts and 
chondrocytes (Suva et al., 1987) and shares PTH1-R with PTH with a little 
difference within a wide range of cell types including a population of pre-
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hypertrophic chondrocytes in the growth plate (Burdan et al., 2009; McCauley 
and Martin, 2012). Common outcome for PTH/PTH1-R binding transduction 
is involved in G-protein coupling-dependent manner (Fig.2.1. right), 
ultimately resulting in cell proliferation or differentiation depends on active 
G-protein subunits which the complex reacts with (Sakamoto et al., 2005; 
Weinstein et al., 2001). Interestingly, exogenous PTH administration exerts a 
rapid effect (within minutes or even in half a minute in vitro (Parfitt, 1976b), 
whereby it stimulates osteoblasts to pump Ca2+ ions out of the fluid 
surrounding the bone (which has a higher Ca2+ concentration) and into the 
ECF. 
  
Figure 2.1. PTH action to maintain ECF calcium ions stable (left) and mechanism of 
PTH/PTHrP action on chondrogenic cell lineage in different ways. 
2.1.2. PTH effects on bone 
Parathyroid hormone, a key regulator in bone anabolic, accumulated a 
large body of evidence for its effect in bone turnover (Parfitt, 1976c; 
Rattanakul et al., 2003) as well as bone remodeling (Compston, 2007).  
PTH acts on bone, the body reservoir of calcium, to release calcium in two 
phases (Poole and Reeve, 2005): 
 Immediate effect: mobilizing calcium from skeletal stores that are 
readily available towards gradient between intra/extracellular fluids. 
 Late effect: stimulating release of calcium and phosphate by activation 
of bone resorption. 
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In the later, PTH/PTH1-R complex affected cells of the osteoblastic 
lineage, subsequently resulting in cell-cell contacts and regulating osteoclast 
formation through RANK (the receptor activator of nuclear factor kappa-B), 
osteoprotegerin, and RANK ligand (RANKL) interaction. PTH increases 
osteoclast activity and number indirectly through effects on RANKL and 
osteoprotegerin (Parfitt, 1976a; Roodman, 1999). The net effect of PTH on 
bone varies according to the severity and chronicity of the PTH abundance, 
from osteopenia to osteitis fibrosa cystica, and trabecular bone volume seems 
to be preserved at the expense of cortical bone. 
Clinical reports demonstrated that administration of teriparatide (a 
recombinant human PTH 1-34) at different times significantly altered the 24-
h bone turnover markers as well as the calcium–parathyroid axis in 
postmenopausal osteoporotic female patients (Luchavova et al., 2011). Thus, 
possibly PTH can entrain endogenous circadian clock in bone. 
2.1.3. Sox family and chondrogenesis 
Members evolved from the mammalian Sry on the short arm of the Y 
chromosome encodes a nuclear factor-like protein harboring a DNA-binding 
domain known as the HMG box are namely Sox (SRY-related HMG-box) 
genes. They encode similar sequence namely HMG box with similarity to that 
of Sry at least 60% (Bowles, Schepers, and Koopman, 2000; Kiefer, 2007; 
Wilson and Koopman, 2002). Unlike most transcription factors, SOX 
transcription factors bind to the minor groove of DNA (at consensus 
A/TA/TVAAA/TG) causing a 700 to 850 bend and introducing local 
conformational changes (Gubbay et al., 1990; Bergstrom et al., 2000) (Fig. 
2.2). 
Amongst 20 members of Sox family, Sox9 plays a key role in successive of 
chondrogenesis (Akiyama et al., 2002). Homozygous mutants of Sox9 (Sox9-
/-) gene die around embryonic day 11.5 (E11.5) (Bi et al., 2001). Several types 
of transgenic mice in which Cre is expressed at different steps during 
chondrocyte differentiation were generated: Sox9 flox/flox;11Enh-Cre and Sox9 
flox/flox;Col2a1-Cre mice (Iwai et al., 2008), Sox9flox/flox; Prx1–Cre (Akiyama et 
al., 2002). In these transgenic mice, Cre recombinase activities are controlled 
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by the Col11a2 promoter starting during the round chondrocyte stage whilst 
11Enh-Cre directs recombination at a later stage. Observations from Col2a1-
Cre;Sox9flox/flox conditional knockout mice showed that most 
chondroprogenitor cells were arrested as condensed mesenchymal cells, 
whereas a few cells differentiate into chondrocytes and undergo hypertrophy. 
A complete absence of cartilage and bone observed in limbs of 
Sox9flox/flox;Prx1–Cre mutant embryos. Both transgenic mice and human 
chondrosarcoma cells of Sox9 flox/flox;11Enh-Cre and Sox9 flox/flox;11Prom-Cre 
showed that the expression of Sox9 in differentiated chondrocyte lineage cells 
is essential for cell survival, subsequent hypertrophy and proper endochondral 
bone formation in mice. In another report, Sox9 inactivation in round 
chondrocytes caused premature apoptosis and that Sox9 inactivation in flat 
chondrocytes caused immediate terminal maturation without hypertrophy and 
with excessive apoptosis (Ikegami et al., 2011). Phosphorylation of SOX9 
protein by PKA could enhance its activity (Huang et al., 2000) (Fig.2.3). 
Therefore, either in deficient at various levels or overexpressed forms, Sox9 
gene has been proved to be at the core of generative chondrogenesis. 
    
Figure 2.2. Sox family (left diagram) and mode of action in gene transactivation (A) 
through HMG domain; (B) Sox protein binding to cognate DNA sequence; and (C) possible 
mutual interaction in the mode of action between Sox proteins. 
Two other members of the group D Sox family, Sox5 and Sox6, are crucial 
regulators of chondrocyte development for their co-expression with Sox9 
during chondrogenesis, termed ‘Sox-trio’. Sox9, Sox5 or L-Sox5 (L- long 
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form) and Sox6 genes are synergetic allies in chondrogenesis during early 
stages as well as co-express in all embryonic cartilaginous primordial (Smits 
et al., 2001). Sox5/L-Sox5 and Sox6 proteins share highly identical in their 
sequences, but have similarity with Sox9 protein merely in HMG box DNA-
binding domain (Lefebvre et al., 1998). 
Sox6 plays ‘multifaceted’ roles in different tissues. It is highly expressed in 
adult mouse testes and in the developing embryonic nervous system (Connor 
et al., 1995), and possesses a long coiled-coil domain (for dimerization) which 
shares 91% identity with the corresponding region of L-Sox5 (Lefebvre et al., 
1998; Smits et al., 2001). Further investigation adopting Northern blot 
analysis on Sox6 revealed a 3-kb transcript expressed predominantly in testis 
although its expression was detectable in other tissues at varied levels (Cohen-
barak et al., 2003). Together, transcription factors Sox5 and Sox6 repressed 
specification and terminally differentiation in oligodendrocytes and 
modulated their migration patterns. In reversal, oligodendrocyte precursors 
and terminally differentiated oligodendrocytes deficient in both Sox5 and 
Sox6, appeared precociously in spinal cords. Thus, Sox5 and Sox6 express 
opposite functions to the group E Sox proteins, Sox9 and Sox10, which 
promoted oligodendrocyte specification and terminal differentiation (Stolt et 
al., 2003; 2006). 
In chondrocytes, Sox-trio members recruit together as Sox5 and Sox6 are 
absent in limb buds with Sox9 inactivation, indicating that Sox9 is needed for 
Sox5 and Sox6 expression (Yang et al., 2011). The expression of Sox5 and 
Sox6 is vanished from hypertrophic chondrocytes wherein Sox9 ceases to 
express. Although individual Sox5 and/or Sox6-deficient mice are born with 
mild skeletal abnormalities, double knockouts developed a severe, so-called 
chondrodysplasia, phenotype as they were devoid of cartilage due to a defect 
in chondrocyte proliferation and depletion of cartilage matrix (de 
Crombrugghe et al., 2000) and died in fetus at embryonic day 16.5 resulting 
from a failure in respiration (Dy et al., 2008; Smits et al., 2001). Moreover, 
dual expression of Sox5 and Sox6 was essential to conferring a hypertrophy 
session on differentiation progression of chondrocytes (Smits et al., 2004). 
The function of Sox5 and Sox6 is, thus, thought to be somehow redundant in 
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chondrogenesis, yet has been proved to be of vital for cartilage progression at 
growth plate and controlling endochondral bone in terms of timing (Smits et 
al., 2004). Interestingly, proper expression of the Sox-trio also greatly 
contributed to re-differentiation of dedifferentiated human mesenchymal stem 
cells (Yang et al., 2011). 
Therefore, it is necessary to have a clearer view on how SOX-trio regime 
unfurls its wings in cartilage development. Perhaps, their timely expression 
and action are fairly nice suggestions with previous findings on chondrocyte 
development under several key signaling both in vitro (Newton et al., 2012; 
Yao and Wang, 2013) and in vivo (Kronenberg, 2003; Jakob et al.,  2004). 
2.1.4. Runx family 
The Runx family consists of three members, Runx1/Cbfa2/Pebp2aB, 
Runx2/Cbfa1/Pebp2aA and Runx3/Cbfa3/Pebp2aC, which all possess a runt 
domain for DNA-binding homologue of Drosophila pair-rule gene runt (Sato 
et al., 2008). Runx proteins interact with transcriptional co-activator core 
binding factor b (Cbfb)/polyoma enhancer binding protein 2b (Pebp2b) 
forming a heterodimer; and Cbfb is also required for RUNX2-dependent 
osteoblast and chondrocyte differentiation (Stricker et al., 2002). Of those, 
Runx2 is essential for osteoblast differentiation and required for embryonic 
bone formation as well (Komori et al., 1997) as Runx2-/- transgenic mice have 
complete lack of both endochondral and intramembranous ossification due to 
the deprivation of osteoblastic differentiation (Yoshida et al., 2004). 
Interestingly, Runx2 alone is essential for differentiation of mesenchymal 
cells into osteoblasts while a combined action of Runx2 and Runx3 is essential 
for chondrocyte maturation (Sato et al., 2008; Yoshida et al., 2004), and 
endochondral ossification as well (Goldring et al., 2006). Runx2 alone, 
however, inhibits differentiation of mesenchymal cells into adipocytes and 
chondrocytes. Indeed, it triggers the expression of major bone matrix protein 
genes, including the Col1a1, osteopontin and osteocalcin genes at an early 
stage of osteoblast differentiation and its actions sustain a supply of 
preosteoblasts. Osterix is believed to act downstream of Runx2, since 
mesenchymal cells from Osterix-/- mice express Runx2, however, osterix is 
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not expressed in Runx2-/- mice. Osterix-/- mesenchymal cells retain the ability 
to differentiate into chondrocytes (Mitsugi et al., 2012). 
 
Figure 2.3. Chondrocyte differentiation. Abbreviations: COL II: type II collagen; COL X: 
Type X collagen; Ihh: Indian Hegdhog; RUNX2/3: Runt-related protein 2/3; PKA: 
phosphate kinase A; PTH: parathyroid hormone. 
2.2. Methods 
2.2.1. ATDC5 cell culture 
ATDC5 cells were plated at a density of 1  104 cells/cm2 in DMEM/F12 
medium containing 5% fetal bovine serum (FBS). For induction of 
differentiation, culture media were replaced with a medium formula 
containing 10 µg/ml transferrin, 3 x 10-8 M sodium selenite and 10 µg/ml 
bovine insulin (ITS) (Nakamura et al., 2009). 
2.2.2. PTH supplement 
Rat PTH (1-34) was added into the culture medium at the concentration of 
10 nM for different periods. 
2.2.3. Quantitative Real-time PCR (qPCR) 
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Appropriate expression of mRNA was quantified by real time-based RT-
PCR using a MiniOpticonTM (Bio-Rad, Hercules, CA, USA) with an iQ 
SYBR Green Supermix (Bio-Rad, Hercules, CA, USA). The relative amount 
of transcript was normalized by glyceraldehyde-3-phosphate dehydrogenase 
(Gapdh) expression in a real time base and calibrated by fold changed when 
compared to none-induced culture (Hinoi et al., 2006). Primers used are listed 
in table 2.1. 




Gapdh AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA 
Per1 CAGGCTAACCAGGAATATTACCAGC CACAGCCACAGAGAAGGTGTCCTGG 
Runx2 CCGCACGACAACCGCACCAT CGCTCCGGCCCACAAATCTC 
Sox5 GATGGGGATCTGTGCTTGTT CTCGCTGGAAAGCTATGACC 
Sox6 GGATTGGGGAGTACAAGCAA CATCTGAGGTGATGGTGTGG 
Sox9 CGACTACGCTGACCATCAGA AGACTGGTTGTTCCCAGTGC 
Col II TGAAGACCCAGACTGCCTCAA AGCCGCGAAGTTCTTTTCTCC 
2.3. Results 
PTH induction the rise in the circadian clock gene Per1 transactivation. 
We first examined whether PTH affects the expression at transcriptional 
level of endogenous factors essential for chondrogenic differentiation, 
including Runx2, Sox5, Sox6 and Sox9, at the concentration effective in 
inducing Per1 upregulation (Hinoi et al., 2006). 
Cells were exposed to 10 nM PTH for different periods up to 48 h, 
followed by determination of the mRNA levels by real time-based RT-PCR. 
Exposure to PTH led to a rapid but transient increase in Per1 mRNA 
expression 1 h after supplemented, with concomitant decrease of Sox6 
expression after the exposure for 12 to 48 h in ATDC5 cells (Figure 2.4). 
Nonetheless, PTH induced a biphasic increase in Sox9 levels during the 
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exposure for 1 to 48 h, without significantly affecting the mRNA levels of 
Runx2 and Sox5. 
 
Figure 2.4. Expression profiles of different chondrogenic genes in ATDC5 cells exposed to 
PTH. ATDC5 cells cultured for 1 day were exposed to 10 nM PTH for 1 to 48 h, followed 
by isolation of total RNA and subsequent real time-based RT-PCR analysis. *P<0.05, 
**P<0.01, significantly different from each control value obtained in cells cultured in the 
absence of PTH. 
2.4. Conclusions 
An interesting study using mouse model raised a thought of identifying 
target genes in chondrocytes that are induced by CREB in response to 
mitogenic signals during development (Long et al., 2001). Likewise, PTH has 
been demonstrated to have an effect on the rapid elevation of Per1 mRNA in 
ATDC5 cell culture through the mechanism of G-protein coupling activation 
resulting in gene activation in the PKA/CREB signaling (Hinoi et al., 2006). 
It is the cAMP-PKA signaling pathway to exert Per1 upstream in our 
experimental conditions because: (i) a phosphorylation of CREB at Ser-133 
and/or Ser-129 are required for the recruitment of the CREB binding 
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protein/p300 co-activator for gene transcription in the presence of PTH 
(Gerritsen et al., 1997 Yamamoto et al., 1990), and (ii) Per1 gene promoter 
also possesses CRE sequence (Hida et al., 2000) and (iii)  rapid rise in pCREB 
during the first hour after light induction (Naruse et al., 2004) was seen in line 
with Per1 mRNA level transiently rose, although mostly related to light 
response (Travnickova-Bendova et al., 2002). One possibility to make Per1 
expressed its response at a very early stage (1 h after PTH induction) could be 
attributable to the possession of both CRE-binding site together with E-box 
within its promoter (Yamaguchi et al., 2000) (Fig.2.5). 
 









THE UPREGULATION OF PER1 AFFECTS CHONDROCYTIC 
DIFFERENTIATION 
3.1. Clock gene Per1 overexpression 
Transcription regulation of Per1 and Per2 is believed via E-box and D-
box embedded in promoter region (Yamajuku et al., 2010; Hida et al., 2000; 
Kume et al., 1999; S. Yamaguchi et al., 2000). There was also body of 
evidence that of all five E-box plus three CRE-binding sites within Per1 full-
length promoter synergistically affecting Per1 transcription (Nomura et al., 
2006; Hida et al. 2000). 
As for PTH induction the upstream in both clock gene Per1 and Per2 
mRNA transcripts in ATDC5 cell culture via promoter activity detection 
based on putative CRE-binding site upstream of Per1 promoter (Hinoi et al., 
2006).  
3.2. Promoter activation of Sox9 target genes during 
chondrogenesis 
As long been known that Sox9 transcription is boosted by PTHrP (Huang 
et al., 2000) and FGF (Murakami et al., 2000). In turn, Sox9 protein can act 
on several chondrocytic genes through binding sites in their promoters. These 
binding sequences have been identified as enhancers of several genes 
including Col II (or Col2a1) (Lefebvre et al., 1996), Col11a2 (Bridgewater et 
al., 1998). In these studies, Sox9 protein binds specifically to sequences in the 
first intron of human Col II gene since a mutation/deletion of these sequences 
completely abolished Sox9 binding and chondrocyte-specific expression of a 
Col II-driven reporter gene (Col II-lacZ) in transgenic mice. Furthermore, 
ectopic expression of Sox9 transactivated both a Col II-driven reporter gene 
and the endogenous Col II gene in transgenic mice. These results 
demonstrated that Col II expression is directly regulated by Sox9 protein in 
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vivo and implicated abnormal regulation of Col II during chondrogenesis as a 
cause of the skeletal abnormalities associated with campomelic dysplasia. 
These enhancers, which direct expression of reporter genes in cartilage of 
transgenic mice, are under Sox9 regulation both in vitro and in vivo. And 
deletion of these enhancer sequence resulted in vanishing of Sox9 activity 
(Akiyama et al., 2002). Therefore, it is undeniable to raise a thought of Sox9 
expression directly modulates target genes through these downstream 
sequences, and, at a larger manner, it could act on various gene transcriptions 
during proliferation of chondrocytes for its complete absence in hypertrophic 
chondrocytes. 
A 48-bp element of intron 1 of mouse Col II gene that when exists in the 
form of 4 tandem copies conferred chondrocyte specific expression both in 
transgenic mice and in transient experiments of tissue culture cells (Zhou et 
al., 1998). Besides, a multipmerized 18-bp element located at the 3’-end of 
the 48-bp sequence also acted as a powerful chondrogenic specific enhancer 
in transient transfection assay of rat chondro-sarcoma cells (RCS) as well as 
mouse primary chondrocytes but not in fibroblastic cell lineage (Zhou et al., 
1995). They were cloned directly upstream of an 89-bp minimal sequence for 
Col II promoter (Murakami et al., 2000). Thus, this construct of Col II gene 
should well reflex entirely Sox9 protein activity (de Crombrugghe et al., 2000). 
Previous studies also demonstrated that a mutation in the sequence of this 
enhancer abolished its activity on Col II gene expression (Zhou et al., 1998) 
and was confirmed in observing chondrocyte development both in vivo and in 
vitro. 
3.3. Gene delivery in mammalian cells 
For gene delivery in mammals, it has been reported the effective utilization 
of pcDNA 3.1 for gene overexpression in several culture systems, including 
chondrocytic cells (Hinoi et al., 2006; Kawakita et al., 2008; Takarada et al., 
2012). And the gene transfection method adopted Lipofectamine 2000 is 
widely chosen for gene delivery in mammalian cells (Cardoso et al., 2009; 
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Podesta and Kostarelos, 2009); thus, also adapted for establishing stable 
transfectants of Per1 in ATDC5 in our experiments. 
3.4. Methods 
3.4.1. Establishment of stable Per1 transfectants 
 
Figure 3.1. The establishment of Per1 transfectants in ATDC5 cells. 
ATDC5 cells were plated at a density of 2  104 cells/cm2 in DMEM/F12 
containing 5% FBS on culture dishes (Φ35 mm). After 24 h, cells were 
transfected with pcDNA3.1 vector containing the full-length coding region of 
Per1 or with the empty vector (E.V.) using 2 µg of DNA and Lipofectamine 
2000 and Plus reagent. After 24 h, and every 48 h thereafter for 2 weeks, 
culture media were replaced with DMEM/F12 containing 5% FBS and 500 
µg/ml G418 (Geneticin). The ability of resistance to G418 is conferred by the 
Neo-gene (Neomycin resistance encoding gene) from Tn5 encoding an 
aminoglycoside 3'-phosphotransferase, APH 3' II. Pools of 28 clones of 
ATDC5 cells resistant to G418 (ATDC5-Per1) were isolated for further 
studies. Pools of clones between passages 2 and 5 were used for these 
experiments (Uno et al., 2011). 
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3.4.2. Reporter assay 
In dual genetic reporter applications, changes in the activity of one reporter 
correlate to the effects of the specific experimental conditions on gene 
expression, while the constitutive activity of the second reporter provides an 
internal control by which experimental values can be normalized (Schagat et 
al., 2007). The pRL Vectors are designed to provide constitutive expression 
of Renilla luciferase in mammalian cells. These vectors contain the Renilla 
luciferase cDNA (Rluc) cloned from Renilla reniformis. Vectors are available 
in several promoter configurations and may be used in combination with any 
experimental firefly luciferase vector to provide an internal control of reporter 
activity. The pRL-SV40 Vector contains the SV40 early enhancer/promoter 
region that provides strong, constitutive expression of Rluc in a variety of cell 
types.  
Reporter vectors (pGL3-basic-targeted promoter-Luc) were co-
transfected with a pSV40-Renilla luciferase (pSV40-RL-Luc) construct into 
ATDC5 cells using Lipofectamine 2000 and Plus reagent. 24 h after 
transfection, cells were lysed, and luciferase activity was determined using 
specific substrates in a luminometer according to the manufacturer’s protocol. 
Transfection efficiency was normalized by determining the activity of Renilla 
luciferase (Uno et al., 2011) (Fig.3.2). 
 
Figure 3.2. Dual luciferase assay. 
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3.4.3. Northern blot 
Northern blot or RNA-gel blotting is a method applying denaturing 
polyacrylamide gel electrophoresis of RNA followed by the electrophoretic 
transfer of RNA onto a solid support (membranes) and then detection by a 
hybridization with a labelled, complementary RNA probe. It’s quantitate, 
technically straight-forward, relatively inexpensive and is often employed to 
validate small RNA identified by higher throughput methods. 
Total RNA was extracted from cultured cells as described previously 
(Hinoi et al., 2003). RNA was dissolved in DEPC-treated water and quantiﬁed 
by measuring the absorbance at 260 nm using a Nanodrop UV 
spectrophotometer (Labtech). RNA was stored at - 800C until use. The 
extracted RNA was then resolved on 1% formaldehyde/agarose gel, and 
transferred onto positively charged nylon transfer membranes. After fixing 
RNA to the blot by UV crosslinking, the blotted membranes were 
prehybridized at 680C for 1 h, and subsequently hybridized with a denatured 
DIG-labeled cRNA probe of type II collagen (Col II) at 680C for 16 h. The 
membranes were then washed and incubated with anti-DIGAP- Fab fragments, 
followed by the incubation with CDP-star (chemiluminescence substrate). 
The membranes were then exposed to X-ray films for appropriate periods to 
detect chemiluminescence (Takarada et al., 2008). 
3.4.4. qPCR and ATDC5 culture 
qPCR was performed as described in 2.2.3 and ATDC5 cell culture was 
conducted as previously described in 2.2.1. 
3.5. Results 
3.5.1. Per1 was transfected stably into ATDC5 cells 
The ATDC5-Per1 clone #28 of stable transfectants (referred as ATDC5-
Per1 #28 hereafter) showed a significant increase in Per1 mRNA level 
observed and cell survival (Fig.3.3A). Thus, we investigated further impact of 
Per1 increase based on previous observations when exposed cells to PTH 
during pre-chondrocytic ATDC5 development. 
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3.5.2. Early chondrogenic genes in response to Per1 overexpression 
In order to elucidate the significance of transient Per1 mRNA upregulation 
in chondrocytes exposed to PTH, we next attempted to establish several stable 
Per1 transfectants in ATDC5 cells. We have previously confirmed 
dramatically high endogenous mRNA levels and corresponding PER1 protein 
in the clone #28 cultured for 2 days (Takarada et al., 2012). Real time based 
RT-PCR analysis again revealed high expression of Per1 in the clone #28 
cultured for 3 days, whilst unaltered Runx2 levels was seen (Figure 3.3A). 
Both ATDC5-EV and ATDC5-Per1 #28 cells were then cultured in the 
presence of bovine insulin, transferrin, and sodium selenite (ITS system) for 
7 days, followed by determination of the mRNA levels of Sox9 allies with real 
time-based RT-PCR. Interestingly, stable overexpression of Per1 was found 
to almost diminish Sox6 expression without significantly affecting either Sox5 
or Sox9 gene expression (Fig.3.3B). 
 
Figure 3.3. Stable overexpression of Per1 in ATDC5 cells. ATDC5-Per1 #28 and ATDC5-E.V. 
were cultured (A) for 3 days and subsequent determination of the mRNA levels by real 
time-based RT-PCR for Per1 and Runx2, then (B) Sox5, Sox6, and Sox9 genes (for 7 days). 
**P<0.01, significantly different from each control value obtained in cells with EV. 
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3.5.3. Col II transcription reduced in Per1 stable transfectants  
In growth plate chondrocytes, the process of calcification was 
characterized in terms of distribution of alkaline phosphatase (ALP) activity 
and alterations to immunolocalization of types I and II collagens and 
glycosaminoglycans of proteoglycans during their development (Schofield et 
al., 1975). In ATDC5-Per1 #28 cells cultured for 14 to 21 days, a drastic 
decrease in different maturation markers, including Alcian blue staining 
(demonstrating the synthesis of cartilaginous proteoglycans) and alkaline 
phosphatase activity, ALPase, was seen in addition to downregulation of 
several differentiation marker genes such as type II collagen (Col II) for 
proliferating chondrocytes and type X collagen (Col X) for hypertrophic 
chondrocytes, respectively (Takarada et al. 2012). Thus, we next examined 
the transcriptional activation mediated by Sox9 allies endogenously expressed 
in stable Per1 transfectant cells using a 4x48-p89-Luc reporter plasmid with 
four tandem copies of the Sox9 binding site linked to the minimal promoter 
of Col II (Fig.3.4A, B). The reporter plasmid was transiently transfected into 
ATDC5-EV and ATDC5-Per1 #28 cells, followed by determination of 
luciferase activity after transfection. Luciferase activity was significantly 
attenuated after 48 h transfection in ATDC5-Per1 #28 cells stably 
overexpressing Per1 compared to that in ATDC5-EV cells (Fig.3.4C). 
Northern blotting analysis confirmed a significant decrease in mRNA 
expression of the proliferating chondrocytic marker type II Collagen (Col II) 
in ATDC5-Per1 #28 cells cultured for 7 days (Fig.3.4D). Once Sox9 binds to 
its cognate DNA sequence on Col II promoter through HMG-domain, Col II 
will be activated resulting in transcription mRNA level rising detected via 





Figure 3.4. Col II transactivation. Stable transfectants of ATDC5-Per1 #28 were transfected 
with (A) 4x48-p89-Luc following (B) protocol, then (C) determination of Col II promoter 
activity by luciferase reporter assay 48 h after transfection. (D) ATDC5- Per1 #28 were 
cultured for 3 days, followed by evaluation of total RNA and Northern blotting analysis 
for Col II gene expression. **P<0.01, significantly different from each control value 
obtained in cells with EV. 
3.6. Conclusions 
The result appeared to be consistent with the first observation when induced 
by exogenous parathyroid hormone. Both Sox5 and Sox6 are defective of a 
DNA binding domain (de Crombrugghe et al., 2000), but essential for 
promotion of the transactivation of particular target genes encoding cartilage-
specific extracellular matrix including Col II. The HMG domains of mouse 
Sox5 and Sox6 have the similar specificity for binding to the sequence 5’-
AACAAT-3’ (Connor et al., 1995). Besides, they possess a coiled-coil 
domain located in L-Sox5 and Sox6 mediating protein dimerization, thus, 
efficient binding to adjacent HMG DNA sites. In cotransfection experiments 
observed that L-Sox5 (only expressed in chondrocytes), Sox6, and Sox9 
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proteins cooperatively activated expression of Col II gene (Lefebvre et al., 
1998). 
Moreover, Sox9 protein binds to the type II collagen (Col II) promoter 
region and activates the transcription followed by translation of Col II protein, 
a cartilage-specific matrix material. The synthesis of extracellular matrix like 
aggrecan, a cartilage-specific proteoglycan, and other type IX and X collagen 
proteins are also promoted in the presence of Sox9 (Sekiya et al., 2000; 
Takahashi et al., 1998; Kamisan et al., 2013). While Per1 expression sharply 
increased, not only Sox6 expressed a decreased mRNA expression level but a 
lower amount of Col II gene transcript was obtained as well. The result 



















CHONDROGENIC DIFFERENTIATION IN COORDINATION 
WITH PER1 REPRESSION 
4.1. Gene silencing by short-interference RNA 
Small-interference RNAs are approximately 20 ~24 nucleotides in length 
serving as regulatory molecules. In living cells, they not only act as “guards” 
to prevent cells from invasion of any exogenous nucleic acid (like viruses, 
exogenous RNAs…) but get involved in maintaining genome integrity by 
silencing transcription from undesired loci (retro-transposon, repeat 
sequences) as well (Naqvi et al., 2009).  
4.1.1. siRNA processing 
The most prevalent requirement for siRNA generation is a long double-
stranded (ds) RNA molecule in vivo. These dsRNAs are formed either from 
any transcription event generating messages with complementary sequences 
or via some enzymatic activity capable of converting RNA from single strand 
to double strand. The key molecule in siRNA generation is Dicer, an RNaseIII 
type endonuclease. Animals usually encode a single type of Dicer to generate 
various classes of small RNAs with exceptions of Drosophila and C. elegans 
which encoding two dicers for each (Lee et al., 2004). In in vitro studies or 
cell culture system, exogenous siRNA pathway follows parallel to 
endogenous pathway, but differs in the fact that the cytoplasmic Dicer 
generates the siRNA duplexes. The RITS complex lead to transcriptional gene 
silencing that involves various proteins. 
Another important protein involved in siRNA biogenesis in C. elegans is 
RNA dependent RNA polymerase (RdRP). The major function of this protein 
is to generate secondary siRNAs, a step termed signal amplification in siRNA 
pathway. RdRP can recognize aberrant RNA molecules to produce dsRNAs 
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either in a primer dependent or an independent manner. The dsRNA 
molecules thus formed are later cleaved by downstream dicer activity. 
The core complex (RISC) receives short RNAs from Dicer and using it as 
a guide to identify its homolgous substrate. Upon each type of signal (in the 
manner of structure and location), RNAis’ fates could be in different 
directions: either promoting inhibition of ribosomes access leading to 
translational halt or degrading duplex RNA (Hannon, 2002). At RNA III 
domain, it cleaves dsRNA precursors into shorter ones, about 21-nt in length 
for each segment. 
The siRNA processing in vivo undergoes some major steps (Fig.4.1): 
(i) Cognate genomic locus is transcribed via pol II / pol III/ pol IV enzymes 
to form double stranded RNA structure or newly formed dsRNAs (Lee 
et al., 2004; Borchert et al., 2006); 
 (ii) The newly formed dsRNAs are, in turn, recognized by RNase III type 
endonucleases (Drosha and Dicer in D. melanogaster, C. elegans) to 
generate duplex unwound RNAs with 19 to 28 nt in length under effect 
of Argonaute protein 2 (Ago2); 
(iii) The single stranded mature small RNAs as guide molecules to multi 
protein complex called RNA Induced Silencing Complex (RISC) or 
RNA Induced Transcriptional Silencing Complex (RITS) (Pal-Bhadra 
et al., 2002; Noma et al., 2004). Noted that nuclease could be integrated 
in RISC (Hannon, 2002); 
(iv) The whole process finally achieves either the cleavage/ the repression 
at transcriptional level of the homologous message(s) that is determined 
by the specificity of complementary complex. Alternatively, the RISC 
induces silencing at transcriptional level at corresponding locus by 
recruiting specific proteins  (Pal-Bhadra et al., 2002) or activating 





Figure 4.1. Small interference siRNA processing. Once inside the cellular matrix through 
SID-1 channel, dsRNAs under the effect of DICER will be chopped into small interference 
RNAs. These siRNAs then integrate with a recruited Argonaute protein-2 (Ago2), 
becoming unwound and exposed under the enzymatic activity of active phosphorylated 
helicase domain of Dicer (phosphorylated by ATP) into single strands followed by being 
loaded to siRISC. If that RNA duplex has perfect sequence match to cognate mRNA, Ago2 
will cleave the passenger or sense strand leaving the active or anti-sense one for RISC to 
be produced. In turn, this siRNA serves as a guide to the targeted sites resulting in specific 
mRNA cleavage. 
4.1.2. Systematic nature of silencing 
Genetic studies in animals supports for a hypothesis that siRNA into cells 
is mediated by a transmembrane protein called Systemic RNA Interference – 
Deficient 1 (SID-1). SID-1 mediates the uptake of siRNA in the length-
dependent manner, i.e the longer the molecule (around 500 bps) the faster the 
speed of uptake occurs compared to that for smaller molecules (approximately 
30 bps) under passive diffusion mode (Feinberg and Hunter, 2003). SiRNA 
functions, thus, upon its binding to target sequences, which is well governed 
by an essential region within the siRNA sequence called “seed region” (Lewis 
et al., 2005). The ribonucleotides include the 2-7 positions (with reference to 
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5′ end) of siRNA constitute the “seed region” and are crucial to confer siRNAs 
their target specificity. Via “seed region”, RISC aims at, unwinds along with 
annealing and ultimately forces target mRNA into repression by cleaving 
them. Because siRNAs bind to the sequences from which they are derived, 
they are not under any kind of selection pressure (Mette et al., 2000). It should 
be noted that although the seed region is important in target recognition, the 
complementarity in other region of siRNA is critical during the cleavage event. 
SiRNAs have been involved in almost all possible nucleic acid regulatory 
pathways like target cleavage (Hammond et al., 2000; Elbashir et al., 2001), 
transcriptional gene silencing (Taverna et al., 2002; Volper et al., 2002) and 
DNA elimination (Mochizuki et al., 2004; Liu et al., 2004). 
4.1.3. Gene Knock down by SiRNA delivery in vitro 
siRNAs has great potential in the field of knock-down gene research in 
mammalian cells (McManus and Sharp, 2002). They are thought to be the 
main protagonists in RNAi. The only difference in siRNA processing under 
in culture system is that exogenous dsRNAs undergo initial modification by 
dicer protein in vivo whilst the delivered siRNAs are quickly loaded siRISC, 
which then catalyzes multiple rounds of RNAi degradation. This is quite an 
amazing persistence amongst several organisms, such as in round-worms C. 
elegans and fruit fly D. melanogaster (Grishok et al., 2001; Wasi, 2003). 
In adult mice, naked siRNAs have been delivered by transfection methods 
(Cardoso et al., 2009; Podesta and Kostarelos, 2009) and the transfected 
siRNAs have been used successfully for studying the role of proteins in DNA 
damage response and cell cycle control, general cell cycle metabolism, 
signaling, the cytoskeleton and its rearrangement during mitosis, membrane 
trafficking, transcription, and DNA methylation (Elbashir et al., 2001). The 
knockdown phenotype and Northern blot analysis can also be used efficiently 
to detect the effects of siRNA (Agrawal et al., 2003). 
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As a way of introducing siRNA into mammalian cells, Lipofectamine 2000 
is a cationic liposome based reagent that provides high transfection efficiency 
and high levels of transgene expression in a range of mammalian cell types in 
vitro using a simple protocol (Chang et al., 2012). Optimum transfection 
efficiency and subsequent cell viability depend on a number of experimental 
variables such as cell density, liposome and DNA concentrations, liposome-
DNA complex time, and the presence or absence of media components such 
as antibiotics and serum were investigated in primary neuron culture 
(Muratovska and Eccles, 2004).  
4.2. Methods 
4.2.1. Transfection ATDC5 cells with Per1-siRNA 
ATDC5 cells were plated at 2 x 104 cells/cm2 in DMEM/F12 in the 
presence of 5% FBS 24 h before transfection in Φ35 mm dishes. siRNA with 
Plus reagent were prepared along with reagent only as si-control. On the 
following day, cells were brought into transfection of either siRNA for Per1 
(B-Bridge) or negative control siRNA (as Control Per1-siRNA) at 30 nM by 
Lipofectamine 2000 for 24 h and subsequent replacement of the medium to 
DMEM/F12 containing 5% FBS. BLOCK-iTM Alexa Fluor Red Fluorescent 
Oligo and Silencer Gapdh siRNA (Human, Mouse, Rat) was used for the 
evaluation of siRNA transfection efficiency in ATDC5 cells. 
4.2.2. ATDC5 cell culture 
Performed as described in 2.2.1 
4.2.3. qPCR 
Performed as described in 2.2.3 
4.2.4. Western blot 
4.2.4.1.  Cell lysate preparation 
Cell lysate was treated with (10% glycerol, 2% sodium dodecyl sulfate 
(SDS), 0.01% Bromophenol blue and 5% (BPB) 2-mercaptoethanol (2-ME), 
10 mM Tris- HCl buffer the (pH 6.8) (v/v = 1:4), followed by protein 
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denaturing for 5 min at 1000C, and subsequently stored at -200C until use. 
Otherwise, raw cell lysate (not treated) was stored at -800C until use. 
4.2.4.2.  Polyacrylamide gel electrophoresis (SDS-PAGE) 
Prepared casting gel shifts consisting of 10% resolving and 4.5% 
concentrating of polyacrylamide gel. Each preparation was thawed at room 
temperature from frozen sample at the day of Western blot. Let samples 
resolved in casting gel of SDS-PAGE gel shifts. Run the gel at 200V with 
electrical intensity of 15 mA per gel shift going through the stacking part of 
the gel and through the resolving gel. Allow migration to continue until the 
blue dye front is at the end of the glass plates, but has not migrated off the gel. 
4.2.4.3.  Protein blotting 
 Protein blotting for PVDF membrane was subjected to activation 
treatment with methanol 100% in advance at room temperature.  
 Disassembled gel apparatus and carefully pry plates apart. Then cut off 
stacking gel with a clean razor blade  
 Soaked gel in Transfer Buffer for a few minutes.  
 Opened transfer apparatus gel cassettes with the black panel lying flat 
on the bottom of the tray cover with paper sheet(s), the other panel 
should be against the side of the tray.  
 Prepare the transfer sandwich on the black panel:  
 Papers 
 SDS gel  
 PVDF membrane  
 Remove air bubbles by rolling a glass tube on the membrane.  
 Cover the sandwich with the clear panel, and insert the gel cassette into 
the electrode module with the black panel facing the black cathode 
electrode panel.   
 Transfer for 30 min hours at r.t. at transferred current (1.6 mA/cm2).  
 Stain with 1x Ponceau S and rinse in ultra-pure H2O (ddH2O). 
After blotting, washed membrane(s) with 0.05% TBST for 5 min. 
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4.2.4.4. .Blocking – Incubation with antibodies - Detection 
 Incubate the membrane with 5% skim milk in 0.05% TBST (20 mM 
Tris-HCl (pH 7.5) buffer, 0.05% Tween 20, and NaCl 137 mM) on a 
shaker for 1 hours at r.t.  
 Dilute primary antibody with 1% skim milk in 0.05% TBST and 
incubate the membrane with the diluted primary antibody O/N at 4 ºC.  
 Wash the membrane three times with 0.05% TBST on the Shaker for 
10 min each time.  
  For HRP conjugated primary antibody, incubated for 1 hour at r.t with 
secondary antibody diluted in 1% skim milk in 0.05% TBST. 
 Washed the membrane 3 times with 0.05% TBST for 10 min each time. 
Ultimately, detecting protein signal using ECL kit (2 mL/membrane with 
ECL: ECL2 = 1:1, v/v), to detect antibody-positive protein is exposed to X-
ray film chemiluminescence. 
4.2.5. Reporter assay 
Performed as described in 3.4.2. 
4.3. Results 
4.3.1. Per1 was down regulated in siRNA transfected cells 
Here, we investigated the effects of knockdown of Per1 on chondrocyte 
differentiation. An attempt was next made to elucidate chondrocytic 
maturation in ATDC5 cells transfected with small interfering RNA (siRNA) 
(Fig.4.2A) for the knockdown of Per1 expression. Under microscopic 
observation both in phase and fluorescence condition, approximately 90% of 
cells were successfully transfected with siRNA conjugated with Alexa594 in 
ATDC5 cells transfected under the present experimental conditions 
(Fig.4.2B). Therefore, cultured cells were next transfected with siRNA for 
Per1 gene, followed by further culture in DMEM/F12 containing 5% FBS for 
24 through 60 hours with subsequent determination of the Per1 mRNA levels 
by real time-based RT-PCR. The Per1 mRNA levels were significantly 
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decreased in ATDC5 cells transfected with Per1 siRNA when determined at 
24, 36 and 48 h, but not at 60 h, after the transfection (Fig.4.2C). In cells 
transfected with Per1 siRNA, a marked reduction of Per1 protein was found 
60 h after transfection (Fig.4.2D). 
 
Figure 4.2. Knockdown of Per1 in ATDC5 cells. (A) ATDC5 cells were transfected with 
siRNA conjugated with Alexa594, followed by (B) observation under a fluorescent 
microscope, and (C) further culture for different periods from 24 to 60 h and subsequent 
determination of the Per1 mRNA levels at 24 to 60 h after transfection, and (D) the PER1 
protein levels obtained from Western blotting analysis 60 h after transfection, 
respectively. (*P<0.05, **P<0.01, significantly different from each control value obtained 
in cells with Control siRNA). 
4.3.2. Sox6 and Col II transcriptional activity was upgraded 
In contrast, under the same experimental conditions, a significant and 
sustained increase in Sox6 mRNA expression was observed, along with the 
increased mRNA levels of Col II (Fig.4.3), in ATDC5 cells cultured for 36 to 




      
Figure 4.3. Effect of Per1 knockdown on ATDC5 cells. Cells were also subjected to 
determination of mouse Sox6 (left) and Col II mRNA transcript levels. (*P<0.05, **P<0.01, 
significantly different from each control value obtained in cells with Control siRNA). 
4.4. Conclusion 
From previous results, it was inferred that Per1 gene expression might play 
a suppression role for Sox6 and subsequent Col II expression with confirmed 
decreases in both promoter activity as well as corresponding mRNA transcript 
levels. Ideally, once reducing Per1 expression should Sox6 and Col II mRNA 
transcripts be raised. The outcome of experiment on Per1 knock down 
partially by suppressing its mediators, mRNA, to translational protein turned 
out to be as expected and was in a favor of Per1 suppression role on both Sox6 












CLOCK GENE EXPRESSION AFFECTS CHONDROGENESIS 
5.1. Analysis of protein – DNA interaction in E-box binding motif 
The interactions of PAS domain of Clock and Bmal1 was investigated 
using two-hybrid assay (Gu et al., 2000) and revealed that Clock and Bmal1 
not only interact at PAS AB domain but also between various combinations 
of shorter PAS constructs which all contain PAS B domain but not in PAS 
AB with PAS A alone. Also, Clock phosphorylation is believed to be DNA-
binding-related event but not that of Bmal1 phosphorylation. Once the 
complex has formed followed by phosphorylation by certain kinases (Meng 
et al., 2008; Tamaru et al., 2009; Zhang et al., 2011) in the cytoplasm, the 
hetoreodimer translocates into the nucleus in which Bmal1 is the key factor 
shuttling the localization between cytosol and nuclear of Clock (Kwon et al., 
2006). 
Clock/Bmal1 heterodimer mediates transcriptional activation of target 
genes or clock-controlled genes (CCGs) via cognate E-box sequence (a 
consensus sequence of CACGTG) lying within these genes’ promoters as a 
set of cis-regulatory enhancer tandems (Murre et al., 1989; Gekakis et al., 
1998; Hogenesch et al., 1998; Lee et al., 2010; Travnickova-Bendova et al., 
2002). So far, a total of approximately 320 E-Box controlled genes have been 
found in the SCN and other tissues including calvarial bone (Herzog, 2007; 
Yan et al., 2008; Kohsaka and Bass, 2006). The E-Box plays an important role 
in circadian genes (Liu et al., 2008; Vieira et al., 2008; Bozek et al., 2007; 
Panda et al., 2002; Vallone et al., 2004; Vincent, 2001) and binding of the 
heterodimer to the E-box also drives the circadian D-box binding protein 
(Dbp) encoding gene transcription and chromatin transitions (changes from 
chromatin to facultative chromatin) in periphery (Ripperger and Schibler, 
2006). For instance, Clock protein regulates Dbp expression by binding to E-
box motifs in enhancer regions located in its first and second introns. Another 
CCG, Sirt1, whose circadian rhythmic mRNA peaks in early evening is 
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mediated by Per2 and NAD+ (Nakahata et al., 2008; Belden and Dunlap, 2008) 
to alter solely rhythmic amplitude as its accumulation in mouse hepatocyte 
and fibroblast culture is required for high-magnitude (Asher et al., 2008).  
5.2. Methods 
5.2.1. Sox6 promoter design 
Mouse Sox6 promoter was at first obtained by cloning with the forward 
primer 5’-GGTACC (KpnI site)- ATGGGCTGGCTTTGAAAACT-3’ (-
2,190 to -2,171) and the reverse primer 5’-CTCGAG (XhoI site)-
CAGAGAATTAATCTAAACA -3’ (+181 to +200) with mouse tail genomic 
DNA. The deletion mutant of mouse sox6 promoter plasmid was made from 
the forward primer 5’-GGTACC (KpnI site)- AATTGTTGTTACTTTCTA-3’ 
(-1,080 to -1,061) and the reverse primer 5’-CTCGAG (XhoI site)-
CAGAGAATTAATCTAAACA -3’ (+181 to +200). (Fig 5.1). 
 
Figure 5.1. pGL3-Sox6 promoter-Luc. 
5.2.2. Reporter assay 




Polymerase reaction (PCR) was performed based on sequences found in 
the 5’-flanking region. The mouse sox6 promoter fragment (-2,190 to +200) 
and the deletion mutant of mouse sox6 promoter fragment (-1,080 to +200) 
were cloned into the promoterless pGL-3 basic vector, to create the 
recombinant plasmid -2,190/+200 ~ Sox6-Luc (-1,080 to +200 ~ Sox6-Luc). 
5.2.4. ATDC5 culture 
Performed as described in 2.2.1. 
5.2.5. Chromatin Immunoprecipation (ChIP) assay 
ATDC5 cells were cultured as previously described elsewhere (Takarada 
et al., 2012). In detail, ATDC5 cells were treated with formaldehyde for cross-
linking followed by sonication in lysis buffer containing several protease 
nhibitors (1 mM phenylmethylsulfonyl fluoride, 1 μg/ml aprotinin, and 1 
μg/ml pepstatin). Immunoprecipitation was performed with the anti-Bmal1 
(Rabbit, Santa Cruz) antibody followed by extraction of DNA with 
phenol/chloroform (Fig. 5.4A). 
5.3. Results 
5.3.1. Effects of different clock combine to Sox6 promoter activity 
The Sox6 promoter regions were subjected to a DBTSS 
(http://dbtss.hgc.jp) and TRANSFAC (http://www.gene-
regulation.com/index.html) database search. A database analysis revealed that 
2.2 kb of the 5’ flanking region of the mouse Sox6 gene contains one putative 
E-box (CACGTG), which is a target element recognized by the master clock 
molecules Bmal1/Clock heterodimer. For identification of the promoter 
element responsible for the gene transactivation, a deletion mutant was made 
from the 5’ flanking region of the mouse Sox6 gene for preparation of 
particular luciferase reporter plasmid constructs (Fig.5.1). 
In HEK293 cells with Sox6-Luc (-2190/+200), the introduction of Bmal1 
and/or Clock led to a significant increase in luciferase activity in a manner 
60 
 
sensitive to the inhibition by Per1 transfection (Fig.5.2B). However, 
luciferase activity was not significantly affected by the introduction of 
Bmal1/Clock in cells with Sox6-Luc (-1080/+200) (Fig.5.2C). 
 
Figure 5.2. Cotransfection of Clock/Bmal1/Per1 into HEK293 cells following (A) protocol 
with (B) Sox6-full length promoter-Luc and (C) Sox6-deleted promoter-Luc. *P<0.05, 
**P<0.01, significantly different from each control value obtained in cells with EV. 
##P<0.01, significantly different from the value obtained in cells with Bmal1/Clock. 
5.3.2. Effect of Per1 upregulation on Sox6 promoter activity 
Stable Per1 transfectants were thus transfected with Sox6-Luc (-
2190/+200), followed by determination of luciferase activity 48 h after 
transfection. Luciferase activity was significantly decreased in ATDC5-Per1 
#28 cells transfected with Sox6-Luc (-2190/+200) compared to ATDC5-EV 
cells (Fig.5.3A). In accordance to Per1 stable transfection result, transient 
61 
 
overexpression of Per1 led to a similarly significant reduction of luciferase 
activity in ATDC5 cells with Sox6-Luc (-2190/+200) (Fig.5.3). 
 
Figure 5.3. Sox6 promoter activity: (A) Protocol; (B) Stable transfectant cells, ATDC5-Per1 
#28, were transiently transfected with Sox6 promoter-Luc, and (C) ATDC5 cells were 
transiently transfected with Sox6 promoter-Luc. *P<0.05, **P<0.01, significantly different 
from each control value obtained in cells with EV. 
5.3.3. Clock gene Per1 expression and Sox6 transactivation 
We next performed ChIP assays using sequences found in the 5’ flanking 
region (-1388/-1184) or (+242/+540) of the mouse Sox6 gene (Fig.5.4A & B). 
In immunoprecipitates with the anti-Bmal1 antibody of lysates from ATDC5 
cells transfected with Bmal1/Clock, a PCR product was clearly found with the 
5’ flanking region containing an E-box element (-1388/-1184), but not with 





Figure 5.4. ATDC5 cells were transfected with Bmal1, Clock and Per1 expression vectors, 
followed by (A) immunoprecipitation with the anti-Bmal1 antibody and subsequent (B, C) 
PCR using either primers A or primers B. 
5.4. Conclusions 
Altogether, the results were in the favor of a negative relationship between 
clock gene Per1 expression and that of chondrogenic marker gene Sox6. 
Either stable or transient transfection of Per1 into ATDC5 cells virtually 
resulted in downregulation of Sox6 gene, which was consistent with previous 
findings (Hinoi et al., 2006; Takarada et al., 2012). Besides, ChIP assay 
pointed out the participation of core clock (Clock, Bmal1) in Sox6 
transactivation. Therefore, a high possibility supported to the idea of Per1 
expression interfered chondrogenesis by disrupting Sox6 gene expression 







Utilization of ATDC5 cell line, a well-established chondrogenesis pattern, 
revealed a possible mode of action on how clockwork integrated into 
cartilaginous development (Fig.6.1). In this model, clock gene Per1 
expression was dramatically enhanced shortly after PTH was supplemented 
into ATDC5 cell culture possibly via CREB/PKA pathway. The transiently 
excessive Per1 product in turn interrupted the clock regulatory heterodimer 
Clock/Bmal1 which binds to a cognate E-box found upstream of Sox6 gene 
promoter, resulting in a sharply reduction of Sox6 activity, and also trimeric 
SOX activity seen by a marked drop in Col II mRNA expression. In reversal, 
Per1 knockdown recovered the expression of Sox6 and Col II genes. Col II 
synthesis, which denoted an initial hallmark in chondrogenic differentiation 
(Barbieri et al., 2003), was restrained followed by subsequent decreases of 
other ECM proteins (Takarada et al., 2012) could lead to slowing down the 
chondrogenesis pace. 
 
Figure 6.1. A proposed model of Per1 interference to chondrogenesis. 
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In summary, our work has conveyed two main notes as follows: 
 Successfully established a gain/loss-of-function model of clock gene 
Per1 in pre-chondrogenic ATDC5 cells; 
 Directly demonstrated that Per1 mediated Sox6 downregulation by 
inhibiting Clock/Bmal1 dimer activity upon E-box motif. 
6.2. Critical remarks 
This is the first direct demonstration of a negative correlation between Per1 
and Sox6 expression at the level of gene transactivation in pre-chondrocytic 
ATDC5 cells. Sox6 activity partial failure also reduced that of Sox-trio 
including Sox9. Mutations in a single allele of Sox9 result in a severe skeletal 
malformation syndrome namely campomelic dysplasia in humans, which was 
comparable with Sox9 disruptive phenotype in mice (Foster et al., 1994; 
Wagner et al., 1994; Bi et al., 2001). A transgenic mice overexpressing of 
Sox9 showed the delayed endochondral bone formation (Takarada et al., 
2008). In other words, clock gene Per1 possibly mediated a retardation in 
chondrocyte differentiation. Nevertheless, the final conclusion should await 
the demonstration of failure of Per1 to suppress chondrogenic differentiation 
in chondrocytes isolated from mice defective of Per1, especially when bone 
autonomous clocks remains little known (Ozbudak and Pourquié, 2008) in its 
integration on disease severity (Litinski et al., 2009). 
The inconsistent results of Sox9 expression in stable Per1 transfectants 
argue in favor of an idea that PTH negatively regulates chondrogenic 
differentiation for maturation through upregulation of Per1 expression in a 
manner associated with downregulation of Sox6 instead of upregulation of 
Sox9 during chondrogenesis in pre-chondrocytic ATDC5 cells. Expression of 
mouse Per genes is positively regulated by other clock proteins belonging to 
the bHLH-PAS family, Clock and Bmal1, whereas Per proteins constitute 
multimeric complexes with products of the Cry genes such as Cry1, Cry2 or 
even with that of themselves, Per1 protein, which in turn negatively regulates 
the gene transactivation mediated by the Bmal1/Clock complex (Gekakis et 
al., 1998; Griffin Jr et al., 1999; Kume et al., 1999). The data obtained from 
ChIP assays give support to the proposal that the Bmal1/Clock complex 
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promote transcription of the Sox6 gene through the E-box element located 
between -1389 and -1185 bp upstream in a manner sensitive to the inhibition 
by Per1 (Hinoi et al., 2006). Taken together, downregulation of Sox6 would 
lead to suppression of the gene transactivation mediated by the trimeric Sox 
upstream of the Col II gene. The possibility that Per1 may play a role in 
mechanisms underlying the suppressed chondrocytic differentiation mediated 
by PTH in conjunction with downregulation of Sox6 expression during 
chondrogenesis is, though, not cast aside. 
The physiological and pathological significance of peripheral clock genes 
expressed outside the hypothalamic suprachiasmatic nucleus, however, still 
remains to be elucidated. Besides, pancreatic islet is shown to have a self-
sustained molecular clock system (Lamia and Evans, 2010; Shackel, 2009) 
apart from control by the central clock to coordinate insulin secretion with a 
sleep-wake cycle (Marcheva et al., 2010), and that Per1 and Per2 genes were 
also found to express in other endocrine tissues like thyroid, testis, and adrenal 
in both medulla and cortex (Bittman et al., 2003). Sox6 emerged as a 
promising candidate for therapeutic target in treating type 2 diabetes owing to 
its double-faced transcription factor for negatively regulating both cell 
proliferation and insulin secretion in pancreatic β-cells (Iguchi et al., 2007).  
More than half of the cartilaginous matrix-related genes did not have clock-
controlled elements in their promoter regions. However, the circadian phase 
of Sox9 was similar to that of cartilage matrix-related genes, e.g. Col II, under 
LD conditions was reported (Honda et al., 2013). That result implied that Sox9 
probably contributes at least partly to the circadian expression of the matrix- 
related genes. Interestingly, Sox9, known as an upstream regulator for Col2a1 
and Agc1, contains no signal of circadian regulatory elements. Hence, it is 
noteworthy to elucidate how much Sox6 and/or Sox9 genes in chondrocytic 
population get involve in circadian oscillation using different light/dark cycles 
during animal husbandry. With the concept of the circadian clock as a nature’s 
tool to effectively deal with the daily routine, thus, our finding could help 
putting therapeutic interventions against cartilaginous diseases (Rousseau and 
Delmas, 2007; Lotz et al., 2013; Goldring, 2006) up to a wrinkle in addition 
to present mechanic methods (Villemure and Stokes, 2009) by figuring out 




Adams, S. L., Cohen, A.J., Lassova, L. (2007). Integration of signaling pathways regulating 
chondrocyte differentiation during endochondral bone formation. J. Cell Physiol., 213, 635-
641. 
Akiyama, H., Chaboissier, M.-C., Martin, J. F., Schedl, A., & de Crombrugghe, B. (2002). The 
transcription factor Sox9 has essential roles in successive steps of the chondrocyte 
differentiation pathway and is required for expression of Sox5 and Sox6. Gen. Dev., 16, 2813–
2828. 
Asher, G., Gatfield, D., Stratmann, M., Reinke, H., Dibner, C., Kreppel, F., Mostoslavsky, R., Alt, F. W., 
and Schibler, U. (2008). SIRT1 regulates circadian clock gene expression through PER2 
deacetylation. Cell, 134, 317–128. 
Atsumi, T., Miwa, Y., Kimata, K., and Ikawa, Y. (1990). A chondrogenic cell line derived from a 
differentiating culture of AT805 teratocarcinoma cells. Cell Diff. Dev., 30, 109–116. 
Aulehla, A., and Herrmann, B. G. (2004). Segmentation in vertebrates: clock and gradient finally 
joined. Gen. Dev., 18, 2060–2067. 
Bae, K., and Edery, I. (2006). Regulating a circadian clock’s period, phase and amplitude by 
phosphorylation: insights from Drosophila. J. Biochem., 140(5), 609–617. 
Balsalobre, A, Damiola, F., and Schibler, U. (1998). A serum shock induces circadian gene expression 
in mammalian tissue culture cells. Cell, 93(6), 929–937. 
Balsalobre, A, Marcacci, L., and Schibler, U. (2000). Multiple signaling pathways elicit circadian gene 
expression in cultured Rat-1 fibroblasts. Curr. Biol., 10, 1291–1294. 
Balsalobre, A. (2002). Clock genes in mammalian peripheral tissues. Cell Tiss. Res., 309, 193–199. 
Barbieri, O., Astigiano, S., Morini, M., Tavella, S., Schito, A., Corsi, A., Di Martino, D., Bianco, P., 
Cancedda, R., and Garofalo, S. (2003). Depletion of cartilage collagen fibrils in mice carrying a 
dominant negative Col2a1 transgene affects chondrocyte differentiation. Am. J. Physiol. Cell 
Physiol., 285, C1504–1512. 
Beier, F., Leask, T. A., Haque, S., Chow, C., Taylor, A. C., Lee, R. J., Pestell, R. G., Ballock, R. T.,  LuValle, 
P. (1999). Cell cycle genes in chondrocyte proliferation and differentiation. Matrix Biol., 18, 
109–120. 
Belden, W. J., and Dunlap, J. C. (2008). SIRT1 is a circadian deacetylase for core clock components. 
Cell, 134, 212–214. 
Bergstrom, D. E., Young, M., Albrecht, K. H., and Eicher, E. M. (2000). Related function of mouse 
SOX3, SOX9, and SRY HMG domains assayed by male sex determination. Genesis, 28, 111–124. 
Bertani, S., Carboni, L., Criado, A., Michielin, F., Mangiarini, L., and Vicentini, E. (2010). Circadian 
profile of peripheral hormone levels in Sprague-Dawley rats and in common marmosets 
(Callithrix jacchus). In vivo, 24, 827–836. 
Bi, W., Huang, W., Whitworth, D. J., Deng, J. M., Zhang, Z., Behringer, R. R., and de Crombrugghe, B. 
(2001). Haploinsufficiency of Sox9 results in defective cartilage primordia and premature 
skeletal mineralization. PNAS, 98(12), 6698–6703. 
Bjarnason, N.H., Henriksen, E.E., Alexandersen, P., Christgau, S., Henriksen, D.B., and Christiansen, 
C. (2002) Mechanism of circadian variation in bone resorption. Bone, 30, 307-313. 
Bittman, E. L., Doherty, L., Huang, L., and Paroskie, A. (2003). Period gene expression in mouse 
endocrine tissues. Am. J. Physiol. Regul. Integr Comp. Physiol., 285, R561–569. 
Borchert, G. M., Lanier, W., Davidson, B. L. (2006). RNA polymerase III transcribes human miRNAs. 
Nat. Struc. Mol. Biol. 13(12), 1097-1101. 
ii 
 
Bowles, J., Schepers, G., and Koopman, P. (2000). Phylogeny of the SOX family of developmental 
transcription factors based on sequence and structural indicators. Dev. Biol., 227, 239–255. 
Bozek, K., Kiełbasa, S. M., Kramer, A., and Herzel, H. (2007). Promoter analysis of Mammalian clock 
controlled genes. Genom. Infor. Int. Conf. Genome Infor., 18, 65–74. 
Bridgewater, L. C., Lefebvre, V., and de Crombrugghe, B. (1998). Chondrocyte-specific Enhancer 
Elements in the Col11a2 Gene Resemble the Col2a1 Tissue-specific Enhancer. J. Biol. Chem., 
273, 14998–15006. 
Brown, S. A, and Schibler, U. (1999). The ins and outs of circadian timekeeping. Curr. Opi. Genet. 
Dev., 9, 588–594. 
Bugge, A., Feng, D., Everett, L. J., Briggs, E. R., Mullican, S. E., Wang, F., Jager, J., Lazar, M. a. (2012). 
Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic 
function. Gen. Dev., 26, 657–667. 
Burdan, F., Szumiło, J., Korobowicz, A., Farooquee, R., Patel, S., Patel, A., Dave, A., Szumiło, M., 
Solecki, M., Klepacz, R., Dudka, J. (2009). Morphology and physiology of the epiphyseal growth 
plate. Fol. Histochem. Cytobiol., 47(1), 5–16. 
Busino, L., Bassermann, F., Maiolica, A., Lee, C., Nolan, P. M., Godinho, S. I. H., Draetta, G. F., and 
Pagano, M. (2007). SCFFbxl3 controls the oscillation of the circadian clock by directing the 
degradation of cryptochrome proteins. Science, 316, 900–904. 
Cao, Q., Gery, S., Dashti, A., Yin, D., Zhou, Y., Gu, J., and Koeffler, H. P. (2009). A role for the clock 
gene per1 in prostate cancer. Cancer Res., 69, 7619–7525. 
Caplan, A. I. (1991). Mesenchymal stem cells. J. Orthopaedic Res., 9, 641–50. 
Cardoso, A., Trabulo, S., Moreira, J. N., Düzgüneş, N., and de Lima, M. C. P. (2009). Targeted 
lipoplexes for siRNA delivery. In Methods in Enzymology (Vol.465 ed., Vol. 465, pp. 267–287). 
Elsevier Inc. 
Cermakian, N., and Boivin, D. B. (2003). A molecular perspective of human circadian rhythm 
disorders. Brain Res. Brain Res. Rev., 42, 204–220. 
Chang, K., Marran, K., Valentine, A., and Hannon, G. J. (2012). RNAi in cultured mammalian cells 
using synthetic siRNAs. Cold Spring Harb. Prot., 957–961. 
Chappuis, S., Ripperger, J. A., Schnell, A., Rando, G., Jud, C., Wahli, W., and Albrecht, U. (2013). Role 
of the circadian clock gene Per2 in adaptation to cold temperature. Mol. Metab., 2, 184–193. 
Chen, W.-H., Lai, M.-T., Wu, A. T. H., Wu, C.-C., Gelovani, J. G., Lin, C.-T., Hung, S-C., Chiu, W-T., and 
Deng, W.-P. (2009). In Vitro Stage-Specific Chondrogenesis of Mesenchymal Stem Cells 
Committed to Chondrocytes. Arthrit. Rheuma., 60(2), 450–459. 
Cheng, H.-Y. M., Papp, J. W., Varlamova, O., Dziema, H., Russell, B., Curfman, J. P., Nakazawa, T., 
Shimizu, K., Okamura, H., Impey, S., and Obrietan, K. (2007). microRNA modulation of 
circadian-clock period and entrainment. Neuron, 54, 813–829. 
Cho, H., Zhao, X., Hatori, M., Yu, R. T., Barish, G. D., Lam, M. T., Chong, L-W., DiTacchio, L., Atkins, A. 
R., Glass, C. K., Liddle, C., Auwerx, J., Downes, M., Panda, S., and Evans, R. M. (2012). 
Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. Nat., 485, 
123–127. 
Chorev, M. (2002). Parathyroid hormone 1 receptor: insights into structure and function. Receptors 
Channels, 8, 219-242. 
Chua, K. H., Aminuddin, B. S., Fuzina, N. H., and Ruszymah, B. H. I. (2005). Insulin-transferrin-
selenium prevent human chondrocyte dedifferentiation and promote the formation of high 
quality tissue engineered human hyaline cartilage. Eu. Cells Materials, 9, 58–67. 
Cohen-barak, O., Yi, Z., Hagiwara, N., Monzen, K., Komuro, I., and Brilliant, M. H. (2003). Sox6 
regulation of cardiac myocyte development. Nucleic Acids Res., 31(20), 5941–5948. 
iii 
 
Cohen-Kfir, E., Artsi, H., Levin, A., Abramowitz, E., Bajayo, A., Gurt, I., Zhong, L., D'Urso, A., Toiber, 
D., Mostoslavsky, R., and Dresner-Pollak, R. (2011). Sirt1 is a regulator of bone mass and a 
repressor of Sost encoding for sclerostin, a bone formation inhibitor. Endocrin., 152(11), 
4514–4524. 
Compston, J. E. (2007). Skeletal actions of intermittent parathyroid hormone: Effects on bone 
remodeling and structure. Bone, 40, 1447–1452. 
Connor, F., Wright, E., Denny, P., and Koopman, P. (1995). The Sry-related HMG box-containing gene 
Sox6 is expressed in the adult testis and developing nervous system of the mouse, 23(17), 
3365–3372. 
Daan, S. (2000). Colin Pittendrigh, Jürgen Aschoff, and the natural entrainment of circadian systems. 
J. Biol. Rhythms, 15(3), 195–207. 
Daan, S., and Pittendrigh, C. S. (1976). A Functional Analysis of Circadian Pacemakers in Nocturnal 
Rodents. II. The Variability of Phase Response Curves. J. Comp. Physiol., 106, 253–266. 
Damiola, F., Le, N. M., Preitner, N., Fleury-olela, F., and Schibler, U. (2000). Restricted feeding 
uncouples circadian oscillators in peripheral tissues from the central pacemaker in the 
suprachiasmatic nucleus. Gen. Dev., 14, 2950–2961. 
Dardente, H., Fortier, E. E., Martineau, V., and Cermakian, N. (2007). Cryptochromes impair 
phosphorylation of transcriptional activators in the clock: a general mechanism for circadian 
repression. Biochem. J., 402, 525–536. 
De Cesare, D., Fimia, G. M., and Sassone-Corsi, P. (1999). Signaling routes to CREM and CREB: 
plasticity in transcriptional activation. Trends Biochem. Sci., 24(7), 281–285. 
De Crombrugghe, B., Lefebvre, V., Behringer, R. R., Bi, W., Murakami, S., and Huang, W. (2000). 
Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol., 19, 389–394. 
DeBruyne, J. P., Weaver, D. R., and Reppert, S. M. (2007). Peripheral circadian oscillators require 
CLOCK. Curr. Biol., 17(14), R538–539. 
Debruyne, J. P., Weaver, D. R., and Steven, M. (2007). CLOCK and NPAS2 have overlapping roles in 
the suprachiasmatic circadian clock. Nat. Neurosci., 10(5), 543–545. 
Doi, M., Hirayama, J., and Sassone-Corsi, P. (2006). Circadian regulator CLOCK is a histone 
acetyltransferase. Cell, 125(3), 497–508. 
Dubrovsky, Y. V, Samsa, W. E., and Kondratov, R. V. (2010). Deficiency of circadian protein CLOCK 
reduces lifespan and increases age-related cataract development in mice. Aging, 2(12), 936–
44. 
Dy, P., Han, Y., and Lefebvre, V. (2008). Generation of mice harboring a Sox5 conditional null allele. 
Genesis, 46, 294–299. 
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and and Tuschl, T. (2001). Duplexes 
of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nat., 411, 494–
498. 
Etchegaray, J.-P, Lee, C., Wade, P. A., and Reppert, S. M. (2003). Rhythmic histone acetylation 
underlies transcription in the mammalian circadian clock. Nat., 421, 177–182. 
Etchegaray, J.-P., Machida, K. K., Noton, E., Constance, C. M., Dallmann, R., Di Napoli, M. N., 
DeBruyne, J. P., Lambert, C. M., Yu, E. A., Reppert, S. M., and Weaver, D. R. (2009). Casein 
kinase 1δ regulates the pace of the mammalian circadian clock. Mol. Cell. Biol., 29(14), 3853–
3866. 
Etchegaray, J.-P., Yang, X., DeBruyne, J. P., Peters, A. H. F. M., Weaver, D. R., Jenuwein, T., and 
Reppert, S. M. (2006). The polycomb group protein EZH2 is required for mammalian circadian 
clock function. J. Biol. Chem., 281(30), 21209–21215. 
iv 
 
Fawcett, D. W. (1994a). Chapter 7: Cartilage. In D. W. Fawcett (Ed.), Bloom and Fawcett: A Textbook 
of Histology (12th ed., pp. 182–193). New York, NY: Chapman & Hall. 
Fawcett, D. W. (1994b). Chapter 8: Bone. In D. W. Fawcett (Ed.), Bloom and Fawcett: A Textbook of 
Histology (12th ed., pp. 194–233). New York, NY: Chapman & Hall. 
Fawcett, D. W. (1994c). Chapter 19: Parathyroid Glands. In D. W. Fawcett (Ed.), Bloom and Fawcett: 
A Textbook of Histology (12th ed., pp. 498–502). New York, NY: Chapman & Hall. 
Feillet, C. A, Albrecht, U., and Challet, E. (2007). “Feeding time” for the brain: a matter of clocks. J. 
Physiol., 100, 252–260. 
Feinberg, E. H., and Hunter, C. P. (2003). Transport of dsRNA into cells by the transmembrane protein 
SID-1. Science, 301, 1545–1547. 
Foster, J. W., Dominguez-Seglich, M. A., Guioli, S., Kowk, C., Weller, P. A., Stevanovic, M., 
Weissenbach, J., Masour, S., Young, I. D., Goodfellow, P. N., Brook, J. D., and  Schafer, A. J. 
(1994). Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-
related gene. Nat., 372, 525–530. 
Fu, L., Pelicano, H., Liu, J., Huang, P., and Lee, C. (2002). The circadian gene Period2 plays an 
important role in tumor suppression and DNA damage response in vivo. Cell, 111, 41–50. 
Fujita, T., Fukuyama, R., Enomoto, H., and Komori, T. (2004). Dexamethasone inhibits insulin-induced 
chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2. J. 
Cell. Biochem., 93, 374–383. 
Gallego, M., and Virshup, D. M. (2007). Post-translational modifications regulate the ticking of the 
circadian clock. Nat. Rev. Mol. Cell Biol., 8, 139–148. 
Garbarino-Pico, E., and Green, C. B. (2007). Posttranscriptional regulation of mammalian circadian 
clock output. Cold Spring Harb. Symp. Quant. Biol., 72, 145–156. 
Gekakis, N., Staknis, D., Nguyen, H. B., Davis, F. C., Wilsbacher, L. D., King, D. P., Takahashi, J. S., and 
Weitz, C. J. (1998). Role of the CLOCK Protein in the Mammalian Circadian Mechanism. Science, 
280, 1564–1569. 
Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., and Collins, T. (1997). CREB-binding 
protein p͞300 are transcriptional coactivators of p65. PNAS, 94, 2927–2932. 
Gery, S., Komatsu, N., Baldjyan, L., Yu, A., Koo, D., and Koeffler, H. P. (2006). The circadian gene Per1 
plays an important role in cell growth and DNA damage control in human cancer cells. Mol. 
Cell, 22, 375–382. 
Gibson, G, Lin, D. L., and Roque, M. (1997). Apoptosis of terminally differentiated chondrocytes in 
culture. Exp. Cell Res., 233, 372–382. 
Gibson, Gary. (1998). Active Role of Chondrocyte Apoptosis in Endochondral Ossification. 
Microscopy Res. Tech., 43, 191–204. 
Gillette, M. U., and Reppert, S. M. (1987). The Hypothalamic Suprachiasmatic Nuclei : Circadian 
Patterns of Vasopressin Secretion and Neuronal Activity In Vitro. Brain Res. Bullet., 19, 135–
139. 
Ginty, D. D., Kornhauser, J. M., Thompson, M. a, Bading, H., Mayo, K. E., Takahashi, J. S., and 
Greenberg, M. E. (1993). Regulation of CREB phosphorylation in the suprachiasmatic nucleus 
by light and a circadian clock. Science, 260, 238–241. 
Goel, N., Lee, T. M., and Smale, L. (1999). Suprachiasmatic nucleus and intergeniculate leaflet in the 
diurnal rodent Octodon degus: retinal projections and immunocytochemical characterization. 
Neurosci., 92(4), 1491–1509. 
Goldbeter, A., and Pourquié, O. (2008). Modeling the segmentation clock as a network of coupled 
oscillations in the Notch, Wnt and FGF signaling pathways. J. Theoretical Biol., 252, 574–585. 
v 
 
Goldring, M. B. (2006). Update on the biology of the chondrocyte and new approaches to treating 
cartilage diseases. Best Pract. Res. Clin. Rheumatol., 20(5), 1003–1025. 
Goldring, M. B., Tsuchimochi, K., and Ijiri, K. (2006). The control of chondrogenesis. J. Cell. Biochem., 
97, 33–44. 
Golombek, D. A., and Rosenstein, R. E. (2010). Physiology of Circadian Entrainment. Physiol. Rev., 90, 
1063–1102. 
Gotter, A. L., Manganaro, T., Weaver, D. R., Kolakowski, L. F., Possidente, B., Sriram, S., MacLaughlin, 
D. T., and Reppert, S. M. (2000). A time-less function for mouse timeless. Nat. Neurosci., 3(8), 
755–756. 
Griffin Jr, E. A. ., Staknis, D., Weitz, C. J., and Griffin, E. A. (1999). Light-independent role of CRY1 and 
CRY2 in the mammalian circadian clock. Science, 286, 768–771. 
Grimaldi, B., Nakahata, Y., Kaluzova, M., Masubuchi, S., and Sassone-Corsi, P. (2009). Chromatin 
remodeling, metabolism and circadian clocks: the interplay of CLOCK and SIRT1. Int. J. 
Biochem. Cell Biol., 41, 81–86. 
Grishok, A., Pasquinelli, A. E., Conte, D., Li, N., Parrish, S., Ha, I., Baillie, D. L., Fire, A., Ruvkun, G., and 
Mello, C. C. (2001). Genes and mechanisms related to RNA interference regulate expression 
of the small temporal RNAs that control C. elegans developmental timing. Cell, 106, 23–34. 
Gu, Y. Z., Hogenesch, J. B., and Bradfield, C. A. (2000). The PAS superfamily: sensors of environmental 
and developmental signals. Ann. Rev. Pharmacol. Toxicol., 40, 519–561. 
Gubbay, J., Collignon, J., Koopman, P., Capel, B., Economou, A., Münsterberg, A., Vivian, N., 
Goodfellow, P., and Lovell-Badge, R. (1990). A gene mapping to the sex-determining region of 
the mouse Y chromosome is a member of a novel family of embryonically expressed genes. 
Nat., 346, 245–250. 
Guo, B., Chatterjee, S., Li, L., Kim, J. M., Lee, J., Yechoor, V. K., Minze, L. J., Hsueh, W., and Ma, K. 
(2012). The clock gene, brain and muscle Arnt-like 1, regulates adipogenesis via Wnt signaling 
pathway. FASEB J., 26, 3453–3463. 
Hammond, S. M., Caudy, A. A., and Hannon, G. J. (2001). Post-transcriptional gene silencing by 
double-stranded RNA. Nat. Rev. Genet., 2, 110–109. 
Hannon, G. J. (2002). RNA interference. Nat., 418, 244–251. 
Haque, R., Ali, F. G., Biscoglia, R., Abey, J., Weller, J., and Iuvone, P. M. (2010). CLOCK and NPAS2 
have overlapping roles in the circadian oscillation of arylalkylamine N-acetyltransferase 
(Aanat) mRNA in chicken cone photoreceptors. J. Neurochem., 113(5), 1296–1306. 
Harper, J., and Klagsburn, M. (1999). Cartilage to bone — Angiogenesis leads the way. Nat., 5(6), 
617–618. 
Hastings, M. H., Reddy, A. B., and Maywood, E. S. (2003). A clockwork web: circadian timing in brain 
and periphery, in health and disease. Nat. Rev. Neurosci., 4, 649–661. 
Hastings, M., O’Neill, J. S., and Maywood, E. S. (2007). Circadian clocks: regulators of endocrine and 
metabolic rhythms. J. Endocrin., 195, 187–198. 
Herzog, E. D. (2007). Neurons and networks in daily rhythms. Nat., 8, 790 – 802. 
Herzog, E. D., and Schwartz, W. J. (2002). A neural clockwork for encoding circadian time. J. Appl. 
Physiol., 92, 401–408. 
Hida, A., Koike, N., Hirose, M., Hattori, M., Sakaki, Y., and Tei, H. (2000). The human and mouse 
Period1 genes: five well-conserved E-boxes additively contribute to the enhancement of 
mPer1 transcription. Genom., 65, 224–233. 
Hinoi, E., Fujimori, S., and Yoneda, Y. (2003). Modulation of cellular differentiation by N-methyl-D-
aspartate receptors in osteoblasts. FASEB J., 17, 1532–1534. 
vi 
 
Hinoi, E., Ueshima, T., Hojo, H., Iemata, M., Takarada, T., and Yoneda, Y. (2006). Up-regulation of per 
mRNA expression by parathyroid hormone through a protein kinase A-CREB-dependent 
mechanism in chondrocytes. J. Biol. Chem., 281, 23632–23642. 
Hirano, A., Yumimoto, K., Tsunematsu, R., Matsumoto, M., Oyama, M., Kozuka-Hata, H., Nakagawa, 
T., Lanjakornsiripan, D., Nakayama, K. I., and Fukada, Y. (2013). FBXL21 regulates oscillation of 
the circadian clock through ubiquitination and stabilization of cryptochromes. Cell, 152, 1106–
1118. 
Hirota, T., and Fukada, Y. (2004). Resetting mechanism of central and peripheral circadian clocks in 
mammals. Zoolog. Sci., 21, 359–368. 
Hoare, S. R. J. and Usdin, T. B. (2001). Molecular Mechanisms of Ligand Recognition by Parathyroid 
Hormone 1 (PTH1) and PTH2 Receptors. Curr. Pharmaceutical Design, 7(8), 689-713. 
Hoffman, A. E., Zheng, T., Ba, Y., and Zhu, Y. (2008). The circadian gene NPAS2, a putative tumor 
suppressor, is involved in DNA damage response. MCR, 6, 1461–1468. 
Hogenesch, J. B., Gu, Y. Z., Jain, S., and Bradfield, C. A. (1998). The basic-helix-loop-helix-PAS orphan 
MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. PNAS, 95, 
5474–5479. 
Honda, K. K., Kawamoto, T., Ueda, H. R., Nakashima, A., Ueshima, T., Yamada, R. G., Nishimura, 
M., Oda, R., Nakamura, S., Kojima, T., Noshiro. M., Fujimoto, K., Hashimoto, S., and Kato, Y. 
(2013) Different circadian expression of major matrix-related genes in various types of 
cartilage: modulation by light-dark conditions. J Biochem. 154(4), 373-381. 
Huang, W., Zhou, X., Lefebvre, V., and de Crombrugghe, B. (2000). Phosphorylation of SOX9 by Cyclic 
AMP-Dependent Protein Kinase A Enhances SOX9’s Ability To Transactivate a Col2a1 
Chondrocyte-Specific Enhancer. Mol. Cell. Biol., 20(11), 4149–4158. 
Iguchi, H., Urashima, Y., Inagaki, Y., Ikeda, Y., Okamura, M., Tanaka, T., Uchida, A., Yamamoto, T. T., 
Kodama, T., and Sakai, J. (2007). SOX6 Suppresses Cyclin D1 Promoter Activity by Interacting 
with β-catenin and Histone Deacetylase 1, and Its Down-regulation Induces Pancreatic β-cell 
Proliferation. J. Biol. Chem., 282 (26), 19052–19061. 
Iimura, T., Nakane, A., Sugiyama, M., Sato, H., Makino, Y., Watanabe, T., Takagi, Y., Numano, R., and 
Yamaguchi, A. (2012). A fluorescence spotlight on the clockwork development and 
metabolism of bone. J. Bone Mine. Metab., 30, 254–269. 
Iitaka, C., Miyazaki, K., Akaike, T., and Ishida, N. (2005). A role for glycogen synthase kinase-3beta in 
the mammalian circadian clock. J. Biol. Chem., 280(29), 29397–29402. 
Ikegami, D., Akiyama, H., Suzuki, A., Nakamura, T., Nakano, T., Yoshikawa, H., and Tsumaki, N. (2011). 
Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. 
Dev., 138, 1507–1519. 
Inouye, S. T., and Kawamura, H. (1979). Persistence of circadian rhythmicity in a mammalian 
hypothalamic “island” containing the suprachiasmatic nucleus. PNAS, 76(11), 5962–5966. 
Iwai, T., Murai, J., Yoshikawa, H., and Tsumaki, N. (2008). Smad7 Inhibits chondrocyte differentiation 
at multiple steps during endochondral bone formation and down-regulates p38 MAPK 
pathways. J. Biol. Chem., 283(40), 27154–27164. 
Jakob, M., Démarteau, O., Schäfer, D., Hintermann, B., Dick, W., Heberer, M., and Martin, I. (2001). 
Specific growth factors during the expansion and redifferentiation of adult human articular 
chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J. Cell. 
Biochem., 81(2), 368–377. 
Jakob, M., Démarteau, O., Suetterlin, R., Heberer, M., and Martin, I. (2004). Chondrogenesis of 




Johannessen, M., Delghandi, M. P., and Moens, U. (2004). What turns CREB on? Cell. Sig., 16, 1211–
1227. 
Jubiz, W., Canterbury, J. M., Reiss, E., and Tyler, F. H. (1972). Circadian Rhythm in Serum Parathyroid 
Hormone concentation in Human Subjects: correaltion with Serum Calcium, Phosphate, 
Albumin, and Growth Hormone Levels. J. Clin. Invest., 51, 2040–2046. 
Jung-Hynes, B., Reiter, R. J., and Ahmad, N. (2010). Sirtuins, melatonin and circadian rhythms: 
building a bridge between aging and cancer. J. Pineal Res., 48, 9–19. 
Jursky, F., Tamura, S., Tamura, a, Mandiyan, S., Nelson, H., and Nelson, N. (1994). Structure, function 
and brain localization of neurotransmitter transporters. J. Exp.Biol., 196, 283–295. 
Kadam, S., and Emerson, B. M. (2002). Mechanisms of chromatin assembly and transcription. Curr. 
Op Cell Biol. 14(3), 262–268. 
Kamisan, N., Naveen, S. V., Ahmad, R. E., and Tunku, K. (2013). Chondrocyte density, proteoglycan 
content and gene expressions from native cartilage are species specific and not dependent on 
cartilage thickness: a comparative analysis between rat, rabbit and goat. BMC Vet. Res., 9, 62. 
Karsenty, G. (2003). The complexities of skeletal biology. Nat., 423, 316–318. 
Kawakami, Y., Tsuda, M., Takahashi, S., Taniguchi, N., Esteban, C. R., Zemmyo, M., Furumatsu, T., 
Lotz, M., and Belmonte, J. C. I. (2005). Transcriptional coactivator PGC-1α regulates 
chondrogenesis via association with Sox9. PNAS, 102(7), 2414–2419. 
Kawakita, A., Sato, K., Makino, H., Ikegami, H., Takayama, S., Toyama, Y., and Umezawa, A. (2008). 
Nicotine acts on growth plate chondrocytes to delay skeletal growth through the α7 neuronal 
nicotinic acetylcholine receptor. PloS one, 3(12), e3945. 
Kawamoto, T., Noshiro, M., Sato, F., Maemura, K., Takeda, N., Nagai, R., Iwata, T., Fujimoto, K., 
Furukawa, M., Miyazaki, K., Honma, S., Honma, K-I., and Kato, Y. (2004). A novel autofeedback 
loop of Dec1 transcription involved in circadian rhythm regulation. Biochem. Biophys. Res. 
Comm., 313, 117–124. 
Keller, B., Yang, T., Chen, Y., Munivez, E., Bertin, T., Zabel, B., and Lee, B. (2011). Interaction of TGFβ 
and BMP signaling pathways during chondrogenesis. PloS one, 6(1), e16421. 
Kennaway, D. J., Varcoe, T. J., Voultsios, A., and Boden, M. J. (2013). Global loss of bmal1 expression 
alters adipose tissue hormones, gene expression and glucose metabolism. PloS one, 8(6), 
e65255. 
Kiani, C., Chen, L., Wu, Y. J., Yee, A. J., and Yang, B. B. (2002). Structure and function of aggrecan. Cell 
Res., 12, 19–32. 
Kiefer, J. C. (2007). Back to basics: Sox genes. Dev. Dynam., 236, 2356–2366. 
Kim, E.-J., Cho, S.-W., Shin, J.-O., Lee, M.-J., Kim, K.-S., and Jung, H.-S. (2013). Ihh and Runx2/Runx3 
Signaling Interact to Coordinate Early Chondrogenesis: A Mouse Model. PloS one, 8(2), e55296. 
King, D. P., Zhao, Y., Sangoram, A. M., Wilsbacher, L. D., Tanaka, M., Antoch, M. P., Steeves, T. D., 
Vitaterna, M. H., Kornhauser, J. M., Lowrey, P. L., Turek, F. W., and Takahashi, J. S. (1997). 
Positional cloning of the mouse circadian clock gene. Cell, 89, 641–653. 
Knudson, C. B., and Knudson, W. (2001). Cartilage proteoglycans. Cell Dev. Biol., 12, 69–78. 
Kobayashi, T., Soegiarto, D. W., Yang, Y., Lanske, B., Schipani, E., Mcmahon, A. P., and Kronenberg, 
H. M. (2005). Indian hedgehog stimulates periarticular chondrocyte differentiation to regulate 
growth plate length independently of PTHrP. J. Clin. Invest., 115(7), 1734–1742. 
Kohsaka, A., and Bass, J. (2006). A sense of time: how molecular clocks organize metabolism. TEM, 
18(1), 4–11. 
Komori, T., Yagi, H., Nomura, S., Yamaguchi, a, Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, 
Y. H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S., and Kishimoto, T. (1997). 
viii 
 
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to 
maturational arrest of osteoblasts. Cell, 89, 755–764. 
Kondratov, R. V, Chernov, M. V, Kondratova, A. A., Gorbacheva, V. Y., Gudkov, A. V, and Antoch, M. 
P. (2003). BMAL1-dependent circadian oscillation of nuclear CLOCK: posttranslational events 
induced by dimerization of transcriptional activators of the mammalian clock system. Gen. 
Dev., 17, 1921–1932. 
Korenčič, A., Bordyugov, G., Košir, R., Rozman, D., Goličnik, M., and Herzel, H. (2012). The interplay 
of cis-regulatory elements rules circadian rhythms in mouse liver. PloS one, 7(11), e46835. 
Kronenberg, H. M. (2003). Developmental regulation of the growth plate. Nat., 423, 332–336. 
Kubota, T., Michigami, T., and Ozono, K. (2009). Wnt signaling in bone metabolism. J. Bone Mine. 
Metab., 27, 265–271. 
Kume, K., Zylka, M. J., Sriram, S., Shearman, L. P., Weaver, D. R., Jin, X., Maywood, E. S., Hastings, M. 
H., and Reppert, S. M. (1999). mCRY1 and mCRY2 Are Essential Components of the Negative 
Limb of the Circadian Clock Feedback Loop. Cell, 98, 193–205. 
Kwon, I., Lee, J., Chang, S. H., Jung, N. C., Lee, B. J., Son, G. H., Kim, K., and Lee, K. H. (2006). BMAL1 
shuttling controls transactivation and degradation of the CLOCK/BMAL1 heterodimer. Mol. 
Cell. Biol., 26(19), 7318–7130. 
Lago, R., Gomez, R., Otero, M., Lago, F., Gallego, R., Dieguez, C., Gomez-Reino, J. J., and Gualillo, O. 
(2008). A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type 
II and pro-inflammatory cytokines in chondrocytes. Osteoa. Cart., 16, 1101–1109. 
Lamia, K. A., and Evans, R. M. (2010). Tick, tock, a β - cell clock. Nat., 466, 571–572.  
Laurie K. McCauley and T. John Martin. (2012). Twenty-Five Years of PTHrP Progress: From Cancer 
Hormone to Multifunctional Cytokine. J. Bone Bineral Res., 27(6), 1231–1239. 
Le, N. M., Damiola, F., Tronche, F., Schütz, G., and Schibler, U. (2001). Glucocorticoid hormones 
inhibit food-induced phase-shifting of peripheral circadian oscillators. EMBO J., 20(24), 7128–
7136. 
Lee, J., Moulik, M., Fang, Z., Saha, P., Zou, F., Xu, Y., Nelson, D. L., Ma, K., Moore, D. D., and Yechoor, 
V. K. (2013). Bmal1 and β-cell clock are required for adaptation to circadian disruption, and 
their loss of function leads to oxidative stress-induced β-cell failure in mice. Mol. Cell. Biol., 
33(11), 2327–2338. 
Lee, N. K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J. D., Confavreux, C., Dacquin, R., Mee, P. J., McKee, 
M. D., Jung, D. Y., Zhang, Z., Kim, J. K., Mauvais-Jarvis, F., Karsenty, G., and Ducy, P. (2007). 
Endocrine regulation of energy metabolism by the skeleton. Cell, 130, 456–469. 
Lee, Y., Lee, J., Kwon, I., Nakajima, Y., Ohmiya, Y., Son, G. H., Lee, K. H., and Kim, K. (2010). 
Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock. 
J. Cell Sci., 123, 3547–3557. 
Lee, Y. S., Nakahara, K., Pham, J. W., Kim, K., He, Z., Sontheimer, E. J., and Carthew, R. W. (2004). 
Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell, 
117, 69-81. 
Lefebvre, V, Li, P., and de Crombrugghe, B. (1998). A new long form of Sox5 (L-Sox5), Sox6 and Sox9 
are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO 
J., 17(19), 5718–5733. 
Lefebvre, V. (2010). The SoxD transcription factors – Sox5, Sox6, and Sox13 – are key cell fate 
modulators. Int. Biochem. Cell Biol., 42, 429–432. 
Lefebvre, V., Zhou, G., Mukhopadhyay, K., Smith, C. N., Zhang, Z., Zhou, X., Sinha, S., and Maity, S .N. 
(1996). An 18-base-pair sequence in the mouse pro-α1 (II) collagen gene is sufficient for 
ix 
 
expression in cartilage and binds nuclear proteins that are selectively expressed in 
chondrocytes. Mol. Cell. Biol., 16, 4512 – 4523. 
Lehman, M. N., Silver, R., Gladstone, W. R., Kahn, R. M., Gibson, M., and Bittman, E. L. (1987). 
Circadian Rhythmicity lmmunocytochemical with the Host Brain Restored by Neural 
Transplant. Characterization of the Graft and Its Integration. J. Neurosci., 7(6), 1626–1638. 
Lewis, B., Burge, C., Bartel, D. (2005). Conserved seed pairing, often flanked by adenosines, indicates 
that thousands of human genes are microRNA targets. Cell, 120, 15-20. 
Li, Z., Kong, K., and Qi, W. (2006). Osteoclast and its roles in calcium metabolism and bone 
development and remodeling. Biochem. Biophys. Res. Comm., 343, 345–50. 
Litinski, M., Scheer, F. A., and Shea, S. A. (2009). Influence of the Circadian System on Disease 
Severity. Sleep Med. Clin., 4(2), 143–163. 
Liu, A. C., Tran, H. G., Zhang, E. E., Priest, A. A, Welsh, D. K., and Kay, S. A. (2008). Redundant function 
of REV-ERBα and β and non-essential role for Bmal1 cycling in transcriptional regulation of 
intracellular circadian rhythms. PLoS Genet., 4(2), e1000023. 
Liu, C., Li, S., Liu, T., Borjigin, J., and Lin, J. D. (2007). Transcriptional coactivator PGC-1alpha 
integrates the mammalian clock and energy metabolism. Nat., 447, 477–481. 
Liu, Y., Mochizuki, K., and Gorovsky, M. A. (2004). Histone H3 lysine 9 methylation is required for 
DNA elimination in developing macronuclei in Tetrahymena. PNAS. 101(6), 1679-1684. 
Locker, M., Kellermann, O., Boucquey, M., Khun, H., Huerre, M., and Poliard, A. (2004). Paracrine 
and autocrine signals promoting full chondrogenic differentiation of a mesoblastic cell line. J. 
Bone Miner. Res., 19(1), 100–110. 
Long, F., Schipani, E., Asahara, H., Kronenberg, H., and Montminy, M. (2001). The CREB family of 
activators is required for endochondral bone development. Dev., 128, 541–550. 
Lotz, M., Martel-Pelletier, J., Christiansen, C., Brandi, M.-L., Bruyère, O., Chapurlat, R., Collette, J., 
Cooper, C., Giacovelli, G., Kanis, J. A., Karsdal, M. A., Kraus, V., Lems, W. F., Meulnbelt, I., 
Pelletier, J.-P., Raynauld, J.-P., Reiter-Niesert, S., Rizzoli, R., Sandell, L. J., Van Spil, W. E., and 
Reginster, J.-Y. (2013). Value of biomarkers in osteoarthritis: current status and perspectives. 
Ann. Rheum. Dis., 72(11), 1756–1763. 
Lowrey, P. L., and Phillip L. Lowrey, Kazuhiro Shimomura, Marina P. Antoch, Shin Yamazaki, Peter D. 
Zemenides, Martin R. Ralph, Michael Menaker, J. S. T. (2000). Positional Syntenic Cloning and 
Functional Characterization of the Mammalian Circadian Mutation tau. Science, 288, 483–491. 
Luchavova, M., Zikan, V., Michalska, D., Jr, I. R., Kubena, A. A., and Stepan, J. J. (2011). The effect of 
timing of teriparatide treatment on the circadian rhythm of bone turnover in postmenopausal 
osteoporosis. Eu. J. Endocrin., 164, 643–648. 
LuValle, P., and Beier, F. (2000). Cell Cycle Control in Growth Plate Chondrocytes. Front. Biosci., 5, 
493–503. 
Macsai, C. E., Foster, B. K., Xian, C. J. (2008). Roles of Wnt signaling in bone growth, remodeling, 
skeletal disorders and fracture repair. J.  Cell Physiol., 215, 578-587. 
Marcheva, B., Ramsey, K. M., Buhr, E. D., Kobayashi, Y., Su, H., Ko, C. H., Ivanova, G., Omura, C., Mo, 
S., Vitaterna, M. H., Lopez, J. P., Philipson, L. H., Bradfield, C. A., Crosby, S. D., JeBailey, L., 
Wang, X., Takahashi, J. S., and Bass, J. (2010). Disruption of the clock components CLOCK and 
BMAL1 leads to hypoinsulinaemia and diabetes. Nat., 466, 627–631. 
Martel-pelletier, J., Boileau, C., and Roughley, P. J. (2008). Cartilage in normal and osteoarthritis 
conditions. Best Pract. Res. Clin. Rheumat., 22(2), 351–384. 
Mayer-Bernstein, E. L., Jetton, A. E., Matsumoto, S., Markuns, J. F., Lehman, M. N., and Bittman, E. 
L. (1999). Effects of Suprachiasmatic Transplants on Circadian Rhythms of Neuroendocrine 
Function in Golden Hamsters. Endocrin., 140(1), 207–218. 
x 
 
Masuda, T., Ogawa, H., Miyao, Y., Yu, Q., Misumi, I., Sakamoto, T., Okubo, H., Okumura, K., and Yasue, 
H. (1994) Circadian variation in fibrinolytic activity in patients with variant angina. Br. Heart J., 
71, 156-161. 
Maywood, E. S., Drynan, L., Chesham, J. E., Edwards, M. D., Dardente, H., Fustin, J.-M., Hazlerigg, D. 
G., O'Neill, J. S., Codner, G. F., Smyllie, N. J., Brancaccio, M., and Hastings, M. H. (2013). 
Analysis of core circadian feedback loop in suprachiasmatic nucleus of mCry1-luc transgenic 
reporter mouse. PNAS, 110(23), 9547–9552. 
McManus, M. T., and Sharp, P. A. (2002). Gene silencing in mammals by small interfering RNAs. Nat. 
Rev. Genet., 3, 737–747. 
Meister, B. (2007). Neurotransmitters in key neurons of the hypothalamus that regulate feeding 
behavior and body weight. Physiol. Behav., 92, 263–271.  
Melero-Martin, J. M., and Al-Rubeai, M. (2007). In Vitro expansion of chondrocytes. In Ashammakhi, 
N., Reis, R. and Chielini, E. (Ed.), Topics Tiss. Engin.. (Vol. 3, pp. 1–37). 
Mendoza, J., Graff, C., Dardente, H., Pevet, P., and Challet, E. (2005). Feeding cues alter clock gene 
oscillations and photic responses in the suprachiasmatic nuclei of mice exposed to a light/dark 
cycle. J. Neurosci., 25(6), 1514–1522. 
Meng, Q.-J., Logunova, L., Maywood, E. S., Gallego, M., Lebiecki, J., Brown, T. M., Sládek, M., 
Semikhodskii, A. S., Glossop, N. J., Piggins, H. D., Chesham, J. E., Bechtold, D.  A., Yoo, S.-H., 
Takahashi, J. S., Virshup, D. M., Boot-Handford, R. P., Hastings, M. H., and Loudon, A. S. I. 
(2008). Setting clock speed in mammals: the CK1 epsilon tau mutation in mice accelerates 
circadian pacemakers by selectively destabilizing PERIOD proteins. Neuron, 58, 78–88. 
Mette, M F, Aufsatz, W, van der Winden, J, Matzke, MA, Matzke, A J. (2000). Transcriptional silencing 
and promoter methylation triggered by double stranded RNA. EMBO J. 19(19), 5194-5201. 
Minina, E., Wenzel, H. M., Kreschel, C., Karp, S., Gaffield, W., McMahon, A. P., and Vortkamp, A. 
(2001). BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and 
differentiation. Dev., 128, 4523–4534. 
Mitsugi, S., Ariyoshi, W., Okinaga, T., Kaneuji, T., Kataoka, Y., Takahashi, T., and Nishihara, T. (2012). 
Mechanisms involved in inhibition of chondrogenesis by activin-A. Biochem. Biophys. Res. 
Comm., 420(2), 380–384. 
Miura, M., Tanaka, K., Komatsu, Y., Suda, M., Yasoda, A., Sakuma, Y., Ozasa, A., and Nakao, K. (2002). 
Thyroid hormones promote chondrocyte differentiation in mouse ATDC5 cells and stimulate 
endochondral ossification in fetal mouse tibias through Iodothyronine deiodinases in the 
rowth plate. J. Bone Mine. Res., 17(3), 443–454. 
Mochizuki, K., and Gorovsky, M. A. (2004). Conjugation-specific small RNAs in Tetrahymena have 
predicted properties of scan (scn) RNAs involved in genome rearrangement. Gen. Dev. 18(17), 
2068-2073. 
Moore, R. Y. (1989). The geniculohypothalamic tract in monkey and man. Brain Res., 486, 190–194.  
Moore, R. Y., and Speh, J. C. (1993). GABA is the principal neurotransmitter of the circadian system. 
Neurosci. Lett., 150, 112–116 
Moore, R. Y., and Speh, J. C. (1994). A putative retinohypothalamic projection containing substance 
P in the human. Brain Res., 659, 249–53. 
Moore, R. Y, Speh, J. C., and Leak, R. K. (2002). Suprachiasmatic nucleus organization. Cell Tiss. Res., 
309, 89–98. 
Moore, R. Y., and Klein, D. C. (1974). Visual pathways and the Central neural control of a Circadian 
rhythm in pineal serotonin N-Acetyl-transferase activity. Brain Res., 71, 17–33. 
Morin, L. P., and Blanchard, J. (1991). Depletion of brain serotonin by 5,7-DHT modifies hamster 
circadian rhythm response to light. Brain Res., 566, 173–185. 
xi 
 
Murakami, S., Kan, M., McKeehan, W. L., and de Crombrugghe, B. (2000). Up-regulation of the 
chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated 
protein kinase pathway. PNAS, 97(3), 1113–1118. 
Muratovska, A., and Eccles, M. R. (2004). Conjugate for efficient delivery of short interfering RNA 
(siRNA) into mammalian cells. FEBS Lett., 558, 63–68. 
Murre, C., McCaw, P. S., Vaessin, H., Caudy, M., Jan, L. Y., Jan, Y. N., Cabrera, C. V., Buskin, J. N ., 
Hauschka, S. D., Lassar, A. B., Weintraub, H., and Baltimore, D. (1989). Interactions between 
heterologous helix-loop-helix proteins generate complexes that bind specifically to a common 
DNA sequence. Cell, 58, 537–544. 
Nakahata, Y., Kaluzova, M., Grimaldi, B., Sahar, S., Hirayama, J., Chen, D., Guarente, L.  P., and 
Sassone-Corsi, P. (2008). The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated 
chromatin remodeling and circadian control. Cell, 134, 329–40. 
Nakamura, T. J., Nakamura, W., Yamazaki, S., Kudo, T., Cutler, T., Colwell, C. S., and Block, G. D. 
(2011). Age-related decline in circadian output. J. Neurosci., 31(28), 10201–10205. 
Nakamura, Y., Takarada, T., Kodama, A., Hinoi, E., and Yoneda, Y. (2009). Predominant promotion by 
tacrolimus of chondrogenic differentiation to proliferating chondrocytes. J. Pharmacol. Sci., 
109, 413-423. 
Nakashima, A., Kawamoto, T., Honda, K. K., Ueshima, T., Noshiro, M., Iwata, T., Fujimoto, K., Kubo, 
H., Honma, S., Yorioka, N., Kohno, N., and Kato, Y. (2008). DEC1 modulates the circadian phase 
of clock gene expression. Mol. Cell. Biol., 28(12), 4080–4092. 
Naqvi, A. R., Islam, M. N., Choudhury, N. R., and Haq, Q. M. R. (2009). The fascinating world of RNA 
interference. Int. J. Biol. Sci., 5(2), 97–117. 
Naruse, Y., Oh-hashi, K., Iijima, N., and Naruse, M. (2004). Circadian and Light-Induced Transcription 
of Clock Gene Per1 Depends on Histone Acetylation and Deacetylation Circadian and Light-
Induced Transcription of Clock Gene Per1 Depends on Histone Acetylation and Deacetylation. 
Mol. Cell. Biol., 24(14), 6278–6287. 
Newton, P. T., Staines, K. A., Spevak, L., Boskey, A. L., Teixeira, C. C., Macrae, V. E., Canfield, A. E., 
and Farquharson, C. (2012). Chondrogenic ATDC5 cells: An optimised model for rapid and 
physiological matrix mineralisation. Int. J. Mol. Med., 30, 1187–1193. 
Nickla, D.L., Rada, J.A., and Wallman, J. (1999). Isolated chick sclera shows a circadian rhythm in 
proteo- glycan synthesis perhaps associated with the rhythm in ocular elongation. J. Comp. 
Physiol. A., 185, 81-90. 
Noma, K., Sugiyama, T., Cam, H., Verdel, A., and Zofall, M. (2004). RITS acts in cis to promote RNA 
interference-mediated transcriptional and post-transcriptional silencing. Nat Genet. 36(11), 
1174-1180. 
Nomura, K., Takeuchi, Y., and Fukunaga, K. (2006). MAP kinase additively activates the mouse Per1 
gene promoter with CaM kinase II. Brain Res., 1118, 25–33. 
Oishi, K., Sakamoto, K., Okada, T., Nagase, T., and Ishida, N. (1998). Humoral signals mediate the 
circadian expression of rat period homologue (rPer2) mRNA in peripheral tissues. Neurosci. 
Lett., 256, 117–119. 
Okabe, M., and Graham, A. (2004). The origin of the parathyroid gland. PNAS, 101(51), 17716–17719. 
Ohkura, N., Oishi, K., Fukushima, N., Kasamatsu, M., Atsumi, G.I., Ishida, N., Horie, S., and Matsuda, 
J. (2006). Circadian clock molecules CLOCK and CRYs modulate fibrinolytic activity by 
regulating the PAI-1 gene expression. J. Thromb. Haemost., 4, 2478-2485. 
Oleksyszyn, J. and Augustine, A.J. (1996). Plasminogen modulation of IL-1-stimulated degradation in 
bovine and human articular cartilage explants. The role of the endogenous inhibitors: PAI-1, 
alpha 2-antiplasmin, alpha 1-PI, alpha 2-macroglobulin and TIMP. Inflamm. Res., 45, 464-472. 
xii 
 
Osawa, A., Kato, M., Matsumoto, E., Iwase, K., Sugimoto, T., Matsui, T., Ishikura, H., Sugano, S., 
Kurosawa, H., Takiguchi, M., and Seki, N. (2006). Activation of genes for growth factor and 
cytokine pathways late in chondrogenic differentiation of ATDC5 cells. Genomics, 88, 52–64. 
Oster, H. (2006). The genetic basis of circadian behavior. Genes, Brain, and Behavior, 5(suppl. 2), 73-
79. 
Oster, H., Damerow, S., Kiessling, S., Jakubcakova, V., Abraham, D., Tian, J., Hoffmann, M. W., and 
Eichele, G. (2006). The circadian rhythm of glucocorticoids is regulated by a gating mechanism 
residing in the adrenalcortical clock. Cell Metab., 4, 163–73. 
Ozbudak, E. M., and Pourquié, O. (2008). The vertebrate segmentation clock: the tip of the iceberg. 
Curr. Op. Genet. Dev., 18, 317–23. 
Pal-Bhadra, M., Bhadra, U., and Birchler, J. A. (2002). RNAi related mechanisms affect both 
transcriptional and posttranscriptional transgene silencing in Drosophila. Mol Cell. 9(2), 315-
327. 
Panda, S., Antoch, M. P., Miller, B. H., Su, A. I., Schook, A. B., Straume, M., Schultz, P. G., Kay, S. A., 
Takahashi, J.  S., and Hogenesch, J. B. (2002). Coordinated transcription of key pathways in the 
mouse by the circadian clock. Cell, 109, 307–20. 
Pando, M. P., Morse, D., Cermakian, N., and Sassone-Corsi, P. (2002). Phenotypic rescue of a 
peripheral clock genetic defect via SCN hierarchical dominance. Cell, 110, 107–117. 
Parfitt, A. M. (1976a). The Actions of Parathyroid Hormone on Bone: Relation to Bone Remodeling 
and Turnover, Calcium Homeostasis, and Metabolic Bone Diseases. Part I of IV Parts: 
Mechansim of Calcium TransferBetween Blood and Boneand Their Cellular Basis: 
Morphological and Kinetic Approaches to Bone Turnover. Metab., 25(7), 809–844. 
Parfitt, A. M. (1976b). The Actions of Parathyroid Hormone on Bone: Relation to Bone Remodeling 
and Turnover, Calcium Homeostasis, and Metabolic Bone Diseases. Part II of IV Parts: PTH and 
Bone Cells: Bone Turnover and Plasma Calcium Regulation. Metab., 25(8), 909–955. 
Parfitt, A. M. (1976c). The Actions of Parathyroid Hormone on Bone: Relation to Bone Remodeling 
and Turnover, Calcium Homeostasis, and Metabolic Bone Disease. Part III of IV Parts: PTH and 
Osteoblasts, the Relationship Between Bone Turnover and Bone Loss, and the State of the 
Bones in Primary Hyperparathyroidism. Metab., 25(9), 1033–1069. 
Partch, C. L., Shields, K. F., Thompson, C. L., Selby, C. P., and Sancar, A. (2006). Posttranslational 
regulation of the mammalian circadian clock by cryptochrome and protein phosphatase 5. 
PNAS, 103(27), 10467–10472. 
Pegoraro, M., and Tauber, E. (2008). The role of microRNAs (miRNA) in circadian rhythmicity. J. 
Genet., 87(5), 505–511. 
Pendergast, J. S., Friday, R. C., and Yamazaki, S. (2010). Distinct functions of Period2 and Period3 in 
the mouse circadian system revealed by in vitro analysis. PloS one, 5(1), e8552. 
Phornphutkul, C., Wu, K.-Y., and Gruppuso, P. A. (2006). The role of insulin in chondrogenesis. Mol. 
Cell. Endocrin., 249, 107–115. 
Pickard, G. E., Kahn, R., and Silver, R. (1984). Splitting of the Circadian Rhythm of Body Temperature 
in the Golden Hamster. Physiology and Behavior, 32, 763–766. 
Piggins, H. D., Antle, M. C., and Rusak, B. (1995). Neuropeptides Phase Shift the Mammalian 
Circadian Pacemaker. J. Neurosci., 15(8), 5612–5622. 
Pittendrigh, C. S. (1972). Circadian Surfaces and the Diversity of Possible Roles of Circadian 
Organization in Photoperiodic Induction. PNAS, 69(9), 2734–2737. 
Pittendrigh, C. S., and Daan, S. (1976). A Functional Analysis of Circadian Pacemakers in Nocturnal 




Podesta, J. E., and Kostarelos, K. (2009). Chapter 17 - Engineering Cationic Liposome: siRNA 
Complexes for In vitro and In vivo Delivery. In Nejat Düzgüneş, (Ed.), Methods in Enzymology, 
(Vol. 464, pp. 343–354), Burlington: Academic Press. 
Poole, K. E., and Reeve, J. (2005). Parathyroid hormone - a bone anabolic and catabolic agent. Curr. 
Op. Pharmacol., 5, 612–617. 
Preitner, N., Damiola, F., Zakany, J., Duboule, D., Albrecht, U., and Schibler, U. (2002). The Orphan 
Nuclear Receptor REV-ERB alpha Controls Circadian Transcription within the Positive Limb of 
the Mammalian Circadian Oscillator. Cell, 110, 251–260. 
Quintero, J. E., Kuhlman, S. J., and McMahon, D. G. (2003). The biological clock nucleus: a multiphasic 
oscillator network regulated by light. J. Neurosci., 23(22), 8070–8076. 
Ralph, M. R., and Menaker, M. (1988). A Mutation of the Circadian Systems in Golden Hamsters. 
Science, 241, 1225–1227. 
Ratajczak, C. K., Boehle, K. L., and Muglia, L. J. (2009). Impaired steroidogenesis and implantation 
failure in Bmal1-/- mice. Endocrin., 150(4), 1879–1885. 
Rattanakul, C., Lenbury, Y., Krishnamara, N., and Wollkind, D. J. (2003). Modeling of bone formation 
and resorption mediated by parathyroid hormone: response to estrogen/PTH therapy. Biosys., 
70, 55–72. 
Rea, M. A., Glass, J. D., and Cowell, C. S. (1994). Serotonin Modulates Photic Responses 
Suprachiasmatic Nuclei in the Hamster. J. Neurosci., 14(6), 3635–3642. 
Reale, M. E., Webb, I. C., Wang, X., Baltazar, R. M., Coolen, L. M., and Lehman, M. N. (2013). The 
transcription factor Runx2 is under circadian control in the suprachiasmatic nucleus and 
functions in the control of rhythmic behavior. PloS one, 8(1), e54317. 
Reddy, A. B., Wong, G. K. Y., O’Neill, J., Maywood, E. S., and Hastings, M. H. (2005). Circadian clocks: 
Neural and peripheral pacemakers that impact upon the cell division cycle. Mutation Res., 574, 
76–91. 
Refinetti, R., and Menaker, M. (1992). The circadian rhythm of body temperature. Physiol. Behav., 
51(3), 613–637. 
Reick, M., Garcia, J. a, Dudley, C., and McKnight, S. L. (2001). NPAS2: an analog of clock operative in 
the mammalian forebrain. Science, 293, 506–509. 
Renard, E., Porée, B., Chadjichristos, C., Kypriotou, M., Maneix, L., Bigot, N., Legendre, F., Ollitrault, 
D., De Crombrugghe, B., Malléin-Gérin, F., Moslemi, S., Demoor, M., Boumediene, K., and 
Galéra, P. (2012). Sox9/Sox6 and Sp1 are involved in the insulin-like growth factor-I-mediated 
upregulation of human type II collagen gene expression in articular chondrocytes. J. Mol. Med., 
90, 649–666. 
Reppert, S. M., and Weaver, D. R. (2001). Circadian Rhythms. Annu. Rev. Physiol., 63, 647–676. 
Reppert, S. M., and Weaver, D. R. (2002). Coordination of circadian timing in mammals. Nat., 418, 
935–941. 
Richter, H. G., Torres-Farfán, C., Rojas-García, P. P., Campino, C., Torrealba, F., and Serón-Ferré, M. 
(2004). The circadian timing system: making sense of day/night gene expression. Biol. Res., 
37(1), 11–28. 
Ripperger, J. A., and Schibler, U. (2006). Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs 
drives circadian Dbp transcription and chromatin transitions. Nat. Genet., 38(3), 369–374. 
Robson, H., Siebler, T., Stevens, D. A., Shalet, S. M., and Williams, G. R. (2000). Thyroid hormone acts 
directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit 
clonal expansion and cell proliferation. Endocrin., 141(10), 3887–3897. 
Roodman, G. D. (1999). Cell biology of the osteoclast. Exp. Hem., 27, 1229–1241. 
xiv 
 
Rosbash, M. (1995). Molecular control of circadian rhythms. Curr. Op. Genet. Dev., 5, 662–668. 
Roughley, P. J. (2006). The structure and function of cartilage proteoglycans. Eu. Cells Materials, 12, 
92–101. 
Rousseau, J.-C., and Delmas, P. D. (2007). Biological markers in osteoarthritis. Nat. Clin. Pract. 
Rheumat., 3(6), 346–56. 
Ruan, G.-X., Allen, G. C., Yamazaki, S., and McMahon, D. G. (2008). An autonomous circadian clock 
in the inner mouse retina regulated by dopamine and GABA. PLoS biology, 6(10), e249. 
Russell, J.E., Simmons, D.J., Huber, B., and Roos, B.A. (1983). Meal timing as a Zeitgeber for skeletal 
deoxyribonucleic acid and collagen synthesis rhythms. Endocrinology, 113, 2035-2042. 
Russell, J.E., Grazman, B., and Simmons, D.J. (1984). Mineralization in rat metaphyseal bone exhibits 
a circadian stage dependency. Proc. Soc. Exp. Biol. Med., 176, 342-345. 
Sadacca, L. A., Lamia, K. A., deLemos, A. S., Blum, B., and Weitz, C. J. (2011). An intrinsic circadian 
clock of the pancreas is required for normal insulin release and glucose homeostasis in mice. 
Diabetologia, 54, 120–124. 
Sahar, S., Zocchi, L., Kinoshita, C., Borrelli, E., and Sassone-Corsi, P. (2010). Regulation of BMAL1 
protein stability and circadian function by GSK3β-mediated phosphorylation. PloS one, 5(1), 
e8561. 
Sakamoto, A., Chen, M., Kobayashi, T., Kronenberg, H. M., and Weinstein, L. S. (2005). Chondrocyte-
specific knockout of the G protein G(s)α leads to epiphyseal and growth plate abnormalities 
and ectopic chondrocyte formation. J. Bone Mine. Res., 20(4), 663–671. 
Salter, D. M. (1998). The tissue we deal with: (II) Cartilage. Curr. Orthopae., 12, 251–257. 
Sato, F., Kawamoto, T., Fujimoto, K., Noshiro, M., Honda, K. K., Honma, S., Honma, K-I., and Kato, Y. 
(2004). Functional analysis of the basic helix-loop-helix transcription factor DEC1 in circadian 
regulation. Interaction with BMAL1. FEBS, 271, 4409–4419. 
Sato, S., Kimura, A., Ozdemir, J., Asou, Y., Miyazaki, M., Jinno, T., Ae, K., Liu, X., Osaki, M., Takeuchi, 
Y., Fukumoto, S., Kawaguchi, H., Haro, H., Shinomiya, K-I., Karsenty, G., and Takeda, S. (2008). 
The distinct role of the Runx proteins in chondrocyte differentiation and intervertebral disc 
degeneration. Findings in Murine Models and in Human Disease. Arthrit. Rheumat., 58(9), 
2764–2775. 
Sato, T. K., Panda, S., Miraglia, L. J., Reyes, T. M., Rudic, R. D., McNamara, P., Naik, K. A., FitzGerald, 
component of the mammalian circadian clock. Neuron, 43(4), 527–537. 
Sato, T. K., Yamada, R. G., Ukai, H., Baggs, J. E., Miraglia, L. J., Kobayashi, T. J., Welsh, D. K., Kay, S. A., 
Ueda, H. R., and Hogenesch, J. B. (2006). Feedback repression is required for mammalian 
circadian clock function. Nat. Genet., 38(3), 312–319. 
Schagat, T., Paguio, A., and Kopish, K. (2007). Normalizing Genetic reporter assays: Approaches and 
considerations for increasing consistency and statistical significant. Cell Notes, (17), 9–12. 
Schibler, U., Ripperger, J., and Brown, S. A. (2003). Peripheral Circadian Oscillators in Mammals : 
Time and Food. J. Biol. Rhythms, 18(3), 250–260. 
Schofield, B. H., Williams, B. R., and Doty, S. B. (1975). Alcian Blue staining of cartilage for electron 
microscopy. Application of the critical electrolyte concentration principle. Histochemical J., 7, 
139–149. 
Sekiya, I., Tsuji, K., Koopman, P., Watanabe, H., Yamada, Y., Shinomiya, K., Nifuji, A., and Noda, M. 
(2000). SOX9 Enhances Aggrecan Gene Promoter/Enhancer Activity and Is Up-regulated by 
Retinoic Acid in a Cartilage-derived Cell Line, TC6. J. Biol. Chem., 275(15), 10738–10744. 
xv 
 
Seriwatanachai, D., Krishnamra, N., and Charoenphandhu, N. (2012). Chondroregulatory action of 
prolactin on proliferation and differentiation of mouse chondrogenic ATDC5 cells in 3-
dimensional micromass cultures. Biochem. Biophys. Res. Comm., 420, 108–113. 
Shackel, N. A. (2009). Liver “tick tock”. Hepatol., 50(4), 1310–1311. 
Shearman, L P, Zylka, M. J., Reppert, S. M., and Weaver, D. R. (1999). Expression of basic helix-loop-
helix/PAS genes in the mouse suprachiasmatic nucleus. Neurosci., 89(2), 387–397. 
Shearman, L. P., Sriram, S., Weaver, D. R., Maywood, E. S., Chaves, I., Zheng, B., Kume, K., Lee, C. C., 
van der Horst, G. T., Hastings, M. H., and Reppert, S. M. (2000). Interacting Molecular Loops 
in the Mammalian Circadian Clock. Science, 288, 1013–1019. 
Shi, G., Xing, L., Liu, Z., Qu, Z., Wu, X., Dong, Z., Wang, X., Gao, X., Huang, M., Yan, J., Yang, L., Liu, Y., 
Ptácek, L. J., and Xu, Y. (2013). Dual roles of FBXL3 in the mammalian circadian feedback loops 
are important for period determination and robustness of the clock. PNAS, 110(12), 4750–
4755. 
Shimba, S., Ishii, N., Ohta, Y., Ohno, T., Watabe, Y., Hayashi, M., Wada, T., Aoyagi, T., and Tezuka, M. 
(2005). Brain and muscle Arnt-like protein-1 (BMAL1), a component of the molecular clock, 
regulates adipogenesis. PNAS, 102(34), 12071–12076. 
Shinohara, K., Honma, S., Katsuno, Y., Abe, H., and Honma, K. (1995). Two distinct oscillators in the 
rat suprachiasmatic nucleus in vitro. PNAS, 92(16), 7396–7400. 
Shukunami, C., Ishizeki, K., Atsumi, T., Ohta, Y., Suzuki, F., and Hiraki, Y. (1997). Cellular Hypertrophy 
and Calcification of Embryonal Carcinoma-Derived Chondrogenic Cell Line ATDC5 In Vitro. J. 
Bone Mine. Res., 12(8), 1174–1188. 
Shukunami, C., Ohta, Y., Sakuda, M., and Hiraki, Y. (1998). Sequential progression of the 
differentiation program by bone morphogenetic protein-2 in chondrogenic cell line ATDC5. 
Exp. Cell Res., 241, 1–11. 
Shukunami, C., Shigeno, C., Atsumi, T., Ishizeki, K., Suzuki, F., and Hiraki, Y. (1996). Chondrogenic 
Differentiation of Clonal Mouse Embryonic Cell Line ATDC5 In Vitro: Differentiation-
dependent Gene Expression of Parathyroid Hormone (PTH)/PTH-related Peptide Receptor. J. 
Cell Biol., 133(2), 457–468. 
Simmons, D.J. (1964). Circadian Mitotic Rhythm in Epiphyseal Cartilage. Nat., 202, 906-907. 
Simmons, D.J. (1966). Periodicity of S35 uptake in rat femurs. Experientia, 20, 137-138. 
Simmons, D.J. (1974). Chronobiology of endochondral ossification. Chronobiologia, 1, 97-109. 
Smits, P., Dy, P., Mitra, S., and Lefebvre, V. (2004). Sox5 and Sox6 are needed to develop and 
maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth plate. J. 
Cell Biol., 164(5), 747–758. 
Smits, P., P. Li, Mandel, J., Zhang, Z., Deng, J. M., Behringer, R. R., de Crombrugghe, B., and Lefebvre, 
V. (2001). The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev. 
Cell, 1, 277–290. 
Staines, K. A., Pollard, A. S., McGonnell, I. M., Farquharson, C., and Pitsillides, A. A. (2013). Cartilage 
to bone transition in health and disease. J Endocrin., 219(1), R1–12. 
Stavreva, D. A., Wiench, M., John, S., Conway-Campbell, B. L., McKenna, M. A., Pooley, J. R., Johnson, 
T. A., Voss, T. C., Lightman, S. L., and  Hager, G. L. (2009). Ultradian hormone stimulation 
induces glucocorticoid receptor-mediated pulses of gene transcription. Nat. Cell Biol., 11(9), 
1093–1102. 
St-Jacques, B., Hammerschmidt, M., and McMahon, A. P. (1999). Indian hedgehog signaling 
regulates proliferation and differentiation of chondrocytes and is essential for bone formation. 
Gen. Dev., 13, 2072–2086. 
xvi 
 
Stolt, C. C., Lommes, P., Sock, E., Chaboissier, M.-C., Schedl, A., and Wegner, M. (2003). The Sox9 
transcription factor determines glial fate choice in the developing spinal cord. Gen. Dev., 17, 
1677–1689. 
Stolt, C. C., Schlierf, A., Lommes, P., Hillgärtner, S., Werner, T., Kosian, T., Sock, E., Kessaris, N., 
Richardson, W. D., Lefebvre, V., and Wegner, M. (2006). SoxD proteins influence multiple 
stages of oligodendrocyte development and modulate SoxE protein function. Dev. Cell, 11, 
697–709. 
Stricker, S., Fundele, R., Vortkamp, A., and Mundlos, S. (2002). Role of Runx genes in chondrocyte 
differentiation. Dev. Biol., 245, 95–108. 
Sumová, A., Bendová, Z., Sládek, M., Kováciková, Z., and Illnerová, H. (2004). Seasonal molecular 
timekeeping within the rat circadian clock. Physiol. Res., 53, S167–176. 
Suva, L. J., Winslow, G. a, Wettenhall, R. E., Hammonds, R. G., Moseley, J. M., Diefenbach-Jagger, H., 
Rodda, C. P., Kemp, B. E., Rodriguez, H., and Chen, E. Y. (1987). A parathyroid hormone-related 
protein implicated in malignant hypercalcemia: cloning and expression. Science, 237, 893–896. 
Takahashi, I., Nuckolls, G. H., Takahashi, K., Tanaka, O., Semba, I., Dashner, R., Shum, L., and Slavkin, 
H. C. (1998). Compressive force promotes Sox9, type II collagen and aggrecan and inhibits IL-
1 β expression resulting in chondrogenesis in mouse embryonic limb bud mesenchymal cells. 
J. Cell Sci., 111, 2067–2076. 
Takahata, S., Ozaki, T., Mimura, J., Kikuchi, Y., Sogawa, K., and Fujii-Kuriyama, Y. (2000). 
Transactivation mechanisms of mouse clock transcription factors, mClock and mArnt3. Gen. 
Cells, 5, 739–747. 
Takano, A., Isojima, Y., and Nagai, K. (2004). Identification of mPer1 phosphorylation sites 
responsible for the nuclear entry. J. Biol. Chem., 279, 32578–32585. 
Takarada, T., Hinoi, E., Takahata, Y., and Yoneda, Y. (2008). Serine racemase suppresses 
chondrogenic differentiation in cartilage in a Sox9-dependent manner. J. Cell. Physiol., 215, 
320–328. 
Takarada, T., Kodama, A., Hotta, S., Mieda, M., Shimba, S., Hinoi, E., and Yoneda, Y. (2012). Clock 
Genes Influence Gene Expression in Growth Plate and Endochondral Ossification in Mice. J. 
Biol. Chem., 287, 36081–36095. 
Tamaru, T., Hirayama, J., Isojima, Y., Nagai, K., Norioka, S., Takamatsu, K., and Sassone-Corsi, P. 
(2009). CK2α phosphorylates BMAL1 to regulate the mammalian clock. Nat. Struct. Mol. Biol., 
16(4), 446–448. 
Tare, R. S., Babister, J. C., Kanczler, J., and Oreffo, R. O. C. (2008). Skeletal stem cells: phenotype, 
biology and environmental niches informing tissue regeneration. Mol. Cell. Endocrin., 288, 11–
21. 
Tavella, S., Biticchi, R., Schito, A., Minina, E., Di Martino, D., Pagano, A., Vortkamp, A., Horton, W. A., 
Cancedda, R., and Garofalo, S. (2004). Targeted expression of SHH affects chondrocyte 
differentiation, growth plate organization, and Sox9 expression. J. Bone Mine. Res., 19(10), 
1678–1688. 
Taverna, S. D., Coyne, R. S., Allis, C. D. (2002). Methylation of histone h3 at lysine 9 targets 
programmed DNA elimination in Tetrahymena. Cell. 110, 701-711. 
Toh, K. L. (2001). An hPer2 Phosphorylation Site Mutation in Familial Advanced Sleep Phase 
Syndrome. Science, 291, 1040–1043. 
Tonna, E. A., Singh, I. J., and Sandhu, H. S. (1987). Autoradiographic investigation of circadian 
rhythms in alveolar bone periosteum and cementum in young mice. Histol. Histopath., 2, 129–
133. 




Tousson, E., and Meissl, H. (2004). Suprachiasmatic nuclei grafts restore the circadian rhythm in the 
paraventricular nucleus of the hypothalamus. J. Neurosci., 24(12), 2983–2988. 
Travnickova-Bendova, Z., Cermakian, N., Reppert, S. M., and Sassone-Corsi, P. (2002). Bimodal 
regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity. 
PNAS, 99(11), 7728–7733. 
Ueda, H. R., Hayashi, S., Chen, W., Sano, M., Machida, M., Shigeyoshi, Y., Iino, M., and Hashimoto, S. 
(2005). System-level identification of transcriptional circuits underlying mammalian circadian 
clocks. Nat. Genet., 37(2), 187–192. 
Uno, K., Takarada, T., Nakamura, Y., Fujita, H., Hinoi, E., and Yoneda, Y. (2011). A Negative 
Correlation Between Expression Profiles of Runt-Related Transcription Factor-2 and 
Cystine/Glutamate Antiporter xCT Subunit in Ovariectomized Mouse Bone. J. Pharmacol. Sci., 
115, 309–319. 
Urano, T., Sumiyoshi, K., Nakamura, M., Mori, T., Takada, Y., and Takada, A. (1990) Fluctuation of 
tPA and PAI-1 antigen levels in plasma: difference of their fluctuation patterns between male 
and female. Thromb. Res., 60, 133-139. 
Vallone, D., Gondi, S. B., Whitmore, D., and Foulkes, N. S. (2004). E-box function in a period gene 
repressed by light. PNAS, 101(12), 4106–4111. 
van Donkelaar, C. C., and Wilson, W. (2012). Mechanics of chondrocyte hypertrophy. Biomech. 
Model. Mechanobiol., 11, 655–664. 
Vieira, E., Marroquí, L., Batista, T. M., Caballero-Garrido, E., Carneiro, E. M., Boschero, A. C., Nadal, 
A., and Quesada, I. (2012). The clock gene Rev-erbα regulates pancreatic β-cell function: 
modulation by leptin and high-fat diet. Endocrin., 153(2), 592–601. 
Vieira, E., Nilsson, E. C., Nerstedt, A., Ormestad, M., Long, Y. C., Garcia-Roves, P. M., Zierath, J. R., 
and Mahlapuu, M. (2008). Relationship between AMPK and the transcriptional balance of 
clock-related genes in skeletal muscle. Am. J. Physiol. Endocrin. Metab., 295, E1032–7. 
Villemure, I., and Stokes, I. A. F. (2009). Growth plate mechanics and mechanobiology. A survey of 
present understanding. J. Biomech., 42, 1793–1803. 
Vincent, K. J. (2001). Regulation of E-box DNA binding during in vivo and in vitro activation of rat and 
human hepatic stellate cells. Gut, 49, 713–719. 
Viola, A. U., Archer, S. N., James, L. M., Groeger, J. a, Lo, J. C. Y., Skene, D. J., von Schantz, M., and 
Dijk, D.-J. (2007). PER3 polymorphism predicts sleep structure and waking performance. Curr. 
Biol., 17, 613–618. 
Virshup, D. M., Eide, E. J., Forger, D. B., Gallego, M., and Harnish, E. V. (2007). Reversible protein 
phosphorylation regulates circadian rhythms. Cold Spring Harb. Symp. Quant. Biol., 72, 413–
20. 
Vitaterna, M. H., Selby, C. P., Todo, T., Niwa, H., Thompson, C., Fruechte, E. M., Hitomi, K., Thresher, 
R. J., Ishikawa, T., Miyazaki, J., Takahashi, J. S., and Sancar, A. (1999). Differential regulation of 
mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. PNAS, 96(21), 
12114–12119. 
Vitaterna, M. H., King, D. P., Chang, A., Kornhauser, J. M., Lowrey, P. L., Mcdonald, J. D., Dove, W. F., 
Pinto, L. H., Turek, F. W., and Takahashi, J. S. (1994). Mutagenesis and Mapping of a Mouse 
Gene, Clock, Essential for Circadian Behavior. Science, 264, 719–725. 
Volpe, T A, Kidner, C, Hall, I M, et al. (2002). Regulation of heterchromatic silencing and histone H3 
lysine-9 methylation by RNAi. Science. 297, 1833-1837. 
Von Gall, C., Garabette, M. L., Kell, C. a, Frenzel, S., Dehghani, F., Schumm-Draeger, P.-M., Weaver, 
D. R., Korf, H.-W., Hastings, M. H., and Stehle, J. H. (2002). Rhythmic gene expression in 
pituitary depends on heterologous sensitization by the neurohormone melatonin. Nat. 
Neurosci., 5(3), 234–238. 
xviii 
 
Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J., Bricarelli, F. D., Keutel, 
J., Hustert, E., Wolf, U., Tommerup, N., Schempp, W., and Scherer, G. (1994). Autosomal sex 
reversal and campomelic dysplasia are caused by mutations in and around the SRY-related 
gene SOX9. Cell, 79, 1111–1120. 
Wasi, S. (2003). RNA interference: The next genetics revolution? Understanding the RNAissance, 1–
4. 
Weinstein, L. S., Yu, S., Warner, D. R., and Liu, J. (2001). Endocrine manifestations of stimulatory G 
protein α-subunit mutations and the role of genomic imprinting. Endocrin. Rev., 22(5), 675–
705. 
Weir, E. C., Philbrickt, W. M., Amlingt, M., Neffi, L. A., Barons, R., and Broadus, Arthur E. (1996). 
Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes 
chondrodysplasia and delayed endochondral bone formation. PNAS, 93, 10240–10245. 
Welsh, D. K., Logothetis, D. E., Meister, M., and Reppert, S. M. (1995). Individual neurons dissociated 
from rat suprachiasmatic nucleus express independently phased circadian firing rhythms. 
Neuron, 14, 697–706. 
Welsh, D. K. (2007). VIP Activates and Couples Clock Cells. Focus on “Disrupted Neuronal Activity 
Rhythms in the Suprachiasmatic Nucleus of Vasoactive Intestinal Polypeptide-Deficient Mice.” 
J. Neurophysiol., 97, 1885–1886. 
Wilson, M., and Koopman, P. (2002). Matching SOX : partner proteins and co-factors of the SOX 
family of transcriptional regulators. Curr. Op.Genet. Dev., 12, 441–446. 
Wu, X., Yu, G., Parks, H., Hebert, T., Goh, B. C., Dietrich, M. A., Pelled, G., Izadpanah, R., Gazit, D., 
Bunnell, B. A., and Gimble, J. M. (2008). Circadian mechanisms in murine and human bone 
marrow mesenchymal stem cells following dexamethasone exposure. Bone, 42, 861–870. 
Xu, Y., Padiath, Q. S., Shapiro, R. E., Jones, C. R., Wu, S. C., Saigoh, N., Ptácek, L. J., and Fu, Y.-H. (2005). 
Functional consequences of a CKIδ mutation causing familial advanced sleep phase syndrome. 
Nat., 434, 640–644. 
Yamaguchi, S, Mitsui, S., Yan, L., Yagita, K., Miyake, S., and Okamura, H. (2000). Role of DBP in the 
circadian oscillatory mechanism. Mol. Cell. Biol., 20(13), 4773–4781. 
Yamaguchi, S., Mitsui, S., Miyake, S., Yan, L., Onishi, H., Yagita, K., Suzuki, M., Shibata, S., Kobayashi, 
M., and Okamura, H. (2000). The 5’ upstream region of mPer1 gene contains two promoters 
and is responsible for circadian oscillation. Curr. Biol., 10, 873–876. 
Yamaguchi, S., Isejima, H., Matsuo, T., Okura, R., Yagita, K., Kobayashi, M., and Okamura, H. (2003). 
Synchronization of cellular clocks in the suprachiasmatic nucleus. Science, 302, 1408–1412. 
Yamajuku, D., Shibata, Y., Kitazawa, M., Katakura, T., Urata, H., Kojima, T., Nakata, O., and Hashimoto, 
S. (2010). Identification of functional clock-controlled elements involved in differential timing 
of Per1 and Per2 transcription. Nucleic acids Res., 38(22), 7964–7973. 
Yamamoto, K. K., Gonzalez, G. A., Menzel, P., Rivier, J., and Montminy, M. R. (1990). Characterization 
in Transcription of a Bipartite Activator Factor CREB. Cell, 60, 611–617. 
Yamashita, A., Ito, M., Takamatsu, N., and Shiba, T. (2000). Characterization of Solt, a novel SoxLZ / 
Sox6 binding protein expressed in adult mouse testis. FEBS Lett., 481, 147–151. 
Yamazaki, S., Kerbeshian, M. C., Hocker, C. G., Block, G. D., and Menaker, M. (1998). Rhythmic 
properties of the hamster suprachiasmatic nucleus in vivo. J. Neurosci., 18(24), 10709–10723. 
Yan, J., Wang, H., Liu, Y., and Shao, C. (2008). Analysis of gene regulatory networks in the mammalian 
circadian rhythm. PLoS Comput. Biol., 4(10), e1000193. 
Yang, H. N., Park, J. S., Woo, D. G., Jeon, S. Y., Do, H.-J., Lim, H.-Y., Kim, S. W., Kim, J. H., and Park, K.-
H. (2011). Chondrogenesis of mesenchymal stem cells and dedifferentiated chondrocytes by 
transfection with SOX Trio genes. Biomaterials, 32, 7695–7704. 
xix 
 
Yao, Y., and Wang, Y. (2013). ATDC5: an excellent in vitro model cell line for skeletal development. 
J. Cell. Biochem., 114, 1223–1229. 
Yin, L., and Lazar, M. A. (2005). The orphan nuclear receptor Rev-erα recruits the N-CoR/histone 
deacetylase 3 corepressor to regulate the circadian Bmal1 gene. Mol. Endocrin., 19(6), 1452–
1459. 
Yoo, S.-H., Yamazaki, S., Lowrey, P. L., Shimomura, K., Ko, C. H., Buhr, E. D., Siepka, S. M., Hong, H.-
K., Oh, W. J., Yoo, O.  J., Menaker, M., and Takahashi, J. S. (2004). PERIOD2::LUCIFERASE real-
time reporting of circadian dynamics reveals persistent circadian oscillations in mouse 
peripheral tissues. PNAS, 101(15), 5339–5346. 
Yoshida, C. A., Yamamoto, H., Fujita, T., Furuichi, T., Ito, K., Inoue, K., Yamana, K., Zanma, A., Takada, 
K., Ito, Y., and Komori, T. (2004). Runx2 and Runx3 are essential for chondrocyte maturation, 
and Runx2 regulates limb growth through induction of Indian hedgehog. Gen. Dev., 18, 952–
963. 
Zhang, L., Weng, W., and Guo, J. (2011). Posttranscriptional mechanisms in controlling eukaryotic 
circadian rhythms. FEBS Lett., 585, 1400–1405. 
Zheng, B., Albrecht, U., Kaasik, K., Sage, M., Lu, W., Vaishnav, S., Li, Q., Sun, Z. S., Eichele, G., Bradley, 
A., and Lee, C. C. (2001). Nonredundant roles of the mPer1 and mPer2 genes in the 
mammalian circadian clock. Cell, 105, 683–694. 
Zheng, B., Larkin, D. W., Albrecht, U., Sun, Z. S., Sage, M., Eichele, G., Lee, C. C., and Bradley, A. (1999). 
The mPer2 gene encodes a functional component of the mammalian circadian clock. Nat., 400, 
169–173. 
Zhou, G., Garofalo, S., Mukhopadhyay, K., Lefebvre, V., Smith, C. N., Eberspaecher, H., and de 
Crombrugghe, B. (1995). A 182 bp fragment of the mouse pro α1(II) collagen gene is sufficient 
to direct chondrocyte expression in transgenic mice. J. Cell Sci., 108, 3677–3684. 
Zhou, G., Lefebvre, V., Zhang, Z., Eberspaecher, H., and de Crombrugghe, B. (1998). Three High 
Mobility Group-like Sequences within a 48-Base Pair Enhancer of the Col2a1 Gene Are 
Required for Cartilage-specific Expression in Vivo. J. Biol. Chem., 273, 14989–14997. 
Zhou, H., Mak, W., Kalak, R., Street, J., Fong-Yee, C., Zheng, Y., Dunstan, C. R., and Seibel, M. J. (2009). 
Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial 
skeletal development in mice. Dev., 136, 427–36. 
Zhou, Y.-D., Barnard, M., Tan, H., Li, X., Ring, H. Z., Francke, U., Shelton, J., Richardson, J., Russell, D. 
W., and Knight, S. L. M. (1997). Molecular characterization of two mammalian bHLH-PAS 
domain protein selectively expressed in the central nervous system. PNAS, 94, 713–718. 
Zimmerman, W. F., Pittendrigh, C. S., and Pavlidis, T. (1968). Temperature compensation of the 
circadian oscillation in Drosophila pseudoobscura and its entrainment by temperature cycles. 
J. Insect Physiol., 14, 669–684. 
Zylka, M. J., Shearman, L. P., Levine, J. D., Jin, X., Weaver, D. R., and Reppert, S. M. (1998). Molecular 
analysis of mammalian timeless. Neuron, 21, 1115–1122. 
Zylka, M. J., Shearman, L. P., Weaver, D. R., and Reppert, S. M. (1998). Three period homologs in 
mammals: differential light responses in the suprachiasmatic circadian clock and oscillating 
transcripts outside of brain. Neuron, 20, 1103–1110. 
Zvonic, S., Ptitsyn, A.A., Kilroy, G., Wu, X., Conrad, S.A., Scott, L.K., Guilak, F., Pelled, G., Gazit, D., and 
Gimble, J.M. (2007) Circadian oscillation of gene Circadian rhythms in cartilage expression in 
murine calvarial bone. J. Bone Miner. Res. 22. 357-365. 
